	Archives	Search NLM Web Site NLM Home \| About the Archives
Home > NLM Archives > Document content is not current. Links may be broken.

Current Bibliographies in Medicine 93-4

Morbidity and Mortality of Dialysis

CBM 93-4

January 1991 through August 1993

2115 Citations

Prepared by

Martha H. Glock, M.L.S., National Library of Medicine

Willis R. Foster, M.D., Benjamin T. Burton, Ph.D., and
M. James Scherbenske, Ph.D., National Institute of
Diabetes and Digestive and Kidney Diseases

U.S. DEPARTMENT OF HEALTH
AND HUMAN SERVICES
Public Health Service
National Institutes of Health

National Library of Medicine
Reference Section
8600 Rockville Pike
Bethesda, Maryland 20894

1993

SERIES NOTE

Current Bibliographies in Medicine (CBM) is a continuation in part of the
National Library of Medicine's Literature Search Series, which ceased in 1987
with No. 87-15. In 1989 it also subsumed the Specialized Bibliography Series.
Each bibliography in the new series covers a distinct subject area of biomedicine
and is intended to fulfill a current awareness function. Citations are usually
derived from searching a variety of online databases. NLM databases utilized
include MEDLINE, AVLINE, BIOETHICSLINE, CANCERLIT, CATLINE, HEALTH, POPLINE and
TOXLINE. The only criterion for the inclusion of a particular published work is
its relevance to the topic being presented; the format, ownership, or location
of the material is not considered.

Comments and suggestions on this series may be addressed to:

                  Karen Patrias, Editor
                  Current Bibliographies in Medicine
                  Reference Section
                  National Library of Medicine
                  Bethesda, MD 20894
                  Phone: 301-496-6097
                  Fax: 301-402-1384
                  Internet: patrias@nlm.nih.gov

Ordering Information:

Current Bibliographies in Medicine is sold by the Superintendent of Documents,
U.S. Government Printing Office, P.O. 371954, Pittsburgh, PA 15250-7954. To
order the entire CBM series for calendar year 1993 (approximately 7
bibliographies), send $24.00 ($30.00 foreign) to the Superintendent of Documents
citing GPO List ID: CBM93. For your convenience an order blank is given inside
the back cover. Orders for individual bibliographies in the series ($3.50, $4.38
foreign) should be sent to the Superintendent of Documents citing the title, CBM
number, and the GPO List ID given above.

Internet Access:

The Current Bibliographies in Medicine series is also available at no cost to
anyone with Internet access through FTP (File Transfer Protocol). FTP to
nlmpubs.nlm.nih.gov and login: as nlmpubs. The index file in the "bibs"
directory provides information on the bibliographies available.

Use of funds for printing this periodical has been approved by the Director of
the Office of Management and Budget through September 30, 1993.

MORBIDITY AND MORTALITY OF DIALYSIS

Each year, increasing numbers of people with irreversible end stage renal failure
are treated under the United States Medicare ESRD (End-Stage Renal Disease)
programs. Contributing to an increase in the overall size of the national ESRD
program is the increased acceptance of patients, a greater incidence among older
Americans, and an improvement in the survival of patients with ESRD. For
example, during 1990 more than 195,000 Americans were treated for end-stage renal
disease under the Medicare program.

There has been a small but significant improvement in survival in the dialytic
population, first seen over the period of 1988-89 and which has continued over
1989-90. Because of the continuing interest in the adequacy of dialysis therapy
and its impact on mortality, this trend is of particular importance to the renal
community. The question of what constitutes an adequate dialysis dose, however,
remains a very controversial issue among renal care professionals.

This bibliography was prepared in support of the National Institutes of Health
Consensus Development Conference titled Morbidity and Mortality of Dialysis
convened in Bethesda, Maryland on November 1-3, 1993. The purpose of the
Conference was to examine all of the relevant data concerning the delivery of
maintenance dialysis and the management of associated life-threatening
complications. The citations were selected to cover various aspects of dialysis,
including dialysis complications, co-morbidity, adequacy, and causes and
prevention.

The bibliography consists primarily of English language journal articles from
January 1991 through August 1993. The 2115 citations included were individually
selected from a total of 5419 generated by a search of the literature. In
general, books, case reports, letters and editorials have been excluded.

Arrangement of the bibliography is by subject. The four main categories are:
Causes and Prevention of Morbidity and Mortality, including data on risk factors,
role of nutrition, data on outcomes; Adequacy of Dialysis: Access and Dose,
including catheter and membrane studies, hemodynamics and factors affecting blood
flow and volume; Co-Morbidity; and Complications of Dialysis, including pre-
existing, and other non-dialytic morbidity, especially cardiovascular, diabetic
and parathyroid conditions. Within each category, references to controlled
clinical trials have been separated out and are listed first. A citation may
appear in more than one category.

SEARCH STRATEGY

A variety of online databases are usually searched in preparing bibliographies
in the CBM series. To assist you in updating or otherwise manipulating the
material in this search, the strategy used for the NLM's MEDLINE database is
given below. Please note that the search strategies presented here differ from
individual demand searches in that they are generally broadly formulated and
irrelevant citations edited out prior to printing.

SS 1 = SUBS APPLY AE, CO, IS, ME, TD, PX, UT

SS 1 = EXPLODE HEMODIALYSIS

SS 2 = SUBS CANCEL

SS 2 = EXPLODE HEMODIALYSIS

SS 3 = 2 AND MORTALITY (SH) OR 2 AND MORBIDITY OR 2 AND
COMPLICATIONS (SH) OR 2 AND CONTRAINDICATIONS (SH) OR
2 AND IATROGENIC (TW) OR 2 AND QUALITY OF LIFE

SS 4 = VENOUS (TW) AND ACCESS (TW) OR VASCULAR (TW) AND
ACCESS (TW)

SS 5 = 2 AND 4

SS 6 = HEMODIALYSIS (TF) OR PERITONEAL (TF) AND DIALYSIS (TF)

SS 7 = 2 AND 6

SS 8 = 7 AND KIDNEY FAILURE OR 7 AND KIDNEY FAILURE, CHRONIC OR 7 AND
PREDIALYSIS (TW) OR 7 AND CATHETERS, INDWELLING OR 7 AND
EXPLODE CATHETERIZATION OR 7 AND EXPLODE OUTCOME ASSESSMENT

SS 9 = CATHETERS, INDWELLING AND BALLOON ANGIOPLASTY

SS 10 = SUBS APPLY AE, TO

SS 10 = DIALYSIS SOLUTIONS

SS 11 = SUBS CANCEL

SS 11 = 1 OR 3 OR 5 OR 8 OR 9 OR 10

GRATEFUL MED

To make online searching easier and more efficient, the Library offers GRATEFUL
MED, microcomputer-based software that provides a user-friendly interface to most
NLM databases. This software was specifically developed for health professionals
and features multiple choice menus and "fill in the blank" screens for easy
search preparation. GRATEFUL MED runs on an IBM PC (or IBM-compatible) with DOS
2.0 or a Macintosh, and requires a Hayes (or Hayes-compatible) modem. It may be
purchased from the National Technical Information Service in Springfield,
Virginia, for $29.95 (plus $3.00 per order for shipping). For your convenience,
an order blank has been enclosed at the back of this bibliography.

SAMPLE CITATION

Citations in this bibliographic series are formatted according to the rules
established for Index Medicus*. A sample journal citation appears below.

Journal Article:

Authors Article Title

Rubin J, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one
facility.
Am J Kidney Dis 1991 Feb;17(2):165-9.

Abbreviated Journal Date Volume Issue Pages
Title

_________________________________

*For details of the formats used for references, see the following publication:

Patrias, Karen. National Library of Medicine recommended formats for
bibliographic citation. Bethesda (MD): The Library; 1991 Apr. Available from:
NTIS, Springfield, VA; PB91-182030.

TABLE OF CONTENTS

CAUSES AND PREVENTION OF MORBIDITY AND MORTALITY

            Data on Risk Factors
                  Clinical Trials
                  Other
            The Role of Nutrition
                  Clinical Trial
                  Other
            Data on Outcomes
                  Clinical Trial
                  Other

ADEQUACY OF DIALYSIS: ACCESS AND DOSE

Clinical Trials
Other

CO-MORBIDITY

Clinical Trials
Other

COMPLICATIONS OF DIALYSIS

            Anemia and Erythropoietin
                  Clinical Trials
                  Other
            Peritonitis
                  Clinical Trials
                  Other
            Other Dialysis-Related Problems
                  Clinical Trials
                  Other

CAUSES AND PREVENTION OF MORBIDITY AND MORTALITY

Data on Risk Factors

-Clinical Trials

Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and MAC-1 during
dialysis--a prospective, randomized controlled trial. Kidney Int 1992
Feb;41(2):388-95.

Kramer BK, Pickert A, Hohmann C, Liebich HM, Muller GA, Hablitzel M, Risler T.
In vivo clearance and elimination of nine marker substances during hemofiltration
with different membranes. Int J Artif Organs 1992 Jul;15(7):408-12.

Nurmohamed MT, ten Cate J, Stevens P, Hoek JA, Lins RL, ten Cate JW. Long-term
efficacy and safety of a low molecular weight heparin in chronic hemodialysis
patients. A comparison with standard heparin. ASAIO Trans 1991 Jul-
Sep;37(3):M459-61.

Ring T, Nielsen C, Andersen SP, Behrens JK, Sodemann B, Kornerup HJ. Calcium
acetate versus calcium carbonate as phosphorus binders in patients on chronic
haemodialysis: a controlled study. Nephrol Dial Transplant 1993;8(4):341-6.

Salusky IB, Foley J, Nelson P, Goodman WG. Aluminum accumulation during treatment
with aluminum hydroxide and dialysis in children and young adults with chronic
renal disease. N Engl J Med 1991 Feb 21;324(8):527-31. Comment in: N Engl J Med
1991 Feb 21;324(8):558-9; N Engl J Med 1991 Jul 18;325(3):208-9.

Schiffl H, Strasser T. Hemodialysis-related leukotriene B4 generation and
neutropenia during calcium channel blockade. Biomater Artif Cells Immobilization
Biotechnol 1991;19(1):85-96.

Stegmayr BG, Esbensen K, Gutierrez A, Lundberg L, Nielsen B, Stroemsaeter CE,
Wehle B. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or
bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane.
Int J Artif Organs 1992 Jan;15(1):10-8.

Zaoui P, Green W, Hakim RM. Hemodialysis with cuprophane membrane modulates
interleukin-2 receptor expression. Kidney Int 1991 May;39(5):1020-6.

-Other

Acchiardo SR, Runyan K, Hatten KW, Dyson B, Fuller J, Moore L. Impact of Kt-V and
protein catabolic rate (PCR) on hemodialysis (HD) mortality [abstract]. J Am Soc
Nephrol 1992;3(3):351.

Akiba T, Tachibana K, Ozawa K, Chida Y, Ogasawara H, Yoshiyama N, Hoshino M,
Inada T, Marumo F. Long-term use of low molecular weight heparin ameliorates
hyperlipidemia in patients on hemodialysis. ASAIO J 1992 Jul-Sep;38(3):M326-30.

Anwar N, Bhatnagar D, Short CD, Mackness MI, Durrington PN, Prais H, Gokal R.
Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory
peritoneal dialysis. Nephrol Dial Transplant 1993;8(1):71-4.

Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic
dyslipoproteinemia--relation to renal function and dialysis. Nephron
1991;57(4):401-10.

Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P. Increased
concentrations of Apo B-containing triglyceride-rich lipoprotein particles in
patients with chronic renal failure. Miner Electrolyte Metab
1992;18(2-5):199-202.

Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N. The uremic
dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis 1992
Oct;20(4):324-35.

Baris E, McGregor M. The reuse of hemodialyzers: an assessment of safety and
potential savings. Can Med Assoc J 1993 Jan 15;148(2):175-83. Published erratum
appears in Can Med Assoc J 1993 Apr 15;148(8):1278.

Bednar B. Hemodialysis monitoring and evaluation of therapy: review of clinical
indicators and use of data collection tools. ANNA J 1991 Jun;18(3):280-3.

Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hoefsmit EC, Beelen RH.
Immuno-effector characteristics of peritoneal cells during CAPD treatment: a
longitudinal study. Kidney Int 1993 Mar;43(3):641-8.

Boje Rasmussen H, Teisner B, Bangsgaard-Petersen F, Yde-Andersen E, Kassem M.
Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts,
normal human serum, and serum from patients with chronic renal failure. Nephrol
Dial Transplant 1992;7(9):902-7.

Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due
to major causes of death groups. The EDTA Registration Committee. Kidney Int
Suppl 1992 Oct;38:S4-15.

Burrell DE, Antignani A, Goldwasser P, Mittman N, Fein PA, Slater PA, Gan A,
Avram MM. Lipid abnormalities in black renal patients. N Y State J Med 1991
May;91(5):192-6.

Carney SL. Ionized calcium concentration in maintenance hemodialysis patients.
Clin Nephrol 1992 Sep;38(3):167-70.

Caruana RJ, Leffell MS, Lobel SA, Campbell HT, Cheek PL. Chronic T-lymphocyte
activation in chronic renal failure: a study of hemodialysis, CAPD and pre-
dialysis patients. Int J Artif Organs 1992 Feb;15(2):93-8.

Castellano M, Turconi A, Chaler E, Rivarola MA, Belgorosky A. Hypothalamic-
pituitary-gonadal function in prepubertal boys and girls with chronic renal
failure. J Pediatr 1993 Jan;122(1):46-51.

Cavaillon JM, Poignet JL, Fitting C, Delons S. Serum interleukin-6 in long-term
hemodialyzed patients. Nephron 1992;60(3):307-13.

Chazan JA, Lew NL, Lowrie EG. Increased serum aluminum. An independent risk
factor for mortality in patients undergoing long-term hemodialysis. Arch Intern
Med 1991 Feb;151(2):319-22.

Chazan JA, London MR, Pono L. Markedly elevated BUN is not correlated with
increased morbidity and mortality in a large chronic hemodialysis population.
Dial Transplant 1991;20(9):547-50.

Chen WT, Yamaoka K, Nakajima S, Tanaka Y, Yamamoto T, Satomura K, Okada S, Seino
Y. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in
children on continuous ambulatory peritoneal dialysis. Bone Miner 1992
Jun;17(3):389-98.

Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J. Are
antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol
Dial Transplant 1992;7(12):1194-8.

Christ F, Weidel S, Mcintyre K, Jameson T, Kox WJ, Gamble J. Changes in colloid
osmotic pressure (COP) during continuous veno-venous or arteriovenous
hemodialysis (CVVHD-CAVHD) in man. J Physiol (Camb) 1991;438:1-58.

Christensen AJ, Smith TW, Turner CW, Holman JM Jr, Gregory MC, Rich MA. Family
support, physical impairment, and adherence in hemodialysis: an investigation of
main and buffering effects. J Behav Med 1992 Aug;15(4):313-25.

Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC. Health locus of
control and depression in end-stage renal disease. J Consult Clin Psychol 1991
Jun;59(3):419-24.

Christenson M, Fivush B, Racusen L. Safety of intraperitoneal calcium therapy in
a rodent model. Adv Perit Dial 1992;8:15-7.

Coburn JW, Mischel MG, Goodman WG, Salusky IB. Calcium citrate markedly enhances
aluminum absorption from aluminum hydroxide. Am J Kidney Dis 1991
Jun;17(6):708-11.

Coburn JW, Salusky IB, Norris KC, Goodman WG. Oral and parenteral calcitriol for
the management of end-stage renal disease. Contrib Nephrol 1991;90: 166-82.

Coen G, Mazzaferro S, Ballanti P, Bonucci E, Bondatti F, Pasquali M, Perruzza I,
Manni M, Sardella D. Plasma insulin-like growth factor-1 and bone formation
parameters in predialysis chronic renal failure. Miner Electrolyte Metab
1991;17(3):153-9.

Cohen B, Kagan L, Richter B, Topor M, Saveedra M. Children's compliance to
dialysis. Pediatr Nurs 1991 Jul-Aug;17(4):359-65, 420.

Cohen-Solal ME, Sebert JL, Boudailliez B, Westeel PF, Moriniere PH, Marie A,
Garabedian M, Fournier A. Non-aluminic adynamic bone disease in non-dialyzed
uremic patients: a new type of osteopathy due to overtreatment? Bone
1992;13(1):1-5.

Craven J, Littlefield C, Rodin G, Murray M. The Endstage Renal Disease Severity
Index (ESRD-SI). Psychol Med 1991 Feb;21(1):237-43.

Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF. Lipoprotein
(a) is an independent risk factor for cardiovascular disease in hemodialysis
patients. Circulation 1992 Aug;86(2):475-82.

Cressman MD, Hoff HF, Nally JV Jr, Schreiber M Jr, Van Lente F. Lipoprotein a and
the cardiovascular risk of end stage renal disease [abstract]. J Am Soc Nephrol
1991;2(3):234.

Cristol JP, Canaud B, Damon M, Chavis C, Arnoux B, Mion C. Platelet-activating
factor production during hemodialysis: effect of BN 52021. Prostaglandins Leukot
Essent Fatty Acids 1992 Jan;45(1):37-42.

Crum R, Fairchild R, Bronsther O, Dominic W, Ward D, Fernandez R, Brown MR.
Neuroendocrinology of chronic renal failure and renal transplantation.
Transplantation 1991 Nov;52(5):818-23.

Cunningham J, Beer J, Coldwell RD, Noonan K, Sawyer N, Makin HL. Dialysate
calcium reduction in CAPD patients treated with calcium carbonate and
alfacalcidol. Nephrol Dial Transplant 1992;7(1):63-8.

Dagogo-Jack S, Rodger RS, Kendall-Taylor P. Increased salivary concentration of
human epidermal growth factor in patients undergoing CAPD. Perit Dial Int
1991;11(3):270-3.

de Chatel R, Mako J, Toth M, Barna I, Lang RE. Atrial natriuretic peptide (ANP)
in patients with chronic renal failure on maintenance haemodialysis. Int Urol
Nephrol 1991;23(2):177-83.

D'Elia JA, Weinrauch LA, Gleason RE, DeSilva RA, Nesto RW. Preliminary screening
of the relationship of serum lipids to survival of chronic dialysis patients. Ren
Fail 1993;15(2):203-9.

Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelemy C, Petitclerc T,
Jacobs C. Endothelin in chronic renal failure. Nephrol Dial Transplant
1992;7(4):300-5.

Diaz RJ, Washburn S, Cauble L, Siskind MS, Van Wyck D. The effect of dialyzer
reprocessing on performance and beta 2-microglobulin removal using polysulfone
membranes. Am J Kidney Dis 1993 Apr;21(4):405-10.

Dieplinger H, Lobentanz EM, Konig P, Graf H, Sandholzer C, Matthys E, Rosseneu
M, Utermann G. Plasma apolipoprotein A-IV metabolism in patients with chronic
renal disease. Eur J Clin Invest 1992 Mar;22(3):166-74.

Dilena BA, White GH. Assessing acute parathyroid responsiveness in hemodialysis
patients by measuring intact parathyrin in pre- and post-dialysis serum. Clin
Chem 1991 Jul;37(7):1216-20.

Dinarello CA. Interleukin-1 and tumor necrosis factor and their naturally
occurring antagonists during hemodialysis. Kidney Int Suppl 1992;38:S68-77.

Direskeneli H, Ozgun S, Ozener C, Lawrence R, Erman M, Sarsmaz N, Akoglu E. Anti-
lymphocyte, anti-monocyte, and anti-endothelial cell antibodies in chronic
haemodialysis patients. Nephrol Dial Transplant 1992;7(5):422-6.

Djordjevic VB, Strahinjic S, Koracevic D, Miljkovic P, Djordjevic V, Pavlovic D,
Stefanovic V. Erythrocyte delta-aminolevulinate dehydratase measurements in
Balkan endemic nephropathy. Kidney Int Suppl 1991;34:S93-6.

Domingo JL, Gomez M, Llobet JM, Corbella J. Influence of some dietary
constituents on aluminum absorption and retention in rats. Kidney Int
1991;39(4):598-601.

Donati D, Degiannis D, Combates N, Raskova J, Raska K Jr. Effects of hemodialysis
on activation of lymphocytes: analysis by an in vitro dialysis model. J Am Soc
Nephrol 1992 Apr;2(10):1490-7.

Donati D, Degiannis D, Combates N, Raskova J, Raska K Jr. Evidence of mononuclear
cell activation by hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M386-7.

Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, Raska K Jr. Immune
deficiency in uremia: interleukin-2 production and responsiveness and
interleukin-2 receptor expression and release. Nephron 1991;58(3):268-75.

Donati D, Degiannis D, Homer L, Raska K, Raskova J. Interleukin-1 kinetics in
hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M391-2.

Donati D, Degiannis D, Homer L, Raska K Jr, Raskova J. Production and kinetics
of interleukin-1 in hemodialysis. In vivo and in vitro study. Am J Nephrol
1991;11(6):451-8.

Donnelly PK, Burwell N, McBurney A, Ward JW, Walls J, Watkin EM. Clearance of
iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal
failure. Br J Radiol 1992 Dec;65(780):1108-13.

Donnelly SM, Ali MA, Churchill DN. Effect of n-3 fatty acids from fish oil on
hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc
Nephrol 1992 May;2(11):1634-9.

Donovan KL, Pacholok S, Phillips A, Humes JL, Coles GA, Williams JD. Effect of
dialyser composition and reuse on neutrophil count and elastase alpha-1
proteinase inhibitor complex formation. Int J Artif Organs 1992 Mar;15(3):139-43.

Douvdevani A, Rapoport J, Konforti A, Zlotnik M, Chaimovitz C. The effect of
peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by
macrophages/monocytes. Perit Dial Int 1993;13(2):112-7.

Durozard D, Pimmel P, Baretto S, Caillette A, Labeeuw M, Baverel G, Zech P. 31P
NMR spectroscopy investigation of muscle metabolism in hemodialysis patients.
Kidney Int 1993 Apr;43(4):885-92.

Dzurik R, Lajdova I, Spustova V, Opatrny K Jr. Pseudouridine excretion in healthy
subjects and its accumulation in renal failure. Nephron 1992;61(1):64-7.

Eisenhauer T, Muller U, Schuff-Werner P, Armstrong VW, Bosch T, Thiery J, Gurland
H, Seidel D. Simultaneous heparin extracorporeal LDL precipitation and
hemodialysis. First clinical experience. ASAIO Trans 1991 Jul-Sep;37(3):M494-6.

El-Saaran A, Kader O, Gamil F, Sadek SA. Immunological alterations associated
with end-stage renal disease. J Med Res Inst 1991;12(4):39-57.

Elisaf MS, Dardamanis MA, Papagalanis ND, Siamopoulos KC. Lipid abnormalities in
chronic uremic patients. Response to treatment with gemfibrozil. Scand J Urol
Nephrol 1993;27(1):101-8.

Emmett M, Sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium
acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis
1991 May;17(5):544-50.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Plasma 1,5-anhydroglucitol
concentration in patients with end-stage renal disease with and without diabetes
mellitus. Nephron 1992;61(2):181-6.

Espana F, Gilabert J, Vicente V, Estelles A, Vazquez L, Hendl S, Aznar J.
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker
for in vitro diagnosis of prethrombotic states. Thromb Res 1992 Jun
1;66(5):499-508.

Evans RC, Holmes CJ. In vitro study of the transfer of cytokine-inducing
substances across selected high-flux hemodialysis membranes. Blood Purif
1991;9(2):92-101.

Fellner SK, Lang RM, Neumann A, Bushinsky DA, Borow KM. Parathyroid hormone and
myocardial performance in dialysis patients. Am J Kidney Dis 1991
Sep;18(3):320-5.
Felsenfeld AJ, Ross D, Rodriguez M. Hysteresis of the parathyroid hormone
response to hypocalcemia in hemodialysis patients with low turnover aluminum bone
disease. J Am Soc Nephrol 1991 Dec;2(6):1136-43.

Feriani M, Kimmel PL, Kurantsin-Mills J, Bosch JP. Effect of renal replacement
therapy on viscosity in end-stage renal disease patients. Am J Kidney Dis 1992
Feb;19(2):131-9.

Fernandez JM, Carbonell ME, Mazzuchi N, Petruccelli D. Simultaneous analysis of
morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 1992
Apr;41(4):1029-34.

Fervenza FC, Meredith D, Ellory JC, Hendry BM. Abnormal erythrocyte choline
transport in patients with chronic renal failure. Clin Sci 1991 Feb;80(2):137-41.
Feussner G, Wey S, Bommer J, Deppermann D, Grutzmacher P, Ziegler R.
Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance
hemodialysis. Hum Genet 1992 Jan;88(3):307-12.

Fine A, Cox D. Modest reduction of serum albumin in continuous ambulatory
peritoneal dialysis patients is common and of no apparent clinical consequence.
Am J Kidney Dis 1992 Jul;20(1):50-4. Comment in: Am J Kidney Dis 1992
Jul;20(1):76-7.

Fischbach M, Hamel G, Simeoni U, Geisert J. Phosphate dialytic removal:
enhancement of phosphate cellular clearance by biofiltration (with acetate-free
buffer dialysate). Nephron 1992;62(2):155-60.

Fleming LW, Stewart WK, Parratt D. Dextran antibodies, complement conversion and
circulating immune complexes after intravenous iron dextran therapy in dialysed
patients. Nephrol Dial Transplant 1992;7(1):35-9.

Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing
with Renalin. Am J Nephrol 1991;11(1):27-31.

Fluck RJ, McMahon AC, Alameddine FM, Dawnay AB, Baker LR, Raine AE. Platelet
cytosolic free calcium concentration and parathyroid hormone: changing
relationships with haemodialysis in end-stage renal disease. Clin Sci 1992
Jun;82(6):651-8.

Fournier A, Moriniáere P, Ben Hamida F, el Esjer N, Shenovda M, Ghazali A,
Bouzernidj M, Achard JM, Westeel PF. Use of alkaline calcium salts as phosphate
binder in uremic patients. Kidney Int Suppl 1992 Oct;38:S50-61.

Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr. The familial risk of end-stage
renal disease in African Americans. Am J Kidney Dis 1993;21(4):387-93.

Fruits RG, Kinney R, Hegeman T. Maintaining iron balance by decreasing blood
loss. ANNA J 1992 Apr;19(2):156.

Furlong T, Chan YL, Cornish C, McDowall D, Mahony J, Clifton-Bligh P.
Immunoreactive serum calcitonin and skeletal histology in chronic renal failure.
Nephron 1991;58(2):138-43.

Gafter U, Malachi T, Barak H, Levi J. Red blood cell calcium level is elevated
in women: enhanced calcium influx by estrogens. J Lab Clin Med 1993
Mar;121(3):486-92.

Gal G, Kiss E, Foldes J, Dombi A. Disinfection of regenerated dialyzers with
ozone. Int J Artif Organs 1992 Aug;15(8):461-4.

Garnaas KR, Windebank AJ, Blexrud MD, Kurtz SB. Ultrastructural changes produced
in dorsal root ganglia in vitro by exposure to ethylene oxide from hemodialyzers.
J Neuropathol Exp Neurol 1991 May;50(3):256-62.

Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of
serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone
Miner Res 1992 Dec;7(12):1389-98.

Gault MH, Vasdev SC, Longerich I, Purchase L, Sampon C, Johnson E. Heparin, fatty
acids and sodium, potassium-ATPase inhibition by plasma factors during
hemodialysis. Nephron 1992;60(3):292-301.

Gelder FB, McDonald JC, Landreneau MD, McMillan RM, Aultman DF. Identification,
characterization, and quantitation of soluble HLA antigens in the circulation and
peritoneal dialysate of renal patients. Ann Surg 1991;213(6):591-9.

Gellert R, Billip-Tomecka Z, Hijaz H, Bogdanska-Straszynska B, Malecka B Sicinski
A. Intradialytic erythrocyte volume changes. Nephrol Dial Transplant 1991;6 Suppl
3:10-3.

Gendeh BS, Said H, Gibb AG, Aziz NS, Zahir ZM. Gentamicin administration via
peritoneal dialysis fluid: the risk of ototoxicity. J Laryngol Otol
1991;105(12):999-1001.

Gerez L, Madar L, Shkolnik T, Kristal B, Arad G, Reshef A, Steinberger A,
Ketzinel M, Sayar D, Shasha S, et al. Regulation of interleukin-2 and interferon-
gamma gene expression in renal failure. Kidney Int 1991 Aug;40(2):266-72.

Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P. Plasma
histamine in patients with chronic renal failure and nephrotic syndrome. J Clin
Pathol 1991 Mar;44(3):243-5.

Girelli D, Lupo A, Trevisan MT, Olivieri O, Bernich P, Zorzan P, Bassi A,
Stanzial AM, Ferrari S, Corrocher R. Red blood cell susceptibility to lipid
peroxidation, membrane lipid composition, and antioxidant enzymes in continuous
ambulatory peritoneal dialysis patients. Perit Dial Int 1992;12(2):205-10.

Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, Menini C,
Gammaro L, Corrocher R. Low platelet glutathione peroxidase activity and serum
selenium concentration in patients with chronic renal failure: Relations to
dialysis treatments, diet and cardiovascular complications. Clin Sci
1993;84(6):611-7.

Girolami JP, Bascands JL, Vega Vidalle C, Pecher C, Moatti JP, Adam A, Suc JM.
Increase in urinary kallikrein excretion following hemodialysis. Nephron
1991;59(1):51-6.

Gitelman HJ, Alderman FR, Perry SJ. Silicon accumulation in dialysis patients.
Am J Kidney Dis 1992 Feb;19(2):140-3.

Gladziwa U, Bares R, Klotz U, Dakshinamurty KV, Ittel TH, Seiler KU, Sieberth HG.
Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing
hemodialysis. Clin Pharmacol Ther 1991 Dec;50(6):673-81.

Gladziwa U, Wagner S, Dakshinamurty KV, Bechtel B, Mann H, Sieberth HG.
Intragastric long-term pH-metry in hemodialysis patients. A study with
famotidine. Clin Nephrol 1991 Aug;36(2):97-102.

Gladziwa U, Wagner S, Kock R, Mann H, Sieberth HG. Sonographic evaluation of
gallbladder motility in patients with end-stage renal disease on haemodialysis.
Nephrol Dial Transplant 1992;7(8):840-3.

Glez-Gutierrez M, de Francisco AL, Sanz de Castro S, Ruiz JC, Prieto M, Garcia
Fuentes M, Arias M. Interleukin-2 deficit in hemodialysis patients. Role of
prostaglandins. Ren Fail 1992;14(4):563-9.

Goldberg IJ. Lipoprotein metabolism in normal and uremic patients. Am J Kidney
Dis 1993;21(1):87-90.

Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM.
Predictors of mortality in hemodialysis patients. J Am Soc Nephrol
1993;3(9):1613-22.

Goren A, Stankiewicz H, Goldstein R, Drukker A. Fish oil treatment of
hyperlipidemia in children and adolescents receiving renal replacement therapy.
Pediatrics 1991 Aug;88(2):265-8.

Grimm PC, Ettenger RB. High cellular anti-HLA immune responsiveness accompanies
the highly sensitized (high PRA) state in dialysis patients. Transplant Proc 1991
Feb;23(1 Pt 1):405-6.

Gutierrez R, Oster JR, Schlessinger FB, Perez GO, Federman DG, Vaamonde CA. Serum
sulfate concentration and the anion gap in hemodialysis patients. ASAIO Trans
1991 Apr-Jun;37(2):92-6.

Haag-Weber M, Hable M, Fiedler G, Blum I, Schollmeyer P, Kreusser W, Horl WH.
Alterations of polymorphonuclear leukocyte glycogen metabolism and glucose uptake
in dialysis patients. Am J Kidney Dis 1991 May;17(5):562-8.

Haag-Weber M, Horl WH. Calcium-dependent neutrophil activation. Contrib Nephrol
1992;100: 269-85.

Haag-Weber M, Mai B, Horl WH. Effect of hemodialysis on intracellular calcium in
human polymorphonuclear neutrophils. Miner Electrolyte Metabol
1992;18(2-5):151-5.

Haeffner-Cavaillon N, Jahns G, Poignet JL, Kazatchkine MD. Induction of
interleukin-1 during hemodialysis. Kidney Int Suppl 1993 Jan;39: S139-43.

Haffner SM, Gruber KK, Aldrete G Jr, Morales PA, Stern MP, Tuttle KR. Increased
lipoprotein (a) concentrations in chronic renal failure. J Am Soc Nephrol 1992
Nov;3(5):1156-62.

Hakim RM, Nissenson AR. Report of workshop on technique and technology. Am J
Kidney Dis 1993 Jan;21(1):109-10.

Halma C, Daha MR, Feitsma RI, van Holthe MS, Evers-Schouten JH, Pauwels EK, van
Es LA. Does haemodialysis impair macrophage Fc receptor function? Nephrol Dial
Transplant 1992;7(7):618-22.

Hanaki Y, Kamiya H, Ohno M, Hayakawa M, Sugiyama S, Ozawa T. Leukotoxin, 9, 10-
epoxy-12-octadecenoate: a possible responsible factor in circulatory shock and
disseminated intravascular coagulation. Jpn J Med 1991 May-Jun;30(3):224-8.

Haran N, Bar-Khayim Y, Frensdorff A, Barnard G. Tumor necrosis factor (TNF alpha)
binding protein: interference in immunoassays of TNF alpha. Kidney Int 1991
Dec;40(6):1166-70.

Hart PH, Jones CA, Finlay-Jones JJ. Inflammatory fluids regulate TNF-alpha, but
not IL-1 beta, production by human peritoneal macrophages. A study of patients
on continuous ambulatory peritoneal dialysis with peritonitis. J Leukoc Biol 1993
Mar;53(3):309-19.

Hart PH, Jones CA, Jones KL, Finlay-Jones JJ. Reduced secretion of IL-1 beta by
peritoneal cells from patients on continuous ambulatory peritoneal dialysis.
Immunol Cell Biol 1993 Apr;71(Pt 2):99-107.

Hasnain Q, Macdonald G, Haupert GT. Metabolism of uridine in expanded
extracellular volume states. Clin Exp Pharmacol Physiol 1993;20(5):313-6.

Haubitz M, Kloppel B, Lonnemann G, Nonnast-Daniel B. In vitro production of
interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis
therapy. Clin Nephrol 1992 Jul;38(1):30-5.

Haynes AP, Daniels I, Porter C, Fletcher J, Morgan AG. Abnormal cytoplasmic pH
regulation during activation in uremic neutrophils. Kidney Int 1992
Sep;42(3):690-9.

Hegbrant J, Martensson L, Thysell H, Ekman R, Boberg U. Effects of sham
hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
ASAIO J 1992 Jul-Sep;38(3):M197-200.

Hegbrant J, Thysell H, Ekman R. Plasma levels of gastrointestinal regulatory
peptides in patients receiving maintenance hemodialysis. Scand J Gastroenterol
1991 Jun;26(6):599-604.

Hegbrant J, Thysell H, Ekman R. Plasma levels of vasoactive regulatory peptides
in patients receiving regular hemodialysis treatment. Scand J Urol Nephrol
1992;26(2):169-76.

Hegbrant J, Thysell H, Martensson L, Ekman R, Boberg U. Changes in plasma levels
of vasoactive peptides during sequential bicarbonate hemodialysis. Nephron
1993;63(3):309-13.

Hegedus ZL, Frank HA, Steinman TI, Nayak U. Dialysis of plasma soluble
lipofuscins in patients with end-stage renal failure. Arch Int Physiol Biochim
Biophys 1991 Aug;99(4):355-63.

Heimann P, Josephson MA, Fellner SK, Thistlethwaite JR Jr, Stuart FP, Dasgupta
A. Elevated lipoprotein (a) levels in renal transplantation and hemodialysis
patients. Am J Nephrol 1991;11(6):470-4.

Heintz B, Mann H, Kierdorf H, Konigs F, Nelson K, Kirsten R, Heicke N, Wieland
D, Gladziwa U, Sieberth HG. Immunoreactive parathyroid hormone after volume
change in normo- and hypotensive hemodialysis patients. Clin Nephrol 1992
Mar;37(3):140-4.

Heintz B, Reiners K, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann
H, Sieberth HG. Response of vasoactive substances to reduction of blood volume
during hemodialysis in hypotensive patients. Clin Nephrol 1993 Apr;39(4):198-204.

Hellman P, Backman U, Danielson BG, Akerstrom G, Rastad J, Wide L, Ljunghall S.
Values of intact serum parathyroid hormone in different stages of renal
insufficiency. Scand J Urol Nephrol 1991;25(3):227-32.

Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated
circulating levels of interleukin-6 in patients with chronic renal failure.
Kidney Int 1991 May;39(5):954-60.

Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B. Influence of
first and long-term dialysis on uraemia-associated increased basal production of
interleukin-1 and tumour necrosis factor alpha by circulating monocytes. Nephrol
Dial Transplant 1991;6(5):349-57.

Hertel J, Kimmel PL, Phillips TM, Bosch JP. Eosinophilia and cellular cytokine
responsiveness in hemodialysis patients. J Am Soc Nephrol 1992 Dec;3(6):1244-52.

Himmelfarb J, Gerard NP, Hakim RM. Intradialytic modulation of granulocyte C5a
receptors. J Am Soc Nephrol 1991 Oct;2(4):920-6.

Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by
monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991
Mar;17(3):271-6.

Hirano T, Toyoshima Y, Oka K, Tamaki T, Kozaki M. Promotion of lymphocyte
blastogenesis by hemodialysate of chronic renal failure. Nephron
1992;61(1):45-53.

Hisano S, Miyazaki C, Hatae K, Kaku Y, Yamane I, Ueda K, Okamua S. Immune status
of children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1992
Mar;6(2):179-81.

Holley JL, Bernardini J, Piraino B. Risk factors for tunnel infections in
continuous peritoneal dialysis. Am J Kidney Dis 1991 Sep;18(3):344-8.

Holzberger G, Seidl S, Peschke B, Fursch A, Scheuermann EH, Schoeppe W. The
prevalence of anti-HCV in hemodialysis patients and blood donors in Germany.
Transplant Proc 1991;23(5):2658-9.

Holzberger G, Seidl S, Peschke B, Scheuermann EH, Schoeppe W. Second generation
anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
Transplant Proc 1992:24(6):2648-9.

Hombrouckx RO, Bogaert AM, Leroy FM, De Vos JY, Vermaercke NM, Picavet LM, Larno
LA. Polyunsaturated fatty acids of the n-3 class in chronic dialysis. ASAIO J
1992 Jul-Sep;38(3):M331-3.

Honkanen E, Froseth B, Gronhagen-Riska C. Serum hyaluronic acid and procollagen
III amino terminal propeptide in chronic renal failure. Am J Nephrol
1991;11(3):201-6.

Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S. Acute-phase proteins
during hemodialysis: correlations with serum interleukin-1 beta levels and
different dialysis membranes. Nephron 1991;57(3):283-7.

Honkanen E, Kala AR, Gronhagen-Riska C, Ikaheimo R. CAPD with low calcium
dialysate and calcium carbonate: results of a 24-week study. Adv Perit Dial
1992;8:356-61.

Hory B, Racadot E, Saint-Hillier Y, Peters A, Perol C. Soluble interleukin-2
receptors in chronic renal failure. Am J Nephrol 1991;11(4):276-80.

Hosokawa S, Yoshida O. Removal of silicon, aluminum and beta 2-microglobulin in
chronic haemodialysis patients. Int Urol Nephrol 1991;23(3):281-4.

Huang JY, Huang CC, Lim PS, Wu MS, Leu ML. Effect of body iron stores on serum
aluminum level in hemodialysis patients. Nephron 1992;61(2):158-62.

Hubel E, Kiefer T, Weber J, Mettang T, Kuhlmann U. In vivo effect of 1,25-
dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int
1991 Nov;40(5):927-33.

Hutchison AJ, Boulton HF, Herman K, Day JP, Prescott M, Gokal R. Use of oral
stable strontium to provide an index of intestinal calcium absorption in chronic
ambulatory peritoneal dialysis patients. Miner Electrolyte Metabol
1992;18(2-5):160-5.

Hutchison AJ, Gokal R. Improved solutions for peritoneal dialysis: physiological
calcium solutions, osmotic agents and buffers. Kidney Int Suppl 1992;38:S153-9.

Huting J, Schutterle G. Cardiovascular factors influencing survival in end-stage
renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol
1992 Jan 1;69(1):123-7.

Hylander BI, Dalton CB, Castell DO, Burkart J, Rossner S. Effect of
intraperitoneal fluid volume changes on esophageal pressures: studies in patients
on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991
Mar;17(3):307-10.

Ierino FL, Miach PJ, Hogarth PM, McKenzie IFC. Serum soluble Fc gamma RII levels
in dialysis and renal transplant recipients. Transplant Proc 1992;24(5):2328.

Inamoto H, Ozaki R, Matsuzaki T, Wakui M, Saruta T, Osawa A. Incidence and
mortality patterns of malignancy and factors affecting the risk of malignancy in
dialysis patients. Nephron 1991;59(4):611-7.

Innes A, Rowe PA, Burden RP, Morgan AG. Early deaths on renal replacement
therapy: the need for early nephrological referral. Nephrol Dial Transplant
1992;7(6):467-71. Comment in: Nephrol Dial Transplant 1993;8(1):93-4.

Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR. Hemodialysis and
heparin. Alternative methods of measuring heparin and of detecting activation of
coagulation. Clin Nephrol 1991 Jan;35(1):26-33.

Irish AB, Simons LA, Savdie E, Hayes JM, Simons J. Lipoprotein (a) levels in
chronic renal disease states, dialysis and transplantation. Aust N Z J Med 1992
Jun;22(3):243-8.

Iseki K, Kawazoe N, Fukiyama K. Predictive values of clinical indices on survival
in chronic hemodialysis patients a short-term prospective study [abstract]. J Am
Soc Nephrol 1992;3(3):371.

Ittel TH, Schafer C, Schmitt H, Gladziwa U, Sieberth HG. Calcium carbonate as a
phosphate binder in dialysis patients: evaluation of an enteric-coated
preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
Klin Wochenschr 1991 Jan 22;69(2):59-67.

Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity
to activate complement. Complement Inflamm 1991;8(2):61-9.

Jankova T, Tchankova P, Nenov D. Low prekallikrein and high angiotensin-
converting enzyme activity in patients with chronic renal failure on
haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 3:6-9.

Jethon FU, Weber-Fursicht I, Steudle V, Guleke R, Kirschner U. Peritonitis
prevention by eliminating the risk factor disconnection. Contrib Nephrol
1991;89:53-8.

Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokin
1992;22(6):434-46.

Jones KR. Factors associated with hospitalization in a sample of chronic
hemodialysis patients. Health Serv Res 1991 Dec;26(5):671-99.

Jones KR. Risk of hospitalization for chronic hemodialysis patients. Image J Nurs
Sch 1992 Summer;24(2):88-94.

Jorres A, Jorres D, Gahl GM, Schulz E, Mahiout A. Leukotriene release from
neutrophils of patients on hemodialysis with cellulose membranes. Int J Artif
Organs 1992 Feb;15(2):84-8.

Jorres A, Jorres D, Topley N, Gahl GM, Mahiout A. Leukotriene release from
peripheral and peritoneal leukocytes following exposure to peritoneal dialysis
solutions. Nephrol Dial Transplant 1991;6(7):495-501.

Joven J, Vilella E, Ahmad S, Cheung MC, Brunzell JD. Lipoprotein heterogeneity
in end-stage renal disease. Kidney Int 1993 Feb;43(2):410-8.

Jung BC, Laidlaw SA, Kopple JD. Taurine levels in plasma and blood cells in
patients undergoing routine maintenance hemodialysis. Am J Kidney Dis 1991
Jul;18(1):74-9.

Kagan A, Gertler A, Ulman M, Bar-Khayim Y. Serum levels and peritoneal loss of
prolactin in CAPD patients. Adv Perit Dial 1991;7:247-52.

Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart JC, Tacquet A. Plasma level
of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
Kidney Int 1992 Aug;42(2):424-5.

Kandoussi A, Cachera C, Pagniez D, Saile R, Tacquet A. Quantification of beta 2-
microglobulin and albumin in plasma and peritoneal dialysis fluid by a
noncompetitive immunoenzymometric assay. Clin Chem 1993;39(1):93-6.

Kandus A, Benedik M, Bren AF, Drinovec J, Fliser D, Knap B, Kladnik S, Ivanovich
P. Inhibition of complement activation with EDTA in vivo during sham
hemodialysis. Int J Artif Organs 1991 Aug;14(8):515-7.

Katoh S, Ida K, Mizunoya A. Irregular isoantibodies in the sera of patients
undergoing chronic hemodialysis. Int J Artif Organs 1991 Mar;14(3):136-40.

Kawanishi H, Tsuchiya T, Namba S, Takahashi N, Toyota T, Fukuma K, Kawai T.
Clinical application of low calcium peritoneal dialysate. ASAIO Trans 1991 Jul-
Sep;37(3):M404-6.

Kayima JK, Otieno LS, Gitau W, Mwai S. Thyroid hormone profiles in patients with
chronic renal failure on conservative management and regular haemodialysis. East
Afr Med J 1992 Jun;69(6):333-6.

Kerr PG, Argiles A, Canaud B, Flavier JL, Mion C. The effects of reprocessing
high-flux polysulfone dialyzers with peroxyacetic acid on beta 2-microglobulin
removal in hemodiafiltration. Am J Kidney Dis 1992 May;19(5):433-8.

Kerr PG, Argiles A, Mion C. Whole blood serotonin levels are markedly elevated
in patients on dialytic therapy. Am J Nephrol 1992;12(1-2):14-8.

Ketchersid TL, Van Stone JC. Dialysate potassium. Semin Dial 1991;4(1):46-51.

Kiersztejn M, Smogorzewski M, Thanakitcharu P, Fadda GZ, Massry SG. Decreased O2
consumption by PMNL from humans and rats with CRF: role of secondary
hyperparathyroidism. Kidney Int 1992 Sep;42(3):602-9.

Kimura Y, Nakayama M, Kuriyama S, Watanabe S, Kawaguchi Y, Sakai O.
Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha,
25-dihydroxyvitamin D3 in patients on chronic hemodialysis. Clin Nephrol 1991
Feb;35(2):72-7.

Klein GL, Alfrey AC, Shike M, Sherrard DJ. Parenteral drug products containing
aluminum as an ingredient or a contaminant: response to FDA notice of intent.
ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral
Nutrition Solutions. Am J Clin Nutr 1991 Feb;53(2):399-402. Comment in: Am J Clin
Nutr 1991 Nov;54(5):951-3.

Klein JR, Grunewald RW, Steffgen J, Franz HE. Clearance of osteocalcin in adults
with end-stage renal disease undergoing CAPD. Adv Perit Dial 1991;7:225-9.

Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB. Free and
total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int
1992 Jan;41(1):161-5.

Kolb G, Fischer W, Seitz R, Muller T, Egbring R, Lange H, Havemann K.
Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation
factor XIII and thrombin-antithrombin III complex. Nephron 1991;58(1):106-8.

Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane
contact in hemodialysis-induced granulocyte activation. Nephron 1991;57(1):64-8.

Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk factors for
peritonitis among an urban CAPD population. Perit Dial Int 1993;13(2):126-31.

Kouw PM, Olthof CG, ter Wee PM, Oe LP, Donker AJ, Schneider H, de Vries PM.
Assessment of post-dialysis dry weight: an application of the conductivity
measurement method. Kidney Int 1992 Feb;41(2):440-4.

Kraus LM, Kraus AP Jr. Tyrosine and N-carbamoyl-tyrosine in end-stage renal
disease during continuous ambulatory peritoneal dialysis. J Lab Clin Med 1991
Dec;118(6):555-62.

Krediet RT, Asghar SS, Koomen GC, Venneker GT, Struijk DG, Arisz L. Effects of
renal failure on complement C3d levels. Nephron 1991;59(1):41-5.

Ksiazek A, Kozio M. Phagocytic function of neutrophils during dialysis in
relation to some immunological findings. Nephrol Dial Transplant 1991;6 Suppl
3:31-4.

Kumano K, Yokota S, Go M, Suyama K, Sakai T, Era S, Sogami M. Quantitative and
qualitative changes of serum albumin in CAPD patients. Adv Perit Dial
1992;8:127-30.

Kustel M, Buki B, Gyimesi J, Mako J, Komora V, Ribari O. Auditory brainstem
potentials in uraemia. ORL 1993;55(2):89-92.

Kuzniewski M, Suowicz W. Influence of prostacyclin infusion on haemodialysis
efficiency and blood cells. Int Urol Nephrol 1992;24(5):555-63.

Kuzniewski M, Suowicz W, Lisiewicz J. Effect of heparin and prostacyclin-heparin
infusion on blood coagulation in haemodialysed patients. Int Urol Nephrol
1991;23(1):89-96.

Lai KN, Li PK, Woo KS, Lui SF, Leung JC, Law E, Nicholls MG. Vasoactive hormones
in uremic patients on continuous ambulatory peritoneal dialysis. Clin Nephrol
1991 May;35(5):218-23.

Lai KN, Yin JA, Yuen PM, Li PK. Effect of hemodialysis on protein C, protein S,
and antithrombin III levels. Am J Kidney Dis 1991 Jan;17(1):38-42.

Lamb E, Venton TR, Cattell WR, Dawnay A. Serum glycated albumin and fructosamine
in renal dialysis patients. Nephron 1993;64(1):82-8.

Lang CC, Choy AM, Henderson IS, Coutie WJ, Struthers AD. Effect of haemodialysis
on plasma levels of brain natriuretic peptide in patients with chronic renal
failure. Clin Sci 1992 Feb;82(2):127-31.

Lee BW, Yap HK, Tan M, Guan R, Quak SH, Choong L, Murugasu B, Woo KT, Jordan SC.
Cell-mediated immunity in patients on hemodialysis: relationship with hepatitis
B carrier status. Am J Nephrol 1991;11(2):98-101.

Liberek T, Topley N, Jorres A, Coles GA, Gahl GM, Williams JD. Peritoneal
dialysis fluid inhibition of phagocyte function: effects of osmolality and
glucose concentration. J Am Soc Nephrol 1993 Feb;3(8):1508-15.

Lightfoot BO, Caruana RJ. Endothelin-1 in continuous ambulatory peritoneal
dialysis and hemodialysis patients: a preliminary study. Perit Dial Int
1993;13(1):55-8.

Lin CY, Huang TP. Enhancement of ionized calcium and 1,25-
dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in
patients treated with continuous ambulatory peritoneal dialysis. Nephron
1991;59(1):90-5.

Lin CY, Lin CC, Huang TP. Serial changes of interleukin-6 and interleukin-8
levels in drain dialysate of uremic patients with continuous ambulatory
peritoneal dialysis during peritonitis. Nephron 1993;63(4):404-8.

Lin SY, Chen LQ, Wang YH, Zhou JH. Influence of hemoultrafiltration and
hemodialysis on endothelin. Chin Med J (Engl) 1991 Apr;104(4):288-91.

Lind L, Wengle B, Lithell H, Ljunghall S. Reduction in serum alkaline phosphatase
levels by treatment with active vitamin D (alphacalcidol) in primary and
secondary hyperparathyroidism and in euparathyroid individuals. Scand J Urol
Nephrol 1991;25(3):233-6.

Lindblad AS, Nolph KD. Recovery of renal function in continuous ambulatory
peritoneal dialysis: a study of National CAPD Registry data. Perit Dial Int
1992;12(1):43-7.

Lindner A, Gagne ER, Zingraff J, Jungers P, Drueke TB, Hannaert P, Garay R. A
circulating inhibitor of the RBC membrane calcium pump in chronic renal failure.
Kidney Int 1992 Dec;42(6):1328-35.

Lipkin GW, Forbes MA, Cooper EH, Turney JH. Hyaluronic acid metabolism and its
clinical significance in patients treated by continuous ambulatory peritoneal
dialysis. Nephrol Dial Transplant 1993;8(4):357-60.

Lofberg E, Wernerman J, Noree LO, von der Decken A, Vinnars E. Ribosome and free
amino acid content in muscle during hemodialysis. Kidney Int 1991
May;39(5):984-9.

London GM, Marchais SJ, Guerin AP, Fabiani F, Metivier F. Cardiovascular function
in hemodialysis patients. Adv Nephrol Necker Hosp 1991;20: 249-73.

Longfield RN, Wortham WG, Fletcher LL, Nauscheutz WF. Clustered bacteremias in
a hemodialysis unit: cross-contamination of blood tubing from ultrafiltrate
waste. Infect Control Hosp Epidemiol 1992 Mar;13(3):160-4.

Lonnemann G. Dialysate bacteriological quality and the permeability of dialyzer
membranes to pyrogens. Kidney Int Suppl 1993;41:S195-200.

Lonnemann G, Behme TC, Lenzner B, Floege J, Schulze M, Colton CK, Koch KM,
Shaldon S. Permeability of dialyzer membranes to TNF alpha-inducing substances
derived from water bacteria. Kidney Int 1992 Jul;42(1):61-8.

Lonnemann G, Floege J, Shaldon S, Koch KM. Blood-dialyzer interactions: their
role in long-term complications of hemodialysis. Contrib Nephrol 1992;100:155-71.

Lonnemann G, Mahiout A, Schindler R, Colton CK. Pyrogen retention by the
polyamide membranes. Contrib Nephrol 1992;96:47-63.

Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis
patients: relationships among them and to death risk. Semin Nephrol 1992
May;12(3):276-83.

Lubrano R, Taccone-Gallucci M, Piazza A, Morosetti M, Meloni C, Citti G,
Mannarino O, Castello MA, Casciani CU. Vitamin E supplementation and oxidative
status of peripheral blood mononuclear cells and lymphocyte subsets in
hemodialysis patients. Nutrition 1992 Mar-Apr;8(2):94-7.

Luciak M. Oxidative metabolism of peripheral blood neutrophils in chronic renal
failure on conservative and dialysis treatment. Arch Immunol Ther Exp (Warsz)
1992;40(2):93-5.

Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with
different membranes. Nephrol Dial Transplant 1991;6 Suppl 3:66-70.

Lundahl J, Hed J, Jacobson SH. Dialysis granulocytopenia is preceded by an
increased surface expression of the adhesion-promoting glucoprotein Mac-1.
Nephron 1992;61(2):163-9.

Lye WC, Leong SO, Lee EJC. Methicillin-resistant Staphylococcus aureus nasal
carriage and infections in CAPD. Kidney Int 1993;43(6):1357-62.

Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure
and hemodialysis populations. Am J Kidney Dis 1992 Jun;19(6):505-13.

Mackenzie RK, Coles GA, Williams JD. The response of human peritoneal macrophages
to stimulation with bacteria isolated from episodes of continuous ambulatory
peritoneal dialysis-related peritonitis. J Infect Dis 1991;163(4):837-42.

Maillet F, Kazatchkine MD. Specific antibodies enhance alternative complement
pathway activation by cuprophane. Nephrol Dial Transplant 1991;6(3):193-7.

Main J, Ward MK. Potentiation of aluminium absorption by effervescent analgesic
tablets in a haemodialysis patient. BMJ 1992 Jun 27;304(6843):1686.

Malaponte G, Mazzarino C, Fatuzzo P, Interlandi P, Monte V, Nicosia A, Rosa
Calamaro A, Rapisarda F. IL-2 and its receptors in elderly subjects on
hemodialysis. Arch Gerontol Geriatr 1991;12 Suppl 2:527-30.

Malluche HH, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed
patients. Kidney Int Suppl 1992 Oct;38:S62-7.

Man NK, Chauveau P, Kuno T, Poignet JL, Yanai M. Phosphate removal during
hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans
1991 Jul-Sep;37(3):M463-5.

Manescalchi F, De Mayo E, Bertoni E, Martinelli F, Parri F, Ciccarelli C, Baccaro
C, Lo Nostro A, Comodo N. Anti-hepatitis C virus epidemiological study in two
dialysis centers in Florence. Nephron 1992;61(3):342-3.

Marangella M, Bagnis C, Bruno M, Petrarulo M, Gabella P, Linari F. Determinants
of oxalate balance in patients on chronic peritoneal dialysis. Am J Kidney Dis
1993 Apr;21(4):419-26.

Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma
profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
Nephron 1992;60(1):74-80.

Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of alpha 1-
proteinase inhibitor in restraining peritoneal inflammation in CAPD patients.
Kidney Int 1992 Sep;42(3):735-42.

Markert M, Wauters JP. New aspects on oxidative metabolism of neutrophils during
hemodialysis on different dialyzer membranes. Adv Exp Med Biol 1991;297:207-13.

Marsen TA, Pollok M, Baldamus CA. Influence of various hemofilter membranes in
elimination of beta-2-microglobulin during dialysis treatment. Dial Transplant
1992;21(12):788-9, 792, 805.

Martin-Malo A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P.
Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.
Kidney Int Suppl 1993;41: S213-6.

Martinson E, Wieslander A, Kjellstrand P, Boberg U. Toxicity of heat sterilized
peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992
Jul-Sep;38(3):M370-2.

Marumo F, Shichiri M, Emori T, Ando K. Circulating and excreted forms of atrial
natriuretic peptide in healthy subjects and patients with renal diseases. Clin
Nephrol 1992 Oct;38(4):203-8.

Matthys E, Schurgers M, Lamberigts G, Lameire N, Vandecasteele N, Labeur C,
Beisiegel U, Rosseneu M. Effect of simvastatin treatment on the
dyslipoproteinemia in CAPD patients. Atherosclerosis 1991 Feb;86(2-3):183-92.

Maurin N. Antithrombotic management with a stable prostacyclin analogue during
extracorporeal circulation. Contrib Nephrol 1991;93:205-9.

McCance DR, Maxwell AP, Hill CM, Doherty CC. Glomerulonephritis associated with
antibodies to neutrophil cytoplasm and glomerular basement membrane. Postgrad Med
J 1992 Mar;68(797):186-8.

McClellan WM, Anson C, Birkeli K, Tuttle E. Functional status and quality of
life: predictors of early mortality among patients entering treatment for end
stage renal disease. J Clin Epidemiol 1991;44(1):83-9.

McConnell KN, Rolton HA, Modi KS, MacDougall AI. Plasma oxalate in patients with
chronic renal failure receiving continuous ambulatory peritoneal dialysis or
hemodialysis. Am J Kidney Dis 1991 Oct;18(4):441-5.

McKenna RM, MacDonald C, Berstein K, Rush D. Tumor necrosis factor and
hemodialysis [abstract]. Clin Invest Med 1991;14(4 Suppl):A135.

Mege JL, Olmer M, Purgus R, Bertocchio P, Farnarier C, Kaplanski S, Capo C,
Bongrand P. Haemodialysis membranes modulate chronically the production of TNF
alpha, IL1 beta and IL6. Nephrol Dial Transplant 1991;6(11):868-75.

Mege JL, Sanguedolce MV, Purgus R, Moulin B, Bongrand P, Capo C, Olmer M. Chronic
and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-
alpha production: relationship to endotoxins. Am J Kidney Dis 1992
Nov;20(5):482-8.

Memoli B, Libetta C, Rampino T, Dal Canton A, Conte G, Scala G, Ruocco MR,
Andreucci VE. Hemodialysis related induction of interleukin-6 production by
peripheral blood mononuclear cells. Kidney Int 1992 Aug;42(2):320-6.

Memoli B, Libetta C, Rampino T, De Simone W, Meccariello S, Stangerlin P, Dal
Canton A, Andreucci VE. Interleukin-6 production of uraemic haemodialysed
patients: effects of different membranes. Nephrol Dial Transplant 1991;6 Suppl
2:96-8.

Merchant MR, Hutchinson AJ, Butler SJ, Boulton H, Hintchliffe R, Gokal R.
Calcium, magnesium mass transfer and lactate balance study in CAPD patients with
reduced calcium/magnesium and high lactate dialysis fluid. Adv Perit Dial
1992;8:365-8.

Michel A, Goldwasser P, Tan D, Antignani A, Fein PA, Mittman N, Avram MM.
Correlates of four-year survival on hemodialysis [abstract]. J Am Soc Nephrol
1991;2(3):339.

Milly K, Wit L, Diskin C, Tulley R. Selenium in renal failure patients. Nephron
1992;61(2):139-44.

Miyata T, Inagi R, Hong K, Iida Y, Oda O, Kinoshita T, Inoue K, Miyama A, Maeda
K. Fluid-phase activation of the alternative pathway of complement by excess
factor D in regularly dialyzed patients. Nephron 1992;60(2):144-9.

Miyata T, Inagi R, Oda O, Inoue I, Okada H, Miyama A, Nakashima I, Maeda K.
Deterioration of immune complex solubilization activity of serum by increased
concentration of factor D. Nephron 1991;59(3):409-15.

Mocan MZ, Mocan H, Fell GS, Junor BJ, Boyce BF. Autonomous hyperparathyroidism
not associated with increased aluminum absorption. Isr J Med Sci 1992
Jan;28(1):24-6.

Moinard J, Guenard H. Membrane diffusion of the lungs in patients with chronic
renal failure. Eur Respir J 1993 Feb;6(2):225-30.

Mondelli MU, Smedile V, Piazza V, Villa G, Barbieri C, Gattarello G, Mancini F,
Raimondo G. Abnormal alanine aminotransferase activity reflects exposure to
hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant
1991;6(7):480-3.

Montalto G, Carroccio A, Sparacino V, Lorello D, Di Martino D, Soresi M, Galione
A, Notarbartolo A. Pancreatic enzymes in chronic renal failure and transplant
patients. Int J Pancreatol 1992 Dec;12(3):211-7.

Moore GE, Brinker KR, Stray-Gundersen J, Mitchell JH. Determinants of VO2 peak
in patients with end-stage renal disease: on and off dialysis. Med Sci Sports
Exerc 1993 Jan;25(1):18-23.

Morgan JD, Tilsed JV, Bell PR, Veitch PS, Donnelly PK. Continuous ambulatory
peritoneal dialysis in patients with aortic grafts. Br J Surg 1992
Aug;79(8):755-6.

Morton LP, Reynolds L, Zent R, Rayner BL. Hearing thresholds in CAPD patients.
Adv Perit Dial 1992;8:150-2.

Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T,
Ichikawa I. Role for "uremic toxin" in the progressive loss of intact nephrons
in chronic renal failure. Kidney Int 1991 Sep;40(3):461-9.

Moughal NA, McGregor SJ, Brock JH, Briggs JD, Junor BJ. Expression of transferrin
receptors by monocytes and peritoneal macrophages from renal failure patients
treated by continuous ambulatory peritoneal dialysis (CAPD). Eur J Clin Invest
1991 Dec;21(6):592-6.

Mrowka Ch, Schiffl H. Comparative evaluation of beta 2-microglobulin removal by
different hemodialysis membranes: a six-year follow-up. Nephron 1993;63(3):368-9.

Muijsken MA, Heezius HJ, Verhoef J, Verbrugh HA. Role of mesothelial cells in
peritoneal antibacterial defence. J Clin Pathol 1991 Jul;44(7):600-4.

Muirhead N, Mitton R. Use of bone char as an adsorbent in preparation of water
for dialysis. ASAIO J 1992 Jul-Sep;38(3):M334-7.

Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado
IV. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int
1992 Apr;41(4):1055-8.

Murphy BG, McNamee P, Duly E, Henry W, Archbold P, Trinick T. Increased serum
apolipoprotein (a) in patients with chronic renal failure treated with continuous
ambulatory peritoneal dialysis. Atherosclerosis 1992 Mar;93(1-2):53-7.

Nakahama H, Nakanishi T, Uyama O, Sugita M, Miyazaki M, Yokokawa T, Okamura K,
Tanaka Y, Shirai D. Niceritrol reduces plasma lipoprotein (a) levels in patients
undergoing maintenance hemodialysis. Renal Fail 1993;15(2):189-93.

Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, Yokokawa T, Okada M, Kubori
S. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and
hemodialysis patients. Nephron 1992;61(2):132-4.

Nakamura M, Suzuki H, Yamakawa H, Saruta T. Role of platelet cytosolic calcium
in regulation of blood pressure in patients on chronic hemodialysis. Nephron
1992;61(4):435-41.

Nakamura Y, Chida Y, Tomura S. Enhanced coagulation-fibrinolysis in patients on
regular hemodialysis treatment. Nephron 1991;58(2):201-4.
Nakamura Y, Tomura S, Tachibana K, Chida Y, Marumo F. Enhanced fibrinolytic
activity during the course of hemodialysis. Clin Nephrol 1992 Aug;38(2):90-6.

Nakano H, Gomi H, Shibasaki T, Ishimoto F, Sakai O. An experimental study on
selective elimination of beta 2-microglobulin using immunoadsorption method in
patients with chronic renal failure. Biomater Artif Cells Immobilization
Biotechnol 1991;19(1):61-9.

Nelson SR, Tennent GA, Sethi D, Gower PE, Ballardie FW, Amatayakul-Chantler S,
Pepys MB. Serum amyloid P component in chronic renal failure and dialysis. Clin
Chim Acta 1991 Aug 30;200(2-3):191-9.

Nguyen P, Toupance O, Chanard J, Potron G. Variations of protein C in uremic
hemodialysed patients. Thromb Res 1993 Mar 15;69(6):509-18.

Nielsen G, Bredahl C, Nielsen C. Continuous blood gas monitoring in haemodialysis
using an electrode inserted in the extracorporeal dialysis circulation. Scand J
Clin Lab Invest 1993 Apr;53(2):197-200.

Nielsen H, Espersen F, Kharazmi A, Antonsen S, Ejlersen E, Joffe P, Pedersen FB.
Specific opsonic activity for staphylococci in peritoneal dialysis effluent
during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992
Oct;20(4):372-5.

Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M, Takahashi
H, Yoshimura M. Serum calcium increases the incidence of arrhythmias during
acetate hemodialysis. Am J Kidney Dis 1992 Feb;19(2):149-55.

Nishitani H, Yamakawa M, Nishizawa Y, Morii H. Bone mineral loss in patients on
maintenance hemodialysis with hyperphosphatemia treated with 1 alpha-
hydroxycholecalciferol and calcium carbonate. J Nutr Sci Vitaminol (Tokyo) 1991
Dec;37 Suppl:S113-8.

Nissenson AR. Dialysis therapy in the elderly patient. Kidney Int Suppl 1993
Feb;40:S51-7.

Nuwayri-Salti N, Jabre F, Daouk M, Sa'ab G, Salem Z. Hematologic parameters and
iron stores in patients on hemodialysis for chronic renal failure. Clin Nephrol
1992 Aug;38(2):101-4.

Nuwayri-Salti N, Jabre F, Saab G, Daouk M, Salem Z. Blood leukocyte contribution
to serum ferritin levels in patients on chronic hemodialysis. Nephron
1991;57(2):144-8.

O'Doherty MJ, Breen D, Page C, Barton I, Nunan TO. Lung 99mTc DTPA transfer in
renal disease and pulmonary infection. Nephrol Dial Transplant 1991;6(8):582-7.

Oettinger CW, Oliver JC, Macon EJ. The effects of calcium carbonate as the sole
phosphate binder in combination with low calcium dialysate and calcitriol therapy
in chronic hemodialysis patients. J Am Soc Nephrol 1992 Oct;3(4):995-1001.

Olivares J, Cruz C, Gas JM, Prados MC, Perdiguero M, Caparros G, Santiago C,
Franco A. Evolution of lipid profiles in long-term peritoneal dialysis. Adv Perit
Dial 1992;8:373-5.

Onishi S, Andress DL, Maloney NA, Coburn JW, Sherrard DJ. Beta 2-microglobulin
deposition in bone in chronic renal failure. Kidney Int 1991 May;39(5):990-5.

Opatrny K Jr, Opatrny K, Vit L, Racek J, Valek A. What are the factors
contributing to the changes in tissue-type plasminogen activator during
haemodialysis? Nephrol Dial Transplant 1991;6 Suppl 3:26-30.

Os I, Nordby G, Lyngdal PT, Eide I. Plasma vasopressin, catecholamines and atrial
natriuretic factor during hemodialysis and sequential ultrafiltration. Scand J
Urol Nephrol 1993;27(1):93-9.

Ozben T. Elevated serum and urine sialic acid levels in renal diseases. Ann Clin
Biochem 1991 Jan;28(Pt 1):44-8.

Ozdemir O, Arik N, Ozcebe O, Arinsoy T, Sungur C, Dundar S, Turgan C, Yasavul U,
Caglar S, Kirazli S. Evidence for the role of dialysis hypoxemia in the
pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator.
Thromb Res 1992 Sep 15;67(6):697-704.

Pacitti A, Tetta C, Mangiarotti G, Canavese C, Segoloni GP. Beta-2-microglobulin
serum profiles in different settings of mass transport and fluid pyrogen content.
Kidney Int Suppl 1993;41:S96-9.

Paczek L, Czarkowska B, Schaefer L, Schaefer RM, Heidland A. Effect of beta 2-
microglobulin on immunoglobulin production. Immunol Lett 1992 Jun;33(1):87-91.

Paczek L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and
interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol
Dial Transplant 1991;6 Suppl 3:41-4.

Padovese P, Gallieni M, Brancaccio D, Pietra R, Fortaner S, Sabbioni E, Minoia
C, Markakis K, Berlin A. Trace elements in dialysis fluids and assessment of the
exposure of patients on regular hemodialysis, hemofiltration and continuous
ambulatory peritoneal dialysis. Nephron 1992;61(4):442-8.

Pagliari B, Baretta A, De Cristofaro V, Sama F, Cantaluppi A, Martis L,
Imbasciati E. Short-term effects of low-calcium dialysis solutions on calcium
mass transfer, ionized calcium, and parathyroid hormone in CAPD patients. Perit
Dial Int 1991;11(4):326-9.

Parfrey PS. Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney
Dis 1993 Jan;21(1):77-80.

Paul JL, Roch-Arveiller M, Man NK, Luong N, Moatti N, Raichvarg D. Influence of
uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal
disease and dialyzed patients. Nephron 1991;57(4):428-32.

Paul JL, Sall ND, Soni T, Poignet JL, Lindenbaum A, Man NK, Moatti N, Raichvarg
D. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron
1993;64(1):106-9.

Pauri P, Salvoni G, Vitolo W, Carletti P, Fanciulli E, Ricciatti AM, Della Bella
S, Mioli VA. Risk factors and clinical expression of HCV infection in
hemodialysis patients. Nephron 1992;61(3):313-4.

Pelegri A, Romero R, Senti M, Nogues X, Pedro-Botet J, Rubies-Prat J. Effect of
bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including
intermediate-density lipoproteins, in patients with chronic renal failure
receiving haemodialysis. Nephrol Dial Transplant 1992;7(7):623-6.

Pereira BJ, Poutsiaka DD, King AJ, Strom JA, Narayan G, Levey AS, Dinarello CA.
In vitro production of interleukin-1 receptor antagonist in chronic renal
failure, CAPD and HD. Kidney Int 1992 Dec;42(6):1419-24.

Pereira BJ, Poutsiaka DD, Strom JA, Narayan G, Levey AS, King AJ, Dinarello CA.
Effect of first use and reuse of cuprophane membrane on interleukin-1-beta il-1-
beta production by peripheral blood mononuclear cells PBMC. J Am Soc Nephrol
1991;2(3):344.

Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Moncalian J, Fernandez-Rivera C,
Cao M, Valdes F. Treatment of Staphylococcus aureus nasal carriers in CAPD with
mupirocin. Adv Perit Dial 1992;8:242-5.

Pertosa G, Gesualdo L, Tarantino EA, Ranieri E, Bottalico D, Schena FP. Influence
of hemodialysis on interleukin-6 production and gene expression by peripheral
blood mononuclear cells. Kidney Int Suppl 1993 Jan;39:S149-53.

Pertosa G, Marfella C, Tarantino EA, Di Cillo M, Manno C, Russo R, Schena FP.
Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of
tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin. Nephrol
Dial Transplant 1991;6 Suppl 2:18-23.

Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and
cytokine production in hemodialyzed patients. Kidney Int Suppl 1993;41:S221-5.

Petersen J, Moore RM Jr, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. The
effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-
microglobulin removal from hemodialysis patients. Am J Kidney Dis 1991
Feb;17(2):174-8. Published erratum appears in Am J Kidney Dis 1991 Jul;18(1):144.

Phillips G, Hudson S, Stewart WK. Microbial growth and blockage of sub-floor
drains in a renal dialysis centre: a problem highlighted. J Hosp Infect 1992
Jul;21(3):193-8.

Piraino B, Perlmutter JA, Holley JL, Johnston JR, Bernardini J. The use of
dialysate containing 2.5 mEq/l calcium in peritoneal dialysis patients. Perit
Dial Int 1992;12(1):75-6.

Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and
technique failure by CAPD connection technique: a national study. Kidney Int 1992
Oct;42(4):967-74.

Portman RJ, Scott RC III, Rogers DD, Loose-Mitchell DS, Lemire JM, Weinberg RB.
Decreased low-density lipoprotein receptor function and mRNA levels in
lymphocytes from uremic patients. Kidney Int 1992;42(5):1238-46.

Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero
MS. Enhanced release of TNF-alpha, but not IL-1 beta, from uremic blood after
endotoxin stimulation. Lymphokine Cytokine Res 1991 Oct;10(5):343-6.

Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero
MS. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation
during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991
Nov;2(5):1007-13.

Puppo F, Gurreri G, Pattarini R, Ranise A, Indiveri F. Proliferation in
autologous mixed lymphocyte reactions, expression of HLA-class II antigen and
serum immunomodulatory activity in patients with renal insufficiency on chronic
dialysis. Allergol Immunopathol (Madr) 1991 Jul-Aug;19(4):167-73.

Querfeld U, LeBoeuf RC, Salusky IB, Nelson P, Laidlaw S, Fine RN. Lipoproteins
in children treated with continuous peritoneal dialysis. Pediatr Res 1991
Feb;29(2):155-9.

Querfeld U, Wendtland J, von Hodenberg E, Mehls O. Lipid levels in monocytes of
patients with moderate hyperlipoproteinemia. Atherosclerosis 1992
Jun;94(2-3):129-34.

Qureshi GA, Baig SM. Application of high performance liquid chromatography in
study of sulphur amino acid metabolism in uremic patients. Biochem Mol Biol Int
1993 Feb;29(2):359-68.

Ramirez JA, Goodman WG, Menezes C, Segre GV, Salusky IB. Disodium
ethylenediaminetetraacetate: adverse effects in dialyzed children. Pediatr
Nephrol 1993 Apr;7(2):182-4.

Reichel H, Recker A, Deppisch R, Stier E, Ritz E. 25-Hydroxyvitamin D3 metabolism
in vitro by mononuclear cells from hemodialysis patients. Nephron
1992;62(4):404-12.

Remuzzi A, Boccardo P, Benigni A. In vitro platelet adhesion to dialysis
membranes. Nephrol Dial Transplant 1991;6 Suppl 2:36-9.

Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M,
Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in
patients with chronic renal failure. Nephron 1991;57(1):10-5.

Ringoir S, Vanholder R. Phagocytic function in the uremic patient. Contrib
Nephrol 1992;100:15-24.

Roccatello D, D'Alfonso S, Peruccio D, Quattrocchio G, Cavalli G, Isidoro C,
Piccoli G, Richiardi PM. Induction of mRNA for tumor necrosis factor alpha in
hemodialysis. Kidney Int Suppl 1993 Jan;39: S144-8.

Rodby RA, Trenholme GM. Vaccination of the dialysis patient. Semin Dial 1991 Apr-
Jun;4(2):102-5.

Rodger RS, Muralikrishna GS, Halls DJ, Henderson JB, Forrest JA, Macdougall AI,
Fell GS. Ranitidine suppresses aluminium absorption in man. Clin Sci 1991
May;80(5):505-8.

Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F. The effect of long-
term intravenous calcitriol administration on parathyroid function in
hemodialysis patients. J Am Soc Nephrol 1991 Nov;2(5):1014-20.

Roger SD, Crewe E, Cunningham A, Harris DC. Hepatitis C virus infection in
haemodialysis patients. Aust N Z J Med 1991 Feb;21(1):22-4.

Ross RD, Kalidindi V, Vincent JA, Kassab J, Dabbagh S, Hsu JM, Pinsky WW. Acute
changes in endothelin-1 after hemodialysis for chronic renal failure. J Pediatr
1993 Jun;122(6):S74-6.

Rudnicki M, McNair P, Transbl I, Nielsen B. Lack of relationship between
parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure. Nephron
1991;58(2):144-9.

Ryan JJ, Beynon HL, Rees AJ, Cassidy MJ. In vitro production of tumor necrosis
factor by monocytes cultured from dialysis patients. Kidney Int Suppl
1993;41:S226-9.

Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno J.
Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-
stage renal disease. Am J Nephrol 1991;11(1):37-43.

Sacchetti A, Harris R, Patel K, Attewell R. Emergency department presentation of
renal dialysis patients: indications for EMS transport directly to dialysis
centers. J Emerg Med 1991 May-Jun;9(3):141-4.

Sadler DB, Brown J, Nurse H, Roberts J. Impact of hemodialysis on left and right
ventricular Doppler diastolic filling indices. Am J Med Sci 1992
Aug;304(2):83-90.

Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma
parameters of the prothrombotic state in chronic uremia. Nephron
1993;63(3):273-8.

Saha H, Pietila K, Mustonen J, Pasternack A, Morsky P. Acute effect of dialysate
calcium concentration and intravenous vitamin D3 on the secretion of parathyroid
hormone in hemodialysis patients. Clin Nephrol 1992 Sep;38(3):145-8.

Saito Y, Kazuwa N, Shirakami G, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y,
Imura H. Endothelin in patients with chronic renal failure. J Cardiovasc
Pharmacol 1991;17 Suppl 7:S437-9.

Sakaguchi K, Morimoto S, Chen YH, Nakamoto Y, Ogihara T. Increases in circulating
level of platelet-activating factor lag behind transient neutropenia during
hemodialysis with cuprophane membranes. Nephron 1991;59(3):455-60.

Sanders PW. Role of nitric oxide in regulation of blood pressure. J Nephrol
1992;5(1):23-30.

Saniabadi AR, Fisher TC, Lau CS, Bridges A, Taylor J, Belch J, Forbes CD.
Dipyridamole increases human red blood cell deformability. Eur J Clin Pharmacol
1992;42(6):651-4.

Santoro A, Spongano M, Ferrari G, Bolzani R, Augella F, Borghi M, Briganti M,
Cagnoli L, Docci D, Feletti C, Fusaroli M, Gattiani A, Sanna G, Stallone C,
Zucchelli P. Analysis of the factors influencing bicarbonate balance during
acetate-free biofiltration. Kidney Int Suppl 1993;41:S184-7.

Saragoca MA, Canziani ME, Cassiolato JL, Gil MA, Andrade JL, Draibe SA, Martinez
EE. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis
patients. J Cardiovasc Pharmacol 1991;17 Suppl 2:S136-8.

Sasagawa I, Nakada T, Hashimoto T, Ishigooka M, Kubota Y, Hirano K, Hirano J,
Suzuki Y. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic
specific antigen in hemodialysis patients. Urol Int 1992;48(2):181-3.

Sato Y, Takagi T, Seto H, Shibayama S, Narumiya K, Osaku A, Koyama S, Uchiyama
T, Kajiwara N. Diastolic properties of the left ventricle in uremic patients
undergoing long-term hemodialysis. Nihon Univ J Med 1991;33(4):279-90.

Savica V, Bellinghieri G, Barbera CM, Egitto M, Consolo F. The coagulative system
in haemodialyzed patients: the relationship between the elderly and
hypertrygliceridaemia. Arch Ital Urol Nefrol Androl 1992 Jun;64(2):155-63.

Schaefer F, Hamill G, Stanhope R, Preece MA, Scharer K. Pulsatile growth hormone
secretion in peripubertal patients with chronic renal failure. Cooperative Study
Group on Pubertal Development in Chronic Renal Failure. J Pediatr 1991
Oct;119(4):568-77.

Schaefer F, Seidel C, Mitchell R, Scharer K, Robertson WR. Pulsatile
immunoreactive and bioactive luteinizing hormone secretion in adolescents with
chronic renal failure. The Cooperative Study Group on Pubertal Development in
Chronic Renal Failure (CSPCRF). Pediatr Nephrol 1991 Jul;5(4):566-71.

Schaefer RM, Paczek L, Heidland A. Cytokine production by monocytes during
haemodialysis. Nephrol Dial Transplant 1991;6 Suppl 2:14-7.

Schaefer RM, Paczek L, Heidland A. Suppression of beta 2-microglobulin release
from lymphocytes by dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl
3:53-6.

Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the
biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD
solutions and effluents. Adv Perit Dial 1992;8:42-6.

Schauer S, Stein G, Suss J, Falkenhagen D, Linss W. Phagocytosis activity of
polymorphonuclear cells of normal persons and dialysis patients is influenced by
different dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl 3:35-40.

Schiffl H. Correlation of blood pressure in end-stage renal disease with platelet
cytosolic free calcium concentration during treatment of renal anemia with
recombinant human erythropoietin. Int J Artif Organs 1992;15(6):343-8.

Schiffl H, D'Agostini B, Held E. Removal of beta 2-microglobulin by hemodialysis
and hemofiltration: a four year follow up. Biomater Artif Cells Immobilization
Biotechnol 1992;20(5):1223-32.

Schiller B, Ziegler-Heitbrock HW, Meyer N, Schmidt B, Blumenstein M. Monocyte
phenotype and interleukin-1 production in patients undergoing haemodialysis.
Nephron 1991;59(4):573-9.

Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch
KM. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 1993
Mar;43(3):712-21.

Schlatter C. Biomedical aspects of aluminium. Med Lav 1992 Sep-Oct;83(5):470-4.

Schmidtmann S, Muller M, von Baehr R, Precht K. Changes of antioxidative
homeostasis in patients on chronic haemodialysis. Nephrol Dial Transplant 1991;6
Suppl 3:71-4.

Schohn DC, Jahn HA, Pelletier BC. Dose-related cardiovascular effects of
spironolactone. Am J Cardiol 1993;71(3):40a-5a.

Selgas R, Castro MJ, Bajo MA, Fernandez-Reyes MJ, Lopez-Revuelta K, Romero JR,
de Alvaro F, Borrego F, Rinon C. Staphylococcus aureus nasal carrier status
(SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-
erythropoietin? Adv Perit Dial 1992;8:253-7.

Selgas R, Lopez-Rivas A, Miranda B, Munoz J, Rinon C, Borrego F, Molina S,
Sanchez-Sicilia L. Characterisation of the mitogenic-induced capacity of
peritoneal effluent on human and mice fibroblasts in culture. Nephrol Dial
Transplant 1991;6(1):44-50.

Selgas R, Martinez ME, Miranda B, Bajo MA, Romero JR, Ausejo M, Sanchez-Cabezudo
MJ, Lopez-Revuelta K, Sanchez-Sicilia L. The pharmacokinetics of a single dose
of calcitriol administered subcutaneously in continuous ambulatory peritoneal
dialysis patients. Perit Dial Int 1993;13(2):122-5.

Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein
abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with
chronic renal failure. Kidney Int 1992 May;41(5):1394-9.

Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma
lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993
Jan;3(7):1409-15.

Shaldon S. Dialyzer reuse: the time has come to stop this practice. Dial
Transplant 1993;22(3):122, 125-6.

Shapira OM, Bar-Khayim Y. ECG changes and cardiac arrhythmias in chronic renal
failure patients on hemodialysis. J Electrocardiol 1992 Oct;25(4):273-9.

Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and
HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992
Jun;37(2):108-12.

Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. High serum lipoprotein(a)
concentrations in uremic patients treated with continuous ambulatory peritoneal
dialysis. Clin Nephrol 1992 Nov;38(5):271-6.

Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of
high density lipoprotein in uremic patients. Kidney Int 1992 Jun;41(6):1653-61.

Shulman LM, Rudich C, Sayar Y, Goldfeld G, Mendelson E, Blau A, Vonsover A.
Detection of CMV-DNA in cells from peritoneal fluid of IPD/CAPD patients by
polymerase chain reaction. Adv Perit Dial 1992;8:258-64.

Sieniawska M, Roszkowska-Blaim M, Weglarska J, Jabczynska A, Welc-Dobies J.
Calcium carbonate as a phosphate binder in children on continuous ambulatory
peritoneal dialysis and hemodialysis. Mater Med Pol 1991 Jul-Sep;23(3):203-8.

Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus
anticoagulant in patients treated with different methods of renal replacement
therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol
1992 Aug;65(2):79-82.

Skroeder NR, Jacobson SH, Holmquist B, Kjellstrand P, Kjellstrand CM. Beta 2-
microglobulin generation and removal in long slow and short fast hemodialysis.
Am J Kidney Dis 1993 May;21(5):519-26.

Sloand EM, Sloand JA, Prodouz K, Klein HG, Yu MW, Harvath L, Fricke W. Reduction
of platelet glycoprotein Ib in uraemia. Br J Haematol 1991 Mar;77(3):375-81.
Comment in: Br J Haematol 1992 May;81(1):131.

Smit JC, Jones JG. Oxygen saturation during hemodialysis. Ren Fail
1993;15(2):239-45.

Smolenski O, Tabarowski Z, Miszta H, Dabrowski Z. Effect of haemodialysate and
its peptide fractions on lactate dehydrogenase activity in erythrocytes from
healthy subjects and patients with end-stage renal disease. Int Urol Nephrol
1992;24(6):673-8.

Smollich BP, Falkenhagen D, Schneidewind J, Mitzner S, Klinkmann H. Importance
of endotoxins in high-flux dialysis. Nephrol Dial Transplant 1991;6 Suppl 3:83-5.
Comment in: Nephrol Dial Transplant 1992;7(8):884-5.

Sohn HJ, Stokes GS, Johnston H. An Na, K ATPase inhibitor from ultrafiltrate
obtained by hemodialysis of patients with uremia. J Lab Clin Med 1992
Aug;120(2):264-71.

Solomon R, Dubey A. Diltiazem enhances potassium disposal in subjects with end-
stage renal disease. Am J Kidney Dis 1992 May;19(5):420-6.

Solski J, Ksiazek A, Szymonik-Lesiuk S, Marzec Z. Membrane ATPase, erythrocyte
sodium and potassium in haemodialysis patients. Int Urol Nephrol
1991;23(3):275-80.

Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum
albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis
1993 Jan;21(1):26-30.

Spiegel DM, Sprague SM. Serum amyloid P component: a predictor of clinical beta
2-microglobulin amyloidosis. Am J Kidney Dis 1992 May;19(5):427-32.

Stein G, Schneider A, Thoss K, Ritz E, Linke RP, Schaefer K, Sperschneider H,
Abendroth K, Funfstuck R. Beta-2-microglobulin-derived amyloidosis: onset,
distribution and clinical features in 13 hemodialysed patients. Nephron
1992;60(3):274-80.

Stein G, Schneider A, Thoss K, Ritz E, Schaefer K, Huller M, Sperschneider H,
Marzoll I. Beta 2-microglobulin serum concentration and associated amyloidosis
in dialysis patients. Nephrol Dial Transplant 1991;6 Suppl 3:57-61.

Steyn ME, Viljoen M, Ubbink JB, van Rensburg BW, Reinach SG. Whole blood
serotonin levels in chronic renal failure. Life Sci 1992;51(5):359-66.

Stockenhuber F, Gottsauner-Wolf M, Marosi L, Liebisch B, Kurz RW, Balcke P.
Plasma levels of endothelin in chronic renal failure and after renal
transplantation: impact on hypertension and cyclosporin A-associated
nephrotoxicity. Clin Sci 1992 Mar;82(3):255-8.

Subra JF, Krari N, Tirot P, Mauras Y, Balit G, Van-Weydevelt FC, Allain P.
Aluminium determination in the skin of patients with and without end-stage renal
failure. Nephron 1991;58(2):170-3.

Sugisaki H, Yamada K, Kataoka H, Kunitomo T. Long-term observation on renal-
osteodystrophy-related parameters in dialysis patients. Nephrol Dial Transplant
1991;6 Suppl 2:99-103.

Sulkova S, Laurincova Z, Valek A. Haemofiltration or haemodialysis in aluminium
elimination? Nephrol Dial Transplant 1991;6 Suppl 3:3-5.

Sulkova S, Valek A. Aluminum elimination in patients receiving regular dialysis
treatment for chronic renal failure. Trace Elem Med 1991;8 Suppl 1: S26-30.

Sulowicz W, Hanicki Z, Chichocki T, Zembala M, Ruggiero I, Uracz W. Functional
characteristics of peritoneal macrophages of renal failure patients on peritoneal
dialysis. Perit Dial Int 1991;11(3):265-9.

Sulowicz W, Hanicki Z, Uracz W, Hajto B, Ruggiero I, Zembala M. Effect of
peritoneal macrophages from intermittent peritoneal dialysis patients on
lymphocytes in culture. Perit Dial Int 1992;12(2):234-40.

Sundaram S, Irvine L, Courtney JM, Lowe GD. Modification of the influence of
biomaterials on contact activation. Int J Artif Organs 1991 Nov;14(11):729-31.

Sunder-Plassmann G, Heinz G, Wagner L, Prychzy B, Derfler K. T-cell selection and
T-cell receptor variable beta-chain usage in chronic hemodialysis patients. Clin
Nephrol 1992 May;37(5):252-9.

Sunder-Plassmann G, Sedlacek PL, Sunder-Plassmann R, Derfler K, Swoboda K,
Fabrizii V, Hirschl MM, Balcke P. Anti-interleukin-1 alpha autoantibodies in
hemodialysis patients. Kidney Int 1991 Oct;40(4):787-91.

Suowicz W, Lisiewicz J, Kosiniak-Kamysz A. Activity of some lysosomal enzymes in
peritoneal lymphocytes from patients with terminal renal failure treated by
intermittent peritoneal dialysis. Rom J Intern Med 1991 Jul-Dec;29(3-4):167-72.

Suppiej A, Caara G, Boniver C, Pozzan GB, Montini G, Zacchello G, Zacchello F.
Somatosensory pathway dysfunction in uremic children. Brain Develop
1991;13(4):238-41.

Svehag SE. Adverse effects of clinical intervention on the complement system.
Complement Inflamm 1991;8(5-6):359-69.

Swars H, Hafner G, Weilemann LS, Ehrenthal W, Schinzel H, Prellwitz W, Meyer J.
Acute dialysis: PMN-elastase as a new parameter for controlling individual
anticoagulation with low molecular weight heparin (Fragmin). Intensive Care Med
1991;17(1):52-6.

Taccone-Gallucci M, Lubrano R, Clerico A, Meloni C, Morosetti M, Meschini L, Elli
M, Trapasso E, Castello MA, Casciani CU. Administration of GSH has no influence
on the RBC membrane: oxidative damage to patients on hemodialysis. ASAIO J 1992
Oct-Dec;38(4):855-7.

Takagi T, Nishikawa M, Mori Y, Matsubara H, Inada M. Effects of atrial
natriuretic peptide infusion and its metabolism in patients with chronic renal
failure. Endocrinol Jpn 1991 Oct;38(5):497-503.

Taylor A, Walker AW. Measurement of aluminium in clinical samples. Ann Clin
Biochem 1992 Jul;29(Pt 4):377-89.

Tetta C, David S, Biancone L, Canino F, Cambi V, Camussi G. Role of platelet
activating factor in hemodialysis. Kidney Int Suppl 1993 Jan;39: S154-7.

Tetta C, Fidelio T, Licata C, Iacono L, Sancipriano G, Biancone L, Ragni R,
Segoloni G, Camussi G. Production of tumor necrosis factor-alpha in patients on
hemodiafiltration. Nephron 1992;61(2):135-8.

Tetta C, Segoloni G, Mariano F, Montrucchio G, Turello E, Camussi G. Leukocyte-
derived mediators and biocompatibility. Nephrol Dial Transplant 1991;6 Suppl
2:24-30.

Thylen P, Lundahl J, Fernvik E, Hed J, Svenson SB, Jacobson SH. Mobilization of
an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during
hemodialysis. Am J Nephrol 1992;12(6):393-400.

Tibi L, Chhabra SC, Sweeting VM, Winney RJ, Smith AF. Multiple forms of alkaline
phosphatase in plasma of hemodialysis patients. Clin Chem 1991 Jun;37(6):815-20.
Comment in: Clin Chem 1991 Jun;37(6):783-4.

Tobe S, Chu MG, Bargman JM. Characterization of peritoneal transport in patients
with failed renal allografts receiving CAPD. Adv Perit Dial 1991;7: 39-43.

Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E.
Effect of hemodialysis on lipid peroxidation and antioxidant system in patients
with chronic renal failure. Metabolism 1992 Nov;41(11):1229-32.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of
hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 Jan-
Mar;39(1):71-80.

Trevino-Becerra A. Successful factors in peritoneal dialysis. Transplant Proc
1991;23(2):1843-4.

Tsai TJ, Tsai HF, Chen YM, Hsieh BS, Chen WY, Yen TS. CAPD in patients unable to
do their own bag change. Perit Dial Int 1991;11(4):356-8.

Turan B, Delilbasi E, Dalay N, Sert S, Afrasyap L, Sayal A. Serum selenium and
glutathione-peroxidase activities and their interaction with toxic metals in
dialysis and renal transplantation patients. Biol Trace Elem Res 1992 Apr-
Jun;33:95-102.

Turi S, Nemeth I, Vargha I, Matkovics B, Dobos E. Erythrocyte defense mechanisms
against free oxygen radicals in haemodialysed uraemic children. Pediatr Nephrol
1991 Mar;5(2):179-83.

Turney JH, Davison AM, Forbes MA, Cooper EH. Hyaluronic acid in end-stage renal
failure treated by haemodialysis: clinical correlates and implications. Nephrol
Dial Transplant 1991;6(8):566-70.

Urena P, Bonnardeaux A, Eckardt KU, Kurtz A, Drueke TB. Insulin-like growth
factor I: a modulator of erythropoiesis in uraemic patients? Nephrol Dial
Transplant 1992;7(1):40-4.

Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T.
Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and
cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant
1992;7(1):16-28.

Van Gool S, Van Damme-Lombaerts R, Cobbaert C, Proesmans W, Eggermont E. Lipid
and lipoprotein abnormalities in children on hemodialysis and after renal
transplantation. Transplant Proc 1991 Feb;23(1 Pt 2):1375-7.

Van Renterghem D, Cornelis R, Vanholder R. Behaviour of 12 trace elements in
serum of uremic patients on hemodiafiltration. J Trace Elem Electrolytes Health
Dis 1992 Sep;6(3):169-74.

Vanholder R, Dell'Aquila R, Jacobs V, Dhondt A, Veys N, Waterloss MA, Van
Landschoot N, Van Biesen W, Ringoir S. Depressed phagocytosis in hemodialyzed
patients: in vivo and in vitro mechanisms. Nephron 1993;63(4):409-15.

Vanholder R, Ringoir S. Cefodizime: enhancement of depressed phagocytosis-
associated respiratory burst activity in chronic uremic patients. Infection
1992;20 Suppl 1:S71-4.

Vanholder R, Ringoir S. Polymorphonuclear cell function and infection in
dialysis. Kidney Int Suppl 1992 Oct;38:S91-5.

Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis
membranes: small- versus large-pore membranes. Nephrol Dial Transplant
1992;7(4):333-9.

Vanholder R, Waterloos M, Van Landschoot N, Ringoir S. Suppression of
phagocytosis in patients on complement activating dialyzers. Clin Mater
1991;8(1-2):89-93.

Vannucchi MT, Vannucchi H, Humphreys M. Serum levels of vitamin A and retinol
binding protein in chronic renal patients treated by continuous ambulatorial
peritoneal dialysis. Int J Vitam Nutr Res 1992;62(2):107-12.

Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME.
Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and
hemodialysis. Kidney Int 1992 May;41(5):1400-7.

Vasile A, Allegra V, Canciani D, Forchi G, Mengozzi G. Prospective and
retrospective assessment of clinical and laboratory parameters in maintenance
hemodialysis patients with and without HCV antibodies. Nephron 1992;61(3):318-9.

Vasson MP, Paul JL, Couderc R, Albuisson E, Bargnoux PJ, Baguet JC, Raichvarg D.
Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int
J Artif Organs 1991 Feb;14(2):92-6.

Vaziri ND, Kaupke CJ, Yousefi S, Gonzales E, Cesario TC. Cytokine levels during
hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M389-91.

Viljoen M, de Oliveira AA, Milne FJ. Physical properties of the red blood cells
in chronic renal failure. Nephron 1991;59(2):271-8.

Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of
125I-beta 2-microglobulin turnover in dialyzed patients. Kidney Int 1992
Dec;42(6):1434-43.

Wadhwa NK, Howell N, Suh H, Cabralda T. Low calcium (2.5 mEq/l) and high calcium
(3.5 mEq/l) dialysate in peritoneal dialysis patients. Adv Perit Dial
1992;8:385-8.

Wakasugi K, Sasaki M, Suzuki M, Azuma N, Nobuto T. Increased concentrations of
free light chain lambda in sera from chronic hemodialysis patients. Biomater
Artif Cells Immobilization Biotechnol 1991;19(1):97-109.

Walshaw MJ, Lim R, Ahmad R, Hind CR. Bronchial reactivity in patients undergoing
long-term haemodialysis for chronic renal failure. Blood Purif 1991;9(2):70-3.

Wanner C, Frommherz K, Horl WH. Hyperlipoproteinemia in chronic renal failure:
pathophysiological and therapeutic aspects. Cardiology 1991;78(3):202-17.

Weinberg U, Dolev S, Werber MM, Shapiro MS, Shilo L, Shenkman L. Identification
and preliminary characterization of two human digitalis-like substances that are
structurally related to digoxin and ouabain. Biochem Biophys Res Commun 1992 Nov
16;188(3):1024-9.

Weinrauch LA, D'Elia JA, Gleason RE, Hampton LA, Smith-Ossman S, DeSilva RA,
Nesto RW. Usefulness of left ventricular size and function in predicting survival
in chronic dialysis patients with diabetes mellitus. Am J Cardiol 1992 Aug
1;70(3):300-3.

Weinstein T, Fishman P, Djaldetti M, Levi J. Cytokine production by mononuclear
cells from patients with chronic renal failure. Isr J Med Sci 1993
Apr;29(4):183-6.

Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal
dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991 Jul;40(1):77-9.

Wilkie ME, Khandan-Nia N, Ghatei MA, Bloom SR, Raftery MJ, Cunningham J. Does the
arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1
release? Nephrol Dial Transplant 1992;7(10):1019-21.

Willems M, de Jong G, Moshage H, Verresen L, Goubau P, Desmyter J, Yap SH.
Surrogate markers are not useful for identification of HCV carriers in chronic
hemodialysis patients. J Med Virol 1991 Dec;35(4):303-6.

Yamada K, Nakayama M, Miura Y, Nakano H, Mimura N, Yoshida S. Role of AVP in the
regulation of vascular tonus and blood pressure in patients with chronic renal
failure. Regul Pept 1993;45(1-2):91-5.

Yamalik N, Delilbasi L, Gulay H, Caglayan F, Haberal M, Caglayan G. The
histological investigation of gingiva from patients with chronic renal failure,
renal transplants, and periodontitis: a light and electron microscopic study. J
Periodontol 1991 Dec;62(12):737-44.

Yamazaki M, Asakura H, Sato T, Tsugawa Y, Matsumura M, Kawamura Y, Ohka T,
Matsuda T. Changes in plasma levels of thrombomodulin during haemodialysis. Blood
Coagul Fibrinolysis 1992 Feb;3(1):113-7.

Yukawa S, Tone Y, Sonobe M, Maeda T, Mimura K, Mune M, Fujiwara S, Tsujimoto K,
Maeshima E, Saika Y, et al. Study on the inhibitory effect of uremic plasma on
lipoprotein lipase. Nippon Jinzo Gakkai Shi 1992 Sep;34(9):979-85.

Zeferos N, Digenis GE, Christophoraki M, Alexopoulos I, Kostakis A, Gyftaki H,
Moulopoulos S. Tumor markers in patients undergoing hemodialysis or kidney
transplantation. Nephron 1991;59(4):618-20.

Zemel D, ten Berge RJ, Struijk DG, Bloemena E, Koomen GC, Krediet RT.
Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic
permeability of the peritoneal membrane. Clin Nephrol 1992 Feb;37(2):97-103.

Zevin D, Malachi T, Gafter U, Friedman J, Levi J. Impaired DNA repair in patients
with end-stage renal disease and its improvement with hemodialysis. Miner
Electrolyte Metab 1991;17(5):303-6.

Zhou XJ, Vaziri ND, Kaupke CJ. Glomerulopressin in end-stage renal disease.
Effect of hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M235-6.

Zimmerman SW, Oxton L, Roecker E, Wakeen M, Johnson CA. Risk factors for
peritoneal dialysis (PD) related infections [abstract]. J Am Soc Nephrol
1991;2(3):371.

The Role of Nutrition

-Clinical Trial

Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY. Controlled low
protein diets in chronic renal insufficiency: meta-analysis. BMJ 1992 Jan
25;304(6821):216-20. Comment in: BMJ 1992 Mar 7;304(6827):640; BMJ 1992 Apr
11;304(6832):983.

-Other

Allman MA, Pang E, Yau DF, Stewart PM, Tiller DJ, Truswell AS. Elevated plasma
vitamers of vitamin B6 in patients with chronic renal failure on regular
haemodialysis. Eur J Clin Nutr 1992 Sep;46(9):679-83.

Bergstrom J. Anorexia and malnutrition in hemodialysis patients. Blood Purif
1992;10(1):35-9.

Bergstrom J. Factors causing catabolism in maintenance hemodialysis patients.
Miner Electrolyte Metab 1992;18(2-5):280-3.

Blagg CR. Importance of nutrition in dialysis patients [editorial]. Am J Kidney
Dis 1991 Apr;17(4):458-61.

Butler BA. Nutritional management of catabolic acute renal failure requiring
renal replacement therapy. ANNA J 1991 Jun;18(3):247-59.

Cancarini G, Costantino E, Brunori G, Manili L, Camerini C, Spitti C, Maiorca R.
Nutritional status in long-term CAPD patients. Adv Perit Dial 1992;8:84-7.

Canepa A, Perfumo F, Carrea A, Giallongo F, Verrina E, Cantaluppi A, Gusmano R.
Long-term effect of amino-acid dialysis solution in children on continuous
ambulatory peritoneal dialysis. Pediatr Nephrol 1991 Mar;5(2):215-9.

Cano N, Stroumza P, Lacombe P, Labastie-Coeyrehourcq J, Durbec JP. Serum
transthyretin and protein intake in haemodialysis patients. Nephrol Dial
Transplant 1992;7(10):1069-70.

Capelli JP, Kushner H, Camiscioli TC, Chen SM, Stuccio-White N. Effect of intra-
dialytic parenteral nutrition IDPN on mortality in ESRD care [abstract]. J Am Soc
Nephrol 1992;3(3):357.

Chiappini MG, Selvaggi G, Traietti P, Bartoli R. Nutritional status in
haemodialysis patients a cross-sectional and longitudinal study [abstract].
Nephrol Dial Transplant 1992;7(7):723.

Compher C, Mullen JL, Barker CF. Nutritional support in renal failure. Surg Clin
North Am 1991;71(3):597-608.

Dabbagh S, Fassinger N, Clement K, Fleischmann LE. The effect of aggressive
nutrition on infection rates in patients maintained on peritoneal dialysis. Adv
Perit Dial 1991;7:161-4.

Dombros NV, Digenis GE, Oreopoulos DG. Malnutrition in continuous ambulatory
peritoneal dialysis and use of intraperitoneal amino acids. Contrib Nephrol
1992;100:188-206.

Domingo JL, Gomez M, Llobet JM, Corbella J. Influence of some dietary
constituents on aluminum absorption and retention in rats. Kidney Int
1991;39(4):598-601.

Druml W, Lochs H, Roth E, Hubl W, Balcke P, Lenz K. Utilization of tyrosine
dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol 1991
Feb;260(2 Pt 1):E280-5.

Dumler F, Schmidt R, Kilates C, Faber M, Lubkowski T, Frinak S. Use of
bioelectrical impedance for the nutritional assessment of chronic hemodialysis
patients. Miner Electrolyte Metab 1992;18(2-5):284-7.

Foulks CJ. Indications for the use of intradialytic parenteral nutrition in the
malnourished hemodialysis patient. J Renal Nutr 1991 Jan;1(1):23-33.

Goldstein DJ, Bertel SF. Unresolved malnutrition of the dialysis patient: is
supplementation enough? Nephrol News Issues 1992 Oct;6(10):40-2, 44-5, 53.

Haag-Weber M, Dumann H, Horl WH. Effect of malnutrition and uremia on impaired
cellular host defence. Miner Electrolyte Metab 1992;18(2-5):174-85.

Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993
Feb;21(2):125-37.

Himmelfarb J, Robinson R, Nye R, McMonagle E, Spratt D. Anabolic and catabolic
hormone levels are better predictors of nutritional status than KT-V or PCR in
hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):369.

Hitchcock PB, Brantley PJ, Jones GN, McKnight GT. Stress and social support as
predictors of dietary compliance in hemodialysis patients. Behav Med 1992
Spring;18(1):13-20.

Hombrouckx RO, Bogaert AM, Leroy FM, De Vos JY, Vermaercke NM, Picavet LM, Larno
LA. Polyunsaturated fatty acids of the n-3 class in chronic dialysis. ASAIO J
1992 Jul-Sep;38(3):M331-3.

Honda M, Kamiyama Y, Hasegawa O, Hoshinaga K, Ogawa O, Kawamura T, Ito H. Effect
of short-term essential amino acid-containing dialysate in young children on
CAPD. Peritoneal Dial Int 1991;11(1):76-80.

Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messana J, Bergstrom J,
Lindholm B, Lim V, Serkes KD, et al. Amino acid solutions for CAPD: rationale and
clinical experience. Miner Electrolyte Metab 1992;18(2-5):309-15.

Jones MR, Martis L, Cantaluppi A. Approaches to correcting protein malnutrition
with modified peritoneal dialysis solutions. Contrib Nephrol 1992;98:174-82.

Laorpatanaskul S, Pochanugool C, Sitprija V. The use of oral essential amino
acids in hemodialysis patients. J Med Assoc Thai 1991 Feb;74(2):66-70.

Lazarus JM. Nutrition in hemodialysis patients. Am J Kidney Dis 1993
Jan;21(1):99-105.

Lindholm B, Bergstrom J. Nutritional aspects on peritoneal dialysis. Kidney Int
Suppl 1992 Oct;38:S165-71.

Lombardi M, Pizzarelli F, Righi M, Cerrai T, Dattolo P, Nigrelli S, Michelassi
S, Sisca S, Alecci A, Di Geronimo P, Maggiore Q. Hepatitis B vaccination in
dialysis patients and nutritional status. Nephron 1992;61(3):266-8.

Lowrie EG, Lew NL, Huang WH. Race and diabetes as death risk predictors in
hemodialysis patients. Kidney Int Suppl 1992 Oct;38:S22-31.

Makoff R. Water-soluble vitamin status in patients with renal disease treated
with hemodialysis or peritoneal dialysis. J Renal Nutr 1991 Apr;1(2):56-73.

Matthys DA, Vanholder RC, Ringoir SM. Benefit of intravenous essential amino-
acids in catabolic patients on chronic maintenance hemodialysis. Acta Clin Belg
1991;46(3):150-8.

Mayer DR, Kosmus W, Pogglitsch H, Mayer D, Beyer W. Essential trace elements in
humans. Serum arsenic concentrations in hemodialysis patients in comparison to
healthy controls. Biol Trace Elem Res 1993 Apr;37(1):27-38.

Mitch WE. Dietary protein restriction in patients with chronic renal failure
[clinical conference]. Kidney Int 1991 Aug;40(2):326-41.

Musk M, Anderson H, Oreopoulos D, Leiter L, Bargman J, Pettit J, Jones M. Effects
of amino acid dialysate on appetite in CAPD patients. Adv Perit Dial
1992;8:153-6.

Mydlik M, Derzsiova K, Guman M, Hrehorovsky M. Vitamin B6 requirements in chronic
renal failure. Int Urol Nephrol 1992;24(4):453-7.

Oksa H, Ahonen K, Pasternack A, Marnela KM. Malnutrition in hemodialysis
patients. Scand J Urol Nephrol 1991;25(2):157-61.

Ono K, Hisasue Y. Is folate supplementation necessary in hemodialysis patients
on erythropoietin therapy. Clin Nephrol 1992 Nov;38(5):290-2.

Rammohan M, Aplasca EC. Caliper method vs bioelectrical impedance analysis for
determining body fat in patients undergoing chronic dialysis and in healthy
individuals. J Am Diet Assoc 1992 Nov;92(11):1395-7.

Rayner HC, Stroud DB, Salamon KM, Strauss BJ, Thomson NM, Atkins RC, Wahlqvist
ML. Anthropometry underestimates body protein depletion in haemodialysis
patients. Nephron 1991;59(1):33-40.

Reid DJ, Barr SI, Leichter J. Effects of folate and zinc supplementation on
patients undergoing chronic hemodialysis. J Am Diet Assoc 1992 May;92(5):574-9.

Riedel E, Hampl H, Nundel M, Farshidfar G. Essential branched-chain amino acids
and alpha-ketoanalogues in haemodialysis patients. Nephrol Dial Transplant
1992;7(2):117-20.

Sanders HN, Narvarte J, Bittle PA, Ramirez G. Hospitalized dialysis patients have
lower nutrient intakes on renal diet than on regular diet. J Am Diet Assoc 1991
Oct;91(10):1278-80. Comment in: J Am Diet Assoc 1992 Jun;92(6):674.

Saxenhofer H, Scheidegger J, Descoeudres C, Jaeger P, Horber FF. Impact of
dialysis modality on body composition in patients with end-stage renal disease.
Clin Nephrol 1992 Oct;38(4):219-23.

Schmidt R, Dumler F, Cruz C, Lubkowski T, Kilates C. Improved nutritional follow-
up of peritoneal dialysis patients with bioelectrical impedance. Adv Perit Dial
1992;8:157-9.

Schulman G, Wingard RL, Hutchison RL, Lawrence P, Hakim RM. The effects of
recombinant human growth hormone and intradialytic parenteral nutrition in
malnourished hemodialysis patients. Am J Kidney Dis 1993 May;21(5):527-34.

Scopelite JA. Dietary modifications: impact on diabetic nephropathy. ANNA J 1992
Oct;19(5):447-52.

Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD. Ascorbic acid
supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis
1991 Jul;18(1):84-90.

Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H. Effects of ascorbic
acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis
patients. Am J Kidney Dis 1992 Jul;20(1):42-9.

Shimomura A, Tahara D, Azekura H, Matsuo H, Kamo M. Key factors to improve
survival of elderly patients on CAPD. Adv Perit Dial 1992;8:166-72.

Singh RG, Gupta AK, Dubey SS, Usha, Sharma MR. Ascorbic acid status in uremics.
Indian J Med Res 1992 Aug;96:266-9.

Snyder S, Bergen C, Sigler MH, Teehan BP. Intradialytic parenteral nutrition in
chronic hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M373-5.

Sreide R, Dracup B, Svarstad E, Iversen BM. Increased total body fat during PD
treatment. Adv Perit Dial 1992;8:173-6.

Steinhauer HB, Lubrich-Birkner I, Kluthe R, Baumann G, Schollmeyer P. Effect of
amino acid based dialysis solution on peritoneal permeability and prostanoid
generation in patients undergoing continuous ambulatory peritoneal dialysis. Am
J Nephrol 1992;12(1-2):61-7.

Tabata T, Shoji S, Morita A, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H.
Effects of dietary phosphorus restriction on secondary hyperpara- thyroidism in
hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatment.
J Nutr Sci Vitaminol (Tokyo) 1991 Dec;37 Suppl: S105-12.

Tietze IN, Pedersen EB. Effect of fish protein supplementation on aminoacid
profile and nutritional status in haemodialysis patients. Nephrol Dial Transplant
1991;6(12):948-54.

Varella L, Utermohlen V. Nutritional support for the patient with renal failure.
Crit Care Nurs Clin North Am 1993 Mar;5(1):79-96.

Vehe KL, Brown RO, Moore LW, Acchiardo SR, Luther RW. The efficacy of nutrition
support in infected patients with chronic renal failure. Pharmacotherapy
1991;11(4):303-7.

Watson AR, Coleman JE, Taylor EA. Gastrostomy buttons for feeding children on
continuous cycling peritoneal dialysis. Adv Perit Dial 1992;8:391-5.

Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova
C, Oreopoulos DG, Anderson GH, Bergstrom J, et al. Nutritional assessment of
continuous ambulatory peritoneal dialysis patients: an international study. Am
J Kidney Dis 1991 Apr;17(4):462-71.

Data on Outcomes

-Clinical Trial

Albertazzi A, Palmieri PF, Mastrangelo E. Efficacy and tolerance of acetate free
biofiltration: a central Italian multicenter trial. Kidney Int Suppl
1993;41:S188-94.

-Other

Alarabi AA, Danielson BG, Wikstrom B. Continuous arteriovenous hemodialysis:
outcome in intensive care acute renal failure patients. Nephron 1993;64(1):58-62.

Alexander SR, Honda M. Continuous peritoneal dialysis for children: a decade of
worldwide growth and development. Kidney Int Suppl 1993 Feb;40: S65-74.

Allen TW. Link between length of hemodialysis treatment and mortality. J Am
Osteopath Assoc 1991;91(4):329.

Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with
renal involvement: patient survival and correlations between initial renal
function, renal histology, therapy and renal outcome. Clin Nephrol 1991
Apr;35(4):139-47.

Antonoff A, Mallinger M. Vocational rehabilitation: limitations and resistance
of renal patients. Dial Transplant 1991;20(10):604-6, 608-9.

Barakat M, Savage JM, Burns A, Stewart M. Efficacy of CAPD as the primary
treatment for end-stage renal failure in children. Child Nephrol Urol
1992;12(4):216-20.

Beckingham IJ, O'Rourke JS, Bishop MC, Blamey RW. Are backup arteriovenous
fistulae necessary for patients on continuous ambulatory peritoneal dialysis?
Lancet 1993 May 29;341(8857):1384-6.

Besselink RA, Schroder CH, van Oort AM. Influence of dialysate exchange on
cardiac left ventricular function in children treated with CAPD. Perit Dial Int
1991;11(2):141-3.

Blagg CR. The US Renal Data System and the Case-Mix Severity Study. Am J Kidney
Dis 1993 Jan;21(1):106-8.

Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on
continuous ambulatory peritoneal dialysis--predictors and correlations with
outcomes. J Am Soc Nephrol 1993 Feb;3(8):1501-7.

Blowey DL, McFarland K, Alon U, McGraw-Houchens M, Hellerstein S, Warady BA.
Peritoneal dialysis in the neonatal period: outcome data. J Perinatol 1993 Jan-
Feb;13(1):59-64.

Brogan D, Kutner NG, Flagg E. Survival differences among older dialysis patients
in the southeast. Am J Kidney Dis 1992 Oct;20(4):376-86.

Brownbridge G, Fielding DM. Psychosocial adjustment to end-stage renal failure:
comparing haemodialysis, continuous ambulatory peritoneal dialysis and
transplantation. Pediatr Nephrol 1991 Sep;5(5):612-6. Comment in: Pediatr Nephrol
1992 Jul;6(4):405-6.

Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due
to major causes of death groups. The EDTA Registration Committee. Kidney Int
Suppl 1992 Oct;38:S4-15.

Brunori G, Camerini C, Cancarini G, Manili L, Sandrini S, Movilli E, Galvani G,
Maiorca R. Hospitalization: CAPD versus hemodialysis and transplant. Adv Perit
Dial 1992;8:71-4.

Chan PC, Tam SC, Robinson JD, Yu L, Ip MS, Chan CY, Cheng IK. Effect of
phosphatidylcholine on ultrafiltration in patients on continuous ambulatory
peritoneal dialysis. Nephron 1991;59(1):100-3.

Chandran PK, Liggett R, Kirkpatrick B. Patient survival on PAN/AN69 membrane
hemodialysis: a ten year analysis. Kidney Int Suppl 1993;41: S287-90.

Choong HL, Pwee HS, Woo KT, Lim CH. Maintenance haemodialysis in Singapore.
Singapore Med J 1991 Jun;32(3):133-8.

Churchill DN. Comparative morbidity among hemodialysis and continuous ambulatory
peritoneal dialysis patients. Kidney Int Suppl 1993 Feb;40: S16-22.

Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP,
Goldstein MB, Jindal K, Mandin H, et al. Canadian Hemodialysis Morbidity Study.
Am J Kidney Dis 1992 Mar;19(3):214-34.

Civati G, Guastoni C, Ballerini L, Perego A, Teatini U, Perrino ML, Benazzi E,
Minetti L. Survival and morbidity in 200 chronic patients treated by high flux
hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):359.

Clark TJ, Richards NT, Adu D, Michael J. Increased prevalence of dialysis-
dependent renal failure in ethnic minorities in the west Midlands. Nephrol Dial
Transplant 1993;8(2):146-8.

Coburn JW. Mineral metabolism and renal bone disease: effects of CAPD versus
hemodialysis. Kidney Int Suppl 1993 Feb;40:S92-100.

Davison JM. Dialysis, transplantation, and pregnancy. Am J Kidney Dis 1991
Feb;17(2):127-32. Comment in: Am J Kidney Dis 1991 Nov;18(5):621.

Dell'Aquila R, Feriani M, Mascalzoni E, Bragantini L, Ronco C, La Greca G.
Oxalate removal by differing dialysis techniques. ASAIO J 1992 Oct-
Dec;38(4):797-800.

Dombros NV, Digenis GE, Balaskas EV, Sombolos K, Abraham G, Oreopoulos DG. Long-
term continuous ambulatory peritoneal dialysis. Clin Nephrol 1993 Feb;39(2):70-4.

Doyle CL, Flanigan MJ, Mabe C. Tidal peritoneal dialysis vs. continuous cyclic
peritoneal dialysis: children's preference. ANNA J 1992 Jun;19(3):249-54.

Dumler F, Schmidt RJ, Cruz C, Faber M, Zasuwa G. Single center success with a
high risk peritoneal dialysis population. Adv Perit Dial 1992;8:105-7.

Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-
time hemodialysis. Am J Kidney Dis 1992 Jan;19(1):49-56.

Ehrich JH, Loirat C, Brunner FP, Geerlings W, Landais P, Mallick NP, Margreiter
R, Raine AE, Selwood NH, Tufveson G, et al. Report on management of renal failure
in children in Europe, XXII, 1991. Nephrol Dial Transplant 1992;7 Suppl 2:36-48.

Ehrich JH, Rizzoni G, Brunner FP, Fassbinder W, Geerlings W, Mallick NP, Raine
AE, Selwood NH, Tufveson G. Renal replacement therapy for end-stage renal failure
before 2 years of age. Nephrol Dial Transplant 1992;7(12):1171-7.

Erroa M, Goldwasser P, Collier JT, Mittman N, Avram MM. Prealbumin and mortality
risk in hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):364.

Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni
G, Selwood NH, Tufveson G, Wing AJ. Combined report on regular dialysis and
transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991;6 Suppl 1:5-35.

Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US
minority groups. Am J Kidney Dis 1992 May;19(5):397-410. Comment in: Am J Kidney
Dis 1992 May;19(5):411-3.

Fine RN. Choice of treatment modality for the infant, child and adolescent with
end-stage renal disease. Contrib Nephrol 1991;89:231-6.

Finkelstein FO, Sorkin M, Cramton CW, Nolph K. Initiatives in peritoneal
dialysis: where do we go from here? Perit Dial Int 1991;11(3):274-8.

Firanek CA, Vonesh EF, Korbet SM. Patient and technique survival among an urban
population of peritoneal dialysis patients: an 8-year experience. Am J Kidney Dis
1991 Jul;18(1):91-6. Published erratum appears in Am J Kidney Dis 1992
Jan;19(1):93.

Fox E, Peace K, Neale TJ, Morrison RB, Hatfield PJ, Mellsop G. "Quality of life"
for patients with end-stage renal failure. Ren Fail 1991;13(1):31-5.

Fox JG, Fowler I, Boulton-Jones JM. Audit of a decade of continuous ambulatory
peritoneal dialysis. Nephrol Dial Transplant 1993;8(3):240-3.

Garcia C, Goldani J, Garcia V. Paediatric dialysis and renal transplantation in
the state of Rio Grande do Sul, Brazil. Pediatr Nephrol 1992 Jan;6(1):74-7.

Garcia CD, Goldani JC, Garcia VD. Twenty years of pediatric renal replacement
therapy in the state of Rio Grande do Sul, Brazil. Transplant Proc 1992
Oct;24(5):1804-5.

Garcia V, Goldani JC, Bittar A, Mattos A. End-stage renal disease in the state
of Rio Grande do Sul, Brazil. Transplant Proc 1992 Oct;24(5):1806.

Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, Jones CA, Agodoa
LY. The impact of comorbid and sociodemographic factors on access to renal
transplantation. JAMA 1993 Feb 3;269(5):603-8.

Gentil MA, Carriazo A, Pavon MI, Rosado M, Castillo D, Ramos B, Algarra GR,
Tejuca F, Banasco VP, Milan JA. Comparison of survival in continuous ambulatory
peritoneal dialysis and hospital haemodialysis: a multicentric study. Nephrol
Dial Transplant 1991;6(6):444-51.

Geronemus RP, Schneider NS, Epstein M. Survival in patients treated with
continuous arteriovenous hemodialysis for acute renal failure and chronic renal
failure. Preliminary observations. Contrib Nephrol 1991;93:29-31.

Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80
years of age. Perit Dial Int 1993;13(2):140-1.

Grant AC, Rodger RS, Howie CA, Junor BJ, Briggs JD, Macdougall AI. Dialysis at
home in the west of Scotland: a comparison of hemodialysis and continuous
ambulatory peritoneal dialysis in age- and sex-matched controls. Perit Dial Int
1992;12(4):365-8.

Hamburger RJ, Brier ME. Peritoneal dialysis mortality rate network 9 [abstract].
J Am Soc Nephrol 1992;3(3):411.

Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of
hemodialysis treatment. JAMA 1991 Feb 20;265(7):871-5. Comment in: JAMA 1991 Feb
20;265(7):909-10; JAMA 1991 Jun 12;265(22):2958-9.

Held PJ, Port FK, Webb RL, Wolfe RA, Garcia JR, Blagg CR, Agodoa LY. The United
States Renal Data System's 1991 annual data report: an introduction. Am J Kidney
Dis 1991 Nov;18(5 Suppl 2):1-16.

Held PJ, Turenne MN, Liska DW, Zobel DL, Webb RL, Alexander SR, Jones C.
Treatment modality patterns and transplantation among the United States pediatric
end-stage renal disease population: a longitudinal study. Clin Transpl
1991;71-85.

Hiatt WR, Koziol BJ, Shapiro JI, Brass EP. Carnitine metabolism during exercise
in patients on chronic hemodialysis. Kidney Int 1992 Jun;41(6):1613-9.

Hirschl MM, Heinz G, Sunder-Plassmann G, Derfler K. Renal replacement therapy in
type 2 diabetic patients: 10 years' experience. Am J Kidney Dis 1992
Dec;20(6):564-8.

Holley JL, Foulks CJ. The utility of a structured evaluation of elderly patients
for continuous peritoneal dialysis. Perit Dial Int 1991;11(2):162-5.

Holley JL, Nespor SL. Nephrologist-directed primary health care in chronic
dialysis patients. Am J Kidney Dis 1993 Jun;21(6):628-31.

Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of
mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992
Dec;3(6):1227-37.

Hughes DA, Beattie TJ, Murphy AV. Haemolytic uraemic syndrome: 17 years'
experience in a Scottish paediatric renal unit. Scott Med J 1991;36(1):9-12.

Hull AR. Impact of reimbursement regulations on patient management. Am J Kidney
Dis 1992 Jul;20(1 Suppl 1):8-11.

Hylander B, Lundblad H, Kjellstrand CM. Changing patient characteristics in
chronic hemodialysis. Scand J Urol Nephrol 1991;25(1):59-63.

Ilson BE, Bland PS, Jorkasky DK, Shusterman N, Allison NL, Dubb JW, Parr GV,
Goebel TK, Stote RM. Intraoperative versus routine hemodialysis in end-stage
renal disease patients undergoing open-heart surgery. Nephron 1992;61(2):170-5.

Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients
in Okinawa, Japan (1971-1990). Kidney Int 1993 Feb;43(2):404-9.

Ishikawa I, Shikura N, Nagahara M, Shinoda A, Saito Y. Comparison of severity of
acquired renal cysts between CAPD and hemodialysis. Adv Perit Dial 1991;7:91-5.

Ishitani M, Wilkowski M, Stevenson W, Pruett T. Outcome of patients requiring
hemodialysis after liver transplantation. Transplant Proc 1993 Apr;25(2):1762-3.

Jenkins DA, Temple RM, Winney RJ, Allan PL, Notgi A, Wild SR. Effect of treatment
mode on the natural history of acquired cystic disease of the kidney in patients
on renal replacement therapy. Nephrol Dial Transplant 1992;7(7):613-7.

Joglar F, Saade M. Improved overall survival of elderly patients on peritoneal
dialysis. Adv Perit Dial 1991;7:63-7.

Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart JC, Tacquet A. Plasma level
of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
Kidney Int 1992 Aug;42(2):424-5.

Kawaguchi Y. Shaded areas of CAPD. Blood Purif 1992;10(1):30-4.

Keller E, Reetze-Bonorden P, Lucking HP, Bohler J, Schollmeyer P. Continuous
arteriovenous hemodialysis: experience in twenty-six intensive care patients.
Contrib Nephrol 1991;93:47-50.

Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of
coexisting disease on survival on renal-replacement therapy. Lancet 1993 Feb
13;341(8842):415-8. Comment in: Lancet 1993 Feb 13;341(8842):412-3; Lancet 1993
Apr 10;341(8850):954; discussion 955; Lancet 1993 Apr 10;341(8850):954-5.

King LK, Kingswood JC, Sharpstone P. Comparison of the efficacy cost and
complication rate of APD and CAPD as long-term outpatient treatments for renal
failure. Adv Perit Dial 1992;8:123-6.

Klein JR, Grunewald RW, Steffgen J, Franz HE. Clearance of osteocalcin in adults
with end-stage renal disease undergoing CAPD. Adv Perit Dial 1991;7:225-9.

Kumar H, Alam F, Naqvi SA. Experience of haemodialysis at the Kidney Centre. JPMA
J Pak Med Assoc 1992 Oct;42(10):234-6.

Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health
status measures in outpatient dialysis. Early experiences in developing an
outcomes assessment program. Med Care 1992 May;30(5 Suppl):MS136-49.

Kyllonen L, Helantera A, Salmela K, Ahonen J. Dialysis method and kidney graft
survival. Transplant Proc 1992;24(1):354.

Lindblad AS, Nolph KD. Recovery of renal function in continuous ambulatory
peritoneal dialysis: a study of National CAPD Registry data. Perit Dial Int
1992;12(1):43-7.

Lowrie EG. Renal replacement therapy: practice, case-mix, and outcome. Lancet
1993 Feb 13;341(8842):412-3. Comment on: Lancet 1993 Feb 13;341(8842):415-8.

Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis
patients: relationships among them and to death risk. Semin Nephrol 1992
May;12(3):276-83.

Lunde NM, Port FK, Wolfe RA, Guire KE. Comparison of mortality risk by choice of
CAPD versus hemodialysis among elderly patients. Adv Perit Dial 1991;7:68-72.

Lupo A, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Viglino G, Salomone M,
Segoloni G, Giangrande A, Limido A, et al. Comparison of survival in CAPD and
hemodialysis: a multicenter study. Adv Perit Dial 1992;8:136-40.

Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock
CA, Prowant B, Farrell PC. The influence of dialysis treatment modality on the
decline of remaining renal function. ASAIO Trans 1991 Oct-Dec;37(4):598-604.

Maheshwari HG, Rifkin I, Butler J, Norman M. Growth hormone binding protein in
patients with renal failure. Acta Endocrinol (Copenh) 1992 Dec;127(6):485-8.

Mailloux LU. With the right population, HHD means better dialysis, outcome.
Nephrol News Issues 1992 Nov;6(11):38-9.

Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone
PA. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney
Dis 1991 Sep;18(3):326-35.

Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality
of CAPD and hemodialysis. Kidney Int Suppl 1993 Feb;40:S4-15.

Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, Scarpioni
LL, Bragantini L, Cancarini GC, Cantaluppi A, et al. A multicenter, selection-
adjusted comparison of patient and technique survivals on CAPD and hemodialysis.
Perit Dial Int 1991;11(2):118-27. Comment in: Perit Dial Int 1993;13(1):71-2.

Mallofre C, Almirall J, Campistol JM, Andreu J, Cardesa A, Revert L. Acquired
renal cystic disease in HD: a study of 82 nephrectomies in young patients. Clin
Nephrol 1992 Jun;37(6):297-302.

Mattoo TK. Acute peritoneal dialysis in newborn babies. Indian Pediatr
1992;29(12):1591-6.

McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis
treatment centers. Ann Intern Med 1992 Aug 15;117(4):332-6.

Morduchowicz G, Winkler J, Boner G. CAPD versus haemodialysis: a comparison in
the same patients. Int Urol Nephrol 1992;24(5):575-9.

Morduchowicz G, Winkler J, Derazne E, Van Dyk DJ, Wittenberg C, Zabludowski JR,
Shohat J, Rosenfeld JB, Boner G. Causes of death in patients with end-stage renal
disease treated by dialysis in a center in Israel. Isr J Med Sci 1992
Nov;28(11):776-9.

Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in
dialysis patients. J Am Soc Nephrol 1992 Dec;3(6):1238-43.

Muthny FA, Koch U. Quality of life of patients with end-stage renal failure. A
comparison of hemodialysis, CAPD, and transplantation. Contrib Nephrol
1991;89:265-73.

Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory
peritoneal dialysis and hemodialysis patient survival with evaluation of trends
during the 1980s. J Am Soc Nephrol 1992 Nov;3(5):1147-55.

Nissenson AR. Chronic peritoneal dialysis in the elderly. Geriatr Nephrol Urol
1991;1(1):3-12.

Nolph KD. What's new in peritoneal dialysis--an overview. Kidney Int Suppl 1992
Oct;38:S148-52.

Nube MJ, De Vet JA, Steffens A, Van Geelen JA. Long-term results of continuous
ambulatory peritoneal dialysis: the first hundred patients. A single centre
study. Neth J Med 1993;42(4):112-21.

O'Donoghue D, Manos J, Pearson R, Scott P, Bakran A, Johnson R, Dyer P, Martin
S, Gokal R. Continuous ambulatory peritoneal dialysis and renal transplantation:
a ten-year experience in a single center. Perit Dial Int 1992;12(2):242, 245-9.

Peterson RA, Kimmel PL, Sacks CR, Mesquita ML, Simmens SJ, Reiss D. Depression,
perception of illness and mortality in patients with end-stage renal disease. Int
J Psychiatry Med 1991;21(4):343-54.

Pollak VE, Thornley-Brown D, Kant KS, Pesce A, Deddens JA. A case study of a
recent decline in the dialysis fatality rate. Contrib Nephrol 1993;102: 59-72.

Port FK. The end-stage renal disease program: trends over the past 18 years. Am
J Kidney Dis 1992 Jul;20(1 Suppl 1):3-7.

Qamar IU, Balfe JW. Experience with chronic peritoneal dialysis in infants. Child
Nephrol Urol 1991;11(3):159-64.

Qureshi N, Held PJ, Bovbjerg RR, Levin NW, Pauly MV, Diamond LH. Mortality and
duration of hemodialysis treatment. JAMA 1991;265(22):2958-9.

Rees L, Rigden SP, Chantler C. The influence of steroid therapy and recombinant
human erythropoietin on the growth of children with renal disease. Pediatr
Nephrol 1991 Jul;5(4):556-8.

Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ, Pryor JL. Outcome of
renal transplantation or dialysis in patients with a history of renal cancer.
Cancer 1992;70(6):1564-7.

Reynolds HN, Borg U, Belzberg H, Wiles CE 3d. Efficacy of continuous
arteriovenous hemofiltration with dialysis in patients with renal failure. Crit
Care Med 1991 Nov;19(11):1387-94.

Rfidah EI, Gill DG, Ni Dhomhnaill T, Shortt H. Continuous ambulatory peritoneal
dialysis in children. Ir Med J 1992 Sep;85(3):107-9.

Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with
renal failure. Am J Kidney Dis 1993 May;21(5 Suppl 2):113-8.

Rizzoni G, Ehrich JH, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings
W, Selwood NH, Tufveson G, Wing AJ. Successful pregnancies in women on renal
replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant
1992;7(4):279-87.

Roger SD, Piper J, Tucker B, Raine AE, Baker LR, Kovacs IB. Comparison of
haemostatic activity in haemodialysis and peritoneal dialysis patients with a
novel technique, haemostatometry. Nephron 1992;62(4):422-8.

Rotellar C, Black J, Winchester JF, Rakowski TA, Mosher WF, Mazzoni MJ,
Amiranzavi M, Garagusi V, Alijani MR, Argy WP. Ten years' experience with
continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):158-64.

Rottembourg J. Residual renal function and recovery of renal function in patients
treated by CAPD. Kidney Int Suppl 1993 Feb;40:S106-10.

Rottembourg J, Allouache M, Issad B, Diab R, Baumelou A, Jacobs C. Outcome and
follow-up on CAPD. Contrib Nephrol 1991;89:16-27.

Saxenhofer H, Scheidegger J, Descoeudres C, Jaeger P, Horber FF. Impact of
dialysis modality on body composition in patients with end-stage renal disease.
Clin Nephrol 1992 Oct;38(4):219-23.

Schafer GE, Doring C, Sodemann K, Russ A, Schroder HM. Continuous arteriovenous
and venovenous hemodialysis in critically ill patients. Contrib Nephrol
1991;93:23-8.

Scharer K, Reiss U, Mehls O, Gretz N, Mohring K, Muller-Wiefel DE, Wingen A.
Changing pattern of chronic renal failure and renal replacement therapy in
children and adolescents: a 20-year single centre study. Eur J Pediatr 1993
Feb;152(2):166-71.

Schwalbe M, Neiberger R, Pena D, Iravani A, Richard G. Mortality in children on
dialysis [abstract]. Pediatr Res 1991;29(4 part 2):351a.

Singh S, Hariharan S. Renal replacement therapy in autosomal dominant polycystic
kidney disease. Nephron 1991;57(1):40-4.

Singh S, Yium J, Macon E, Clark E, Schaffer D, Teschan P. Multicenter study of
change in dialysis therapy-maintenance hemodialysis to continuous ambulatory
peritoneal dialysis. Am J Kidney Dis 1992 Mar;19(3):246-51.

Skroeder NR, Jacobson SH, Holmquist B, Kjellstrand P, Kjellstrand CM. Beta 2-
microglobulin generation and removal in long slow and short fast hemodialysis.
Am J Kidney Dis 1993 May;21(5):519-26.

Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum
albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis
1993 Jan;21(1):26-30.

Sreide R, Svarstad E, Iversen BM. CAPD in patients above 70 years of age. Adv
Perit Dial 1991;7:73-6.

Storch RL, Storch S, London R, Pordy WT. Differences in pattern visual evoked
potential (PVEP) between hemodialysis and peritoneal dialysis patients. Clin
Electroencephalogr 1992 Oct;23(4):169-76.

Stratta P, Canavese C, Dogliani M, Thea A, Porcu M, Salomone M, Vercellone A.
Long-term outcome in patients with vasculitis on chronic dialytic treatment.
Contrib Nephrol 1991;94:151-7.

Stratta RJ, Taylor RJ, Ozaki CF, Bynon JS, Miller SA, Knight TF, Fischer JL,
Neumann TV, Wahl TO, Duckworth WC, et al. A comparative analysis of results and
morbidity in type I diabetics undergoing preemptive versus postdialysis combined
pancreas-kidney transplantation. Transplantation 1993 May;55(5):1097-103.

Sulkova S, Laurincova Z, Valek A. Haemofiltration or haemodialysis in aluminium
elimination? Nephrol Dial Transplant 1991;6 Suppl 3:3-5.

Takahashi C, Ujihara N, Babazono T, Yokoyama H, Nakanishi K, Tomonaga O, Sanaka
T, Hirata Y. Analysis of the clinical course of 130 Japanese non-insulin-
dependent diabetic patients undergoing dialysis. J Diabet Complications 1991 Apr-
Sep;5(2-3):171-2.

Tannen R, Jacobson H. Summary of the joint National Institutes of Health/Renal
Physician's Association workshop on dialysis, morbidity and mortality. Am J
Kidney Dis 1993 Jan;21(1):114-5.

Thompson TJ, Fisher M, Hatfield PJ, Morrison RB, Neale TJ. Diabetic end stage
renal failure--the Wellington experience 1975-1988. Aust N Z J Med 1991
Feb;21(1):29-35.

Tucker CM, Ziller RC, Smith WR, Mars DR, Coons MP. Quality of life of patients
on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit
Dial Int 1991;11(4):341-6. Comment in: Perit Dial Int 1992;12(2):264-5.

Tzamaloukas AH, Murata GH, Avasthi PS. Outcome of cardiopulmonary resuscitation
in patients on chronic dialysis. ASAIO Trans 1991 Jul-Sep;37(3):M369-70.

Verbeelen D, De Neve W, Van Der Niepen P, Sennesael J. Dialysis in patients over
65 years of age. Kidney Int Suppl 1993;41:S27-30.

Verrina E, Andreetta B, Bassi S, Bonaudo R, Caringella DA, Castellani A, Cavalli
P, Edefonti A, Lavoratti G, Longo L, et al. Chronic peritoneal dialysis in
paediatrics: experience of a national registry. Pediatr Nephrol 1992
Jan;6(1):78-81.

Verrina E, Zacchello G, Perfumo F, Edefonti A, Bassi S, Capasso G, Castellani A,
Longo L, Penza R, Piaggio G, et al. Five years' experience of the Italian
Registry of Pediatric Chronic Peritoneal Dialysis. Adv Perit Dial 1992;8:416-8.

Vonesh EF, Maiorca R. A multicenter, selection-adjusted comparison of patient and
technique survival on CAPD and hemodialysis: a clarification. Perit Dial Int
1993;13(1):71-2.

Wadhwa NK, Mendelson WB. A comparison of sleep-disordered respiration in ESRD
patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial
1992;8:195-8.

Wassermann RJ, Saroyan RM, Rice JC, Kerstein MD. Infrainguinal revascularization
for limb salvage in patients with end-stage renal disease. South Med J 1991
Feb;84(2):190-2.

Winchester JF, Rotellar C, Goggins M, Robino D, Alijani MR, Rakowski TA, Argy WP.
Transplantation in peritoneal dialysis and hemodialysis. Kidney Int Suppl 1993
Feb;40: S101-5.

Wolfe RA, Gaylin DS, Port FK, Held PJ, Wood CL. Using USRDS generated mortality
tables to compare local ESRD mortality rates to national rates. Kidney Int 1992
Oct;42(4):991-6.

Wright LF. Survival in patients with end-stage renal disease. Am J Kidney Dis
1991 Jan;17(1):25-8.

Yamamoto Y, Fujimoto S, Eto T. Long-term outcome of chronic hemodialysis patients
[abstract]. Blood Purif 1991;9(1):22.

Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B.
Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol
Dial Transplant 1992;7(9):908-12.

Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant
human growth hormone in adults receiving maintenance hemodialysis. J Am Soc
Nephrol 1991 Dec;2(6):1130-5.

ADEQUACY OF DIALYSIS: ACCESS AND DOSE

-Clinical Trials

Barron PT, Wellington JL, Lorimer JW, Cole CW, Moher D. A comparison between
expanded polytetrafluoroethylene and plasma tetrafluoroethylene grafts for
hemodialysis access. Can J Surg 1993 Apr;36(2):184-6.

Beathard GA. Gianturco self-expanding stent in the treatment of stenosis in
dialysis access grafts. Kidney Int 1993 Apr;43(4):872-7.

Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with
dialysis removes cytokines from the circulation of septic patients. Crit Care Med
1993 Apr;21(4):522-6.

Cheung AK, Dalpias D, Emmerson R, Leypoldt JK. A prospective study on
intradialytic symptoms associated with reuse of hemodialyzers. Am J Nephrol
1991;11(5):397-401.

Churchill DN, Bird DR, Taylor DW, Beecroft ML, Gorman J, Wallace JE. Effect of
high-flux hemodialysis on quality of life and neuropsychological function in
chronic hemodialysis patients. Am J Nephrol 1992;12(6):412-8.

Collins D, Lambert M, Tannenbaum J, Oliverio M, Schwab S. Tolerance of
hemodialysis a randomized prospective trial of high flux vs. conventional high
efficiency hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):360.

Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during
continuous modes of renal replacement therapy in critically ill patients with
acute hepatic and renal failure. Crit Care Med 1993 Mar;21(3):328-38.

Gurudev KC, Pathak V, Prabhakar KS, Bhaskar S, Prakash KC, Prabhakaran, Mani MK.
Short term study on relative merits of acetate and bicarbonate dialysis. J Assoc
Physicians India 1991 Dec;39(12):921-4.

Helling TS, Nelson PW, Shelton L. A prospective evaluation of plasma-TFE and
expanded PTFE grafts for routine and early use as vascular access during
hemodialysis. Ann Surg 1992 Nov;216(5):596-9.

Hibberd AD. Brachiobasilic fistula with autogenous basilic vein: surgical
technique and pilot study. Aust N Z J Surg 1991 Aug;61(8):631-5.

Jaffers G, Angstadt JD, Bowman JS 3d. Early cannulation of plasma TFE and Gore-
Tex grafts for hemodialysis: a prospective randomized study. Am J Nephrol
1991;11(5):369-73.

Kindler J. Torasemide in advanced renal failure. Cardiovasc Drugs Ther 1993 Jan;7
Suppl 1:75-80.

Knight F, Gorynski L, Bentson M, Harmon W. Chronic hemodialysis as a treatment
for the infant or small child with end stage renal disease. ANNA J 1992
Apr;19(2):156.

Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of
peritonitis with conventional versus O-set techniques in continuous ambulatory
peritoneal dialysis. Perit Dial Int 1992;12(2):216-20.

Zaoui P, Green W, Hakim RM. Hemodialysis with cuprophane membrane modulates
interleukin-2 receptor expression. Kidney Int 1991 May;39(5):1020-6.

Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, Oxton L,
Roecker EB, Engeseth S. Randomized controlled trial of prophylactic rifampin for
peritoneal dialysis-related infections. Am J Kidney Dis 1991 Aug;18(2):225-31.

-Other

Acchiardo SR, Hatten KW, Ruvinsky MJ, Dyson B, Fuller J, Moore LW. Inadequate
dialysis increases gross mortality rate. ASAIO J 1992 Jul-Sep;38(3):M282-5.

Acchiardo SR, Kraus AP Jr, Kaufman PA, LaHatte G, Adkins D, Moore LW. Evaluation
of CAPD prescription. Adv Perit Dial 1991;7:47-50.

Acchiardo SR, Kraus AP Jr, LaHatte G, Kaufman PA, Adkins D, Moore LW. Urea
kinetics evaluation of hemodialysis and CAPD patients. Adv Perit Dial
1992;8:55-8.

al-Momen AK, Huraib SO. Low-dose danazol for vascular access and dialyzer
thrombosis in hemodialysis patients. Haemostasis 1992;22(1):12-6.

Alarabi A, Eklund T, Claesson K, Wikstrom B, Danielson BG. Experience with
vascular access for acute renal failure: using Buselmeier shunt and femoral
vessel catheter. Nephron 1991;58(2):192-5.

Alarabi AA, Hansell P, Wikstrom B, Danielson BG. Plasma atrial natriuretic factor
(alpha ANF) during hemodialysis (HD) and hemofiltration (HF). Scand J Urol
Nephrol 1991;25(1):65-9.

Albouze G, Yanai M, Calamai M, Testou D, Jungers P, Man NK. Urea rebound and
residual renal function in the calculation of Kt/V and protein catabolic rate.
Kidney Int Suppl 1993;41:S278-81.

Ansari MM, Viridi JS, Beg MH, Reyazuddin, HS. Smooth venous loop arterio venous
fistula for hemodialysis. Vasc Surg 1991;25(7):565-8.

Antonucci F, Salomonowitz E, Stuckmann G, Stiefel M, Hugentobler M, Zollikofer
CL. Hemodialysis related venous stenoses: treatment with self-expanding
endovascular prostheses. Eur J Radiol 1992 May-Jun;14(3):195-200.

Antonucci F, Salomonowitz E, Stuckmann G, Stiefel M, Largiader J, Zollikofer CL.
Placement of venous stents: clinical experience with a self-expanding prosthesis.
Radiology 1992 May;183(2):493-7.

Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM. Recent advances in
continuous renal replacement therapy: citrate anticoagulated continuous
arteriovenous hemodialysis. ANNA J 1991 Jun;18(3):263-7, 329.

Avendano C, Alvarez JS, Sacristan JA, Adin J, Alsar MJ. Interference of digoxin-
like immunoreactive substances with TDx digoxin II assay in different patients.
Ther Drug Monit 1991 Nov;13(6):523-7.

Bajo MA, Selgas R, Fdez-Reyes MJ, Bosque E, Lopez-Revuelta K, Campos C, Jimenez
C, Borrego F, Rinon C, et al. Adequacy of dialysis in patients longer than 4
years on CAPD. Significance of the urea kinetic model and its relationship with
clinical parameters [abstract]. Nephrol Dial Transplant 1992;7(7):742.

Ballard JL, Bunt TJ, Malone JM. Major complications of angioaccess surgery. Am
J Surg 1992 Sep;164(3):229-32.

Balteau PR, Peluso FP, Coles GA, Michel C, Mignon FM, Tranaeus AP, Verger C,
Zaruba K. Design and testing of the Baxter Integrated Disconnect Systems (IDS).
Perit Dial Int 1991;11(2):131-6.

Bandiani G, Camaiora E, Farina D, Nicolini MA, Perotta U, Tagliazucchi A. Long-
term influence of dialysis treatment of beta 2-microglobulin, interleukin-2 R and
tumour necrosis factor. Nephrol Dial Transplant 1991;6 Suppl 2:61-3.

Baraldi A, Bonucchi D, Di Felice A, Lusvarghi E, Artini P, Manenti A, Gresele P,
Quero E, Nenci GC. Liquid nitrogen snap frozen saphenous vein for vascular access
in dialysis. ASAIO Trans 1991 Jul-Sep;37(3):M225-7.

Barrett NK, Brown E, McIvor J, Picus D, Surratt S, Hicks M, Darcy M. Subclavian
vein and dialysis access planning. Am J Roentgenol 1991;157(5):1125-6.

Barth RH. Urea modeling and Kt/V: a critical appraisal. Kidney Int Suppl
1993;41:S252-60.

Baurmeister U, Vienken J, Grassmann A. Biocompatibility and membrane development.
Nephrol Dial Transplant 1991;6 Suppl 3:17-21.

Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular
access stenosis. Kidney Int 1992 Dec;42(6):1390-7.

Bellomo R, Boyce N. Acute continuous hemodiafiltration: a prospective study of
110 patients and a review of the literature. Am J Kidney Dis 1993
May;21(5):508-18.

Bellomo R, Parkin G, Love J, Boyce N. A prospective comparative study of
continuous arteriovenous hemodiafiltration and continuous venovenous
hemodiafiltration in critically ill patients. Am J Kidney Dis 1993
Apr;21(4):400-4.

Berman J, Celoria G, Garb J. Upper arm arteriovenous bridge grafts for
hemodialysis. Vasc Surg 1992;26(2):85-92.

Berry C, Cestero RV. Indications of hemodialysis access demise related to
clotting and possible associated vessel stenosis: what to look for. ANNA J 1992
Apr;19(2):162.

Besarab A, Dorrell S, Moritz M, Michael H, Sullivan K. Determinants of measured
dialysis venous pressure and its relationship to true intra-access venous
pressure. ASAIO Trans 1991 Jul-Sep;37(3):M270-1.

Besarab A, Moritz M, Sullivan K, Dorrell S, Price JJ. Venous access pressures and
the detection of intra-access stenosis. ASAIO J 1992 Jul-Sep;38(3):M519-23.

Besley M, Thomas A, Salter S, Sang YY, Vas M, Uldall PR. Control of oral
anticoagulation in patients using long-term internal jugular catheters for
haemodialysis access. Int J Artif Organs 1992 May;15(5):277-80.

Beyerlein-Buchner C, Albert FW. Endoscopic peritoneal dialysis catheter
placement. Contrib Nephrol 1991;89:28-30.

Blagg CR. Hemodialysis 1991. Blood Purif 1992;10(1):22-9.

Blagg CR. The US Renal Data System and the Case-Mix Severity Study. Am J Kidney
Dis 1993 Jan;21(1):106-8.

Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L,
Wilkens K. Serum albumin concentration-related Health Care Financing
Administration quality assurance criterion is method-dependent: revision is
necessary. Am J Kidney Dis 1993 Feb;21(2):138-44.

Blake PG, Balaskas EV, Izatt S, Oreopoulos DG. Is total creatinine clearance a
good predictor of clinical outcomes in continuous ambulatory peritoneal dialysis?
Perit Dial Int 1992;12(4):353-8. Comment in: Perit Dial Int 1992;12(4):343-5.

Blake PG, Balaskas E, Blake R, Oreopoulos DG. Urea kinetics has limited relevance
in assessing adequacy of dialysis in CAPD. Adv Perit Dial 1992;8:65-70.

Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Chu GL, Oreopoulos
DG. Lack of correlation between urea kinetic indices and clinical outcomes in
CAPD patients. Kidney Int 1991 Apr;39(4):700-6. Published erratum appears in
Kidney Int 1991 Aug;40(2):388.

Bonomini V. Introducing the biology of bioincompati- bility in dialysis. Nephrol
Dial Transplant 1991;6 Suppl 2:1-3.

Bourquia A, Ramdani B, Essamadi JE, Zaid D. Venous thrombosis after subclavian
vein catheterization for haemodialysis. Rev Med Interne 1993;14(2):79-83.

Bowen J, Gough DCS. Venous loop fistula for vascular access in childhood
haemodialysis. Pediatr Surg Int 1993;8(2):182-3.

Brandes JC, Piering WF, Beres JA, Blumenthal SS, Fritsche C. Clinical outcome of
continuous ambulatory peritoneal dialysis predicted by urea and creatinine
kinetics. J Am Soc Nephrol 1992 Mar;2(9):1430-5.

Briceno JC, Runge TM. Tubing spallation in extracorporeal circuits. An in vitro
study using an electronic particle counter. Int J Artif Organs 1992
Apr;15(4):222-8.

Brock JS, Sussman M, Wamsley M, Mintzer R, Baumann FG, Riles TS. The influence
of human immunodeficiency virus infection and intravenous drug abuse on
complications of hemodialysis access surgery. J Vasc Surg 1992 Dec;16(6):904-10;
discussion 911-2.

Broek AP, Teunis HA, Bargeman D, Sprengers ED, Smolders CA. Characterization of
hollow fiber hemodialysis membranes: pore size distribution and performance. J
Membr Sci 1992;73(2-3):143-52.

Brunner MC, Matalon TA, Patel SK, McDonald V, Jensik SC. Ultrarapid urokinase in
hemodialysis access occlusion. J Vasc Interv Radiol 1991 Nov;2(4):503-6.

Buckley MM, Sorkin EM. Enoxaparin. A review of its pharmacology and clinical
applications in the prevention and treatment of thromboembolic disorders. Drugs
1992;44(3):465-97.

Burger H, Kootstra G, de Charro F, Leffers P. A survey of vascular access for
haemodialysis in the Netherlands. Nephrol Dial Transplant 1991;6(1):5-10.

Burhop KE, Johnson RJ, Simpson J, Chenoweth DE, Borgia J. Biocompatibility of
hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med 1993
Feb;121(2):276-93. Comment in: J Lab Clin Med 1993 Feb;121(2):203-4.

Burkart JM. Adequacy of peritoneal dialysis. Dial Transplant 1993;22(5):234-43.

Burkart JM, Jordan JR, Durnell TA, Case LD. Comparison of exit-site infections
in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial
Int 1992;12(3):317-20. Comment in: Perit Dial Int 1993;13(1):67-8.

Campbell D, Fritsche C, Brandes J. A review of urea and creatinine kinetics in
predicting CAPD outcome. Adv Perit Dial 1992;8:79-83.

Campos A, Taylor JH, Garin EM. Long term experience with hickman catheters in
pediatric hemodialysis patients [abstract]. Pediatr Res 1991:29(4 Pt 2):340a.

Canada-USA (CANUSA) multicentre study of peritoneal dialysis adequacy:
description of the study population and preliminary results. CANUSA Peritoneal
Dialysis Study Group. Adv Perit Dial 1992;8:88-92.

Canaud B, Cristol JP, Mion C. Silastic twin catheters the answer to temporary
vascular access for hemodialysis [abstract]. Blood Purif 1991;9(1):43.

Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L,
Martinez-Vazquez JM. Successful treatment of haemodialysis catheter-related
sepsis without catheter removal. Nephrol Dial Transplant 1993;8(3):231-4.

Capelli JP, Kushner H, Camiscioli T, Chen SM, Stuccio-White NM. Factors affecting
survival of hemodialysis patients utilizing urea kinetic modeling. A critical
appraisal of shortening dialysis times. Am J Nephrol 1992;12(4):212-23.

Carlisle EJ, Blake P, McCarthy F, Vas S, Uldall R. Septicemia in long-term
jugular hemodialysis catheters; eradicating infection by changing the catheter
over a guidewire. Int J Artif Organs 1991 Mar;14(3):150-3.

Caruana RJ, Smith MC, Clyne D, Crow JW, Zinn JM, Diehl JH. Controlled study of
heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for
chronic hemodialysis. Blood Purif 1991;9(5-6):296-304.

Cases A, Reverter JC, Escolar G, Sanz C, Lopez-Pedret J, Revert L, Ordinas A.
Platelet activation on hemodialysis: influence of dialysis membranes. Kidney Int
Suppl 1993;41:S217-20.

Cassioumis D, Fatouros MS, Siamopoulos KC, Giannoukas AD. Short- and long-term
evaluation of arteriovenous fistulas for chronic hemodialysis. Microsurgery
1992;13(5):236-7.

Castiglione A, Pagliaro P, Romagnoni M, Beccari M, Cavaliere G, Veneroni G,
Sorgato G. Flow cytometric analysis of leukocytes eluted from haemodialysers.
Nephrol Dial Transplant 1991;6 Suppl 2:31-5.

Catizone L, Cantaluppi A, Peluso F, Zucchelli P. A new catheter to prevent exit-
site infection in peritoneal dialysis. Adv Perit Dial 1992;8:283-7.

Chan PC, Wu PG, Tam SC, Ip MS, Fang GX, Cheng IK. Factors affecting lymphatic
absorption in Chinese patients on continuous ambulatory peritoneal dialysis
(CAPD). Perit Dial Int 1991;11(2):147-51.

Chandramouly B, Cao H, Cochavi S. Gallium scintigraphy in hemodialysis access
graft infection. Clin Nucl Med 1993;18(2):155-6.

Chandran P, Lane TM, McCleary RA, Burkey S. Residual peritoneal volumes by CT
scanning in CAPD patients. Perit Dial Int 1992;12(2):260-2.

Charra B, Calemard E, Chazot C, Terrat JC, Vanel T, Ruffet M, Laurent G. Dose of
dialysis: what index? Blood Purif 1992;10(1):13-21.

Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival
as an index of adequacy of dialysis. Kidney Int 1992 May;41(5):1286-91.

Chauveau P, Poignet JL, Kuno T, Bonete R, Kerembrun A, Naret C, Delons S, Man NK,
Rist E. Phosphate removal rate: a comparative study of five high-flux dialysers.
Nephrol Dial Transplant 1991;6 Suppl 2:114-5.

Cheng BC, Cheng KK, Lai ST, Yu TJ, Kuo SM, Weng ZC, Chang Y, Lee PC. Long term
result of PTFE graft for hemodialytic vascular access. J Surg Assoc Repub China
1992;25(2):1070-6.

Cheung AK. Clinical phenomena induced by complement and leukocyte interactions
with artificial surfaces. J Clin Apheresis 1992;7(3):147-8.

Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis
membranes: role of complement receptors. Kidney Int 1991 Dec;40(6):1123-33.

Cheung AK, Parker CJ, Janatova J, Brynda E. Modulation of complement activation
on hemodialysis membranes by immobilized heparin. J Am Soc Nephrol 1992
Feb;2(8):1328-37.

Chong TK, Piraino B, Bernardini J. Vestibular toxicity due to gentamicin in
peritoneal dialysis patients. Perit Dial Int 1991;11(2):152-5.

Christensson A, Ljunggren L, Nilsson-Thorell C, Arge B, Diehl U, Hagstam KE,
Lundberg M. In vivo comparative evaluation of hemodialysis tubing plasticized
with DEHP and TEHTM. Int J Artif Organs 1991 Jul;14(7):407-10.

Civati G, Guastoni C, Ballerini L, Perego A, Teatini U, Perrino ML, Benazzi E,
Minetti L. Survival and morbidity in 20 chronic patients treated by high flux
hemodialysis [abstract]. J Am Soc Nephrol 1992;3(3):359.

Civati G, Guastoni C, Teatini U, Perego A, Perrino ML, Benazzi E, Minetti L.
High-flux acetate haemodialysis: a single-centre experience. Nephrol Dial
Transplant 1991;6 Suppl 2:75-81.

Clark KR, Forsythe JL, Rigg KM, Sharp J, Rangecroft L, Wagget J, Parrott NR,
Lennard TW, Coulthard MG. Surgical aspects of chronic peritoneal dialysis in the
neonate and infant under 1 year of age. J Pediatr Surg 1992 Jun;27(6):780-3.

Collins DM, Lambert MB, Middleton JP, Proctor RK, Davidson CJ, Newman GE, Schwab
SJ. Fistula dysfunction: effect on rapid hemodialysis. Kidney Int 1992
May;41(5):1292-6.

Colombi A, Ayer G, Burri G. The straight Tenckhoff catheter. Contrib Nephrol
1991;89:31-4.

Coronel F, Martin-Rabadan P, Romero J. Chemical peritonitis after intraperitoneal
administration of amphotericin B in a fungal infection of the catheter
subcutaneous tunnel. Peritoneal Dial Int 1993;13(2):161-2.

Cruz C, Dumler F, Schmidt R, Gotch F. Enhanced peritoneal dialysis delivery with
PD-PLUS. Adv Perit Dial 1992;8:288-90.

Cruz C, Faber MD. Peritoneoscopic implantation of catheters for peritoneal
dialysis: effect on functional survival and incidence of tunnel infection.
Contrib Nephrol 1991;89:35-9.

Culpepper RM, Hirsch JI, Fratkin MJ. Clearance of 131I by hemodialysis. Clin
Nephrol 1992 Aug;38(2):110-4.

Curry SH, Lorenz A, Henderson GN, Mars DR, Stacpoole PW. Haemodialysis studies
with dichloroacetate. Eur J Clin Pharmacol 1991;40(6):613-7.

Daniels ID, Berlyne GM, Barth RH. Blood flow rate and access recirculation in
hemodialysis. Int J Artif Organs 1992 Aug;15(8):470-4.

Darbord JC, DeCool A, Goury V, Vincent F. Biofilm model for evaluating
hemodialyzer reuse processing. Dial Transplant 1992;21(10):644-5, 649-50.

D'Arcy PF. Anaphylactic reactions with high-flux polyacrylonitrile membranes and
ACE inhibitors. Int Pharm J 1992;6(3):109.

Dasgupta MK, Kowalewska-Grochowska K, Bettcher KB, Tyrrell DL. Stable biofilms
causing recurrent peritonitis and catheter loss in continuous ambulatory
peritoneal dialysis CAPD [abstract]. Clin Invest Med 1991;14(4 Suppl):A136.

Davidson CJ, Newman GE, Sheikh KH, Kisslo K, Stack RS, Schwab SJ. Mechanisms of
angioplasty in hemodialysis fistula stenoses evaluated by intravascular
ultrasound. Kidney Int 1991 Jul;40(1):91-5.

Davies SJ, Brown B, Bryan J, Russell GI. Clinical evaluation of the peritoneal
equilibration test: a population-based study. Nephrol Dial Transplant
1993;8(1):64-70.

De Alvaro F, Bajo MA, Alvarez-Ude F, Vigil A, Molina A, Coronel F, Selgas R.
Adequacy of peritoneal dialysis: does KT/V have the same predictive value as in
HD? A multicenter study. Adv Perit Dial 1992;8:93-7.

de Chatel R, Mako J, Toth M, Barna I, Lang RE. Atrial natriuretic peptide (ANP)
in patients with chronic renal failure on maintenance haemodialysis. Int Urol
Nephrol 1991;23(2):177-83.

de Vries JP, Olthof CG, Visser V, Kouw PM, van Es A, Donker JM, de Vries PM.
Continuous measurement of blood volume during hemodialysis by an optical method.
ASAIO J 1992 Jul-Sep;38(3):M181-5.

Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda Y. Haemodialysis and platelet
activation. Nephrol Dial Transplant 1991;6 Suppl 2:40-2.

Dell'Aquila R, Feriani M, Mascalzoni E, Bragantini L, Ronco C, La Greca G.
Oxalate removal by differing dialysis techniques. ASAIO J 1992 Oct-
Dec;38(4):797-800.

Deppisch R, Betz M, Hansch GM, Rauterberg EW, Ritz E. Biocompatibility of the
polyamide membranes. Contrib Nephrol 1992;96:26-46.

DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux
hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis
1992 Oct;20(4):354-60.

Dewanjee MK, Kapadvanjwala M, Sanchez A, Elson R, Serafini AN, Zilleruelo GE,
Sfakianakis GN. Quantitation of comparative thrombogenicity of dog, pig, and
human platelets in a hemodialyzer. ASAIO J 1992 Apr-Jun;38(2):88-90.

Diaz-Buxo JA. Advances in peritoneal dialysis prescription. Transplant Proc 1991
Apr;23(2):1845-6.

Diaz-Buxo JA. Mechanical complications of chronic peritoneal dialysis catheters.
Semin Dial 1991 Apr-Jun;4(2):106-11.

Didlake R, Curry E, Rigdon EE, Raju S, Bower J. Outpatient vascular access
surgery: impact of a dialysis unit-based surgical facility. Am J Kidney Dis
1992;19(1):39-44.

Docci D, Bilancioni R, Pistocchi E, Baldrati L, Capponcini C, Delvecchio C,
Feletti C. Evolution of serum prealbumin following hemodialysis: effect of
different dialysis membranes. Nephron 1992;62(2):145-9.

Dodson TF, Stewart MT, Martin LG. Polytetrafluoro- ethylene aorta-vena cava graft
for hemodialysis: report of a case. J Vasc Surg 1993 Apr;17(4):759-61.

Domoto DT, Bauman JE, Joist JH. Combined aspirin and sulfinpyrazone in the
prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991
Jun 15;62(6):737-43.

Donnelly PK, Morton D, Woffindin C, Hoenich NA. Characterisation and evaluation
of a new double lumen central venous catheter. Int J Artif Organs 1992
Jun;15(6):331-8.

Dousset V, Grenier N, Douws C, Senuita P, Sassouste G, Ada L, Potaux L.
Hemodialysis grafts: color Doppler flow imaging correlated with digital
subtraction angiography and functional status. Radiology 1991;181(1):89-94.

Dryden MS, Ludlam HA, Wing AJ, Phillips I. Active intervention dramatically
reduces CAPD-associated infection. Adv Perit Dial 1991;7:125-8.

Dryden MS, McCann M, Wing AJ, Phillips I. Controlled trial of a Y-set dialysis
delivery system to prevent peritonitis in patients receiving continuous
ambulatory peritoneal dialysis. J Hosp Infect 1992 Mar;20(3):185-92.

Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips I. Infective complications
associated with the use of the Quinton "Permcath" for long-term central vascular
access in haemodialysis. J Hosp Infect 1991 Dec;19(4):257-62.

Dryden MS, Talsania HG, Martin S, Cunningham M, Richardson JF, Cookson B, Marples
RR, Phillips I. Evaluation of methods for typing coagulase-negative
staphylococci. J Med Microbiol 1992 Aug;37(2):109-17.

Dumler F, Brickman C, Michaels RS, Sally V, Laude B, Perry M. Differences in
biocompatibility induced by modification of polysulfone membrane permeability
characteristics [abstract]. J Am Soc Nephrol 1991;2(3):322.

Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-
time hemodialysis. Am J Kidney Dis 1992 Jan;19(1):49-56.

Duncan JM, Baldwin RT, Caralis JP, Cooley DA. Subclavian vein-to-right atrial
bypass for symptomatic venous hypertension. Ann Thorac Surg 1991
Dec;52(6):1342-3.

Dunea G, Domenico L, Gunnerson P, Winston-Willis F. A survey of permanent double
lumen catheters in hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M276-7.

Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Routine measurement of
hydrostatic intraperitoneal pressure. Adv Perit Dial 1992;8: 108-12.

Dy GR, Bloom EJ, Ijelu GK, Merritts GW, Kramer MS, Raja RM. Effect of recombinant
human erythropoietin on vascular access. ASAIO Trans 1991 Jul-Sep;37(3):M274-5.

Dzurik R, Lajdova I, Spustova V, Opatrny K Jr. Pseudouridine excretion in healthy
subjects and its accumulation in renal failure. Nephron 1992;61(1):64-7.

Edefonti A, Picca M, Ghio L, Bassi S, Cattarelli D, Leccese V. Adequacy of solute
and water removal in children treated with nightly intermittent peritoneal
dialysis. Adv Perit Dial 1992;8:402-5.

Ehrman KO, Gaylord GM. Thrombolytic therapy for occluded dialysis access grafts.
Semin Intervent Radiol 1992;9(3):190-4.

Eisele G, Bailie GR, Lomaestro B. Relationship between peritonitis and exit site
infections in CAPD. Adv Perit Dial 1992;8:227-9.

El-Kashef E, El-Lakany SA, Aggan HAE, Saaran AE, Halim AH. Plasma antithrombin
III concentration and platelet count in hemodialysis patients. J Med Res Inst
1991;12(4):227-39.

Ellis EN, Watts K, Wells TG, Arnold WC. Use of the peritoneal equilibration test
in pediatric dialysis patients. Adv Perit Dial 1991;7:259-61.

Emmett M, Sirmon MD, Kirkpatrick WG, Nolan CR, Schmitt GW, Cleveland MB. Calcium
acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis
1991 May;17(5):544-50.

England RE, Jackson A. Imaging of dialysis access: a review of 67 failing
fistulas investigated by intravenous digital subtraction angiography. Br J Radiol
1993 Jan;66(781):32-6.

Evans JH, Smye SW, Brocklebank JT. Mathematical modelling of haemodialysis in
children. Pediatr Nephrol 1992 Jul;6(4):349-53.

Fahal IH, Yaqoob M. How to insert a temporary peritoneal dialysis cannula. Saudi
Med J 1991;12(6):526-7.

Falkenhagen D, Brown GS. Clinical evaluation of three haemodialysers containing
PMMA membranes of different surface area, with special attention to
thrombogenicity. Nephrol Dial Transplant 1991;6 Suppl 2:43-8.

Fang JT, Huang CC. Percutaneous internal jugular vein catheterization with double
lumen for temporary hemodialysis: experience of 100 cases. Chang Keng I Hsueh
1992 Sep;15(3):114-20.

Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA.
Hemodialysis vascular access morbidity in the United States. Kidney Int
1993;43(5):1091-6.

Fessia SL, Grabowy RS, Bousquet GG. Effectiveness of microwave moist-heat
intraluminal disinfection of CAPD connectology. Adv Perit Dial 1991;7:204-7.

Fischbach M. Assessment of the adequacy of hemodialysis (HD) in children
[abstract]. Pediatr Nephrol 1992;6(5):C40.

Fischbach M, Hamel G, Simeoni U, Geisert J. Phosphate dialytic removal:
enhancement of phosphate cellular clearance by biofiltration (with acetate-free
buffer dialysate). Nephron 1992;62(2):155-60.

Flanigan MJ, Doyle C, Lim VS, Ullrich G. Tidal peritoneal dialysis: preliminary
experience. Perit Dial Int 1992;12(3):304-8.

Flanigan MJ, Ullrich G, Lim VS. Tidal peritoneal dialysis. Urea and total
nitrogen losses. ASAIO Trans 1991 Jul-Sep;37(3):M398-400.

Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing
with Renalin. Am J Nephrol 1991;11(1):27-31.

Flores L, Haser PB, Bradbury K, Carryl S, Shaftan G. Improved venous outflow by
double vein anastomosis in graft angioaccess. Surg Gynecol Obstet 1992
Apr;174(4):332-4.

Follis F, Miller KB, Paone RF, Wernly JA. Iatrogenic pseudoaneurysm of the
innominate artery. Tex Heart Inst J 1992;19(4):294-6.

Fong IW, Capellan JM, Simbul M, Angel J. Infection of arterio-venous fistulas
created for chronic haemodialysis. Scand J Infect Dis 1993;25(2):215-20.

Fox K, Adcock A, Raymond K, Walker P. Analysis of clinical experience with a new
twist lock connectology. Adv Perit Dial 1992;8:291-3.

Francis DM, Goodman DJ, Millar RJ, Walker RG, Becker GJ. Right atrial catheters:
reliable, immediate and durable vascular access for heamodialysis and plasma
exchange. Aust N Z J Surg 1993;63(4):284-8.

Francoise Gachon AM, Mallet J, Tridon A, Deteix P. Analysis of proteins eluted
from hemodialysis membranes. J Biomater Sci Polym Ed 1991;2(4):263-76.

Freedman BI, Anderson RL, Tuttle AB, Canzanello VJ. The Thomas shunt revisited.
Am J Kidney Dis 1992 Jan;19(1):45-8.

Gagnon RF, Richards GK, Subang R. Experimental Staphylococcus epidermidis implant
infection in the mouse. Kinetics of rifampin and vancomycin action. ASAIO J 1992
Jul-Sep;38(3):M596-9.

Gallimore B, Gagnon RF, Subang R, Richards GK. Natural history of chronic
Staphylococcus epidermidis foreign body infection in a mouse model. J Infect Dis
1991 Dec;164(6):1220-3.

Gani JS, Fowler PR, Steinberg AW, Wlodarczyk JH, Nanra RS, Hibberd AD. Use of the
fistula assessment monitor to detect stenoses in access fistulae. Am J Kidney Dis
1991 Mar;17(3):303-6.

Gao W, Sun EW, Lin MZ. Titanium nails used in A-V fistulation for hemodialysis
in 428 patients. Chin Med J (Engl Ed) 1992;105(12):980-6.

Garel L. Pediatric gastrostomy and gastrojejunostomy. Semin Interv Radiol
1991;8(3):210-3.

Gault MH, Vasdev SC, Longerich I, Purchase L, Sampon C, Johnson E. Heparin, fatty
acids and sodium, potassium-ATPase inhibition by plasma factors during
hemodialysis. Nephron 1992;60(3):292-301.

Gawaz MP, Ward RA. Effects of hemodialysis on platelet-derived thrombospondin.
Kidney Int 1991 Aug;40(2):257-65.

Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms
of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological
significance. Ann N Y Acad Sci 1992;667:324-31.

Geary DF, Gajaria M, Fryer-Keene S, Willumsen J. Low-dose and heparin-free
hemodialysis in children. Pediatr Nephrol 1991 Mar;5(2):220-4.

Geary DF, Harvey EA, MacMillan JH, Goodman Y, Scott M, Balfe JW. The peritoneal
equilibration test in children. Kidney Int 1992 Jul;42(1):102-5.

Gellert R, Billip-Tomecka Z, Hijaz H, Bogdanska-Straszynska B, Malecka B Sicinski
A. Intradialytic erythrocyte volume changes. Nephrol Dial Transplant 1991;6 Suppl
3:10-3.

Germain M, Harlow P, Mulhern J, Lipkowitz G, Braden G. Low protein catabolic rate
and serum albumin correlate with increased mortality and abdominal complications
in peritoneal dialysis patients. Adv Perit Dial 1992;8:113-5.

Ghezzi PM, Gervasio R, Botella J. Continuous pH and HCO3 monitoring during
hemodiafiltration without blood sampling. ASAIO Trans 1991 Oct-Dec;37(4):605-7.

Gianese F, Nurmohamed MT, Imbimbo BP, Buller HR, Berckmans RJ, ten Cate JW. The
pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during
haemodialysis for chronic renal failure. Br J Clin Pharmacol 1993
Mar;35(3):335-9.

Gibson SP, Mosquera D. Five years experience with the Quinton Permcath for
vascular access. Nephrol Dial Transplant 1991;6(4):269-74.

Girolami JP, Bascands JL, Vega Vidalle C, Pecher C, Moatti JP, Adam A, Suc JM.
Increase in urinary kallikrein excretion following hemodialysis. Nephron
1991;59(1):51-6.

Godai K, Uemasu J, Kawasaki H. Clinical significance of serum and urinary
neopterins in patients with chronic renal disease. Clin Nephrol 1991
Sep;36(3):141-6.

Gohl H, Buck R, Strathmann H. Basic features of the polyamide membranes. Contrib
Nephrol 1992;96: 1-25.

Gokal R. Recent perspectives on peritoneal dialysis. Contrib Nephrol
1993;102:98-109.

Gokal R, Ash SR, Helfrich GB, Holmes CJ, Joffe P, Nichols WK, Oreopoulos DG,
Riella MC, Slingeneyer A, Twardowski ZJ, et al. Peritoneal catheters and exit-
site practices: toward optimum peritoneal access. Perit Dial Int
1993;13(1):29-39.

Gonella M, Calabrese G, Pratesi G, Baldin C, Mazzotta A, Vagelli G. New
reinfusate composition in high UF haemodiafiltration: electrolyte solution
combined with bicarbonate. Nephrol Dial Transplant 1993;8(1):54-9.

Gonella M, Calabrese G, Pratesi G, Mazzotta A, Vagelli G, Baldin C. The polyamide
membrane in hemodiafiltration. Contrib Nephrol 1992;96:99-105.

Gonthier D, Bernardini J, Holley JL, Piraino B. Erythema: does it indicate
infection in a peritoneal catheter exit site? Adv Perit Dial 1992;8:230-3.

Gora ML, Seth S, Visconti JA, Shields B, Bay W. Stability of dobutamine
hydrochloride in peritoneal dialysis solutions. Am J Hosp Pharm
1991;48(6):1234-7.

Gordge MP, Neild GH. Platelets from patients on haemodialysis show impaired
responses to nitric oxide. Clin Sci 1992 Sep;83(3):313-8.

Gordge MP, Neild GH. Reduced sensitivity to nitric oxide in uraemic platelets
[abstract]. J Am Soc Nephrol 1991;2(3):505.

Gorman SP, Mawhinney WM, Adair CG. The influence of catheter surface
microrugosity on the development and persistence of recurrent peritonitis in CAPD
[abstract]. Pharmacotherapy 1991;11(3):267.

Gotch FA. Adequacy of peritoneal dialysis. Am J Kidney Dis 1993 Jan;21(1):96-8.

Gotch FA. Interpreting and applying kinetics for peritoneal and hemodialysis.
ANNA J 1991 Jun;18(3):272-9.

Gouge SF, Moore J Jr, Atkins F, Hirszel P. Radiocontrast removal by dialysis
membranes. Blood Purif 1991;9(4):182-7.

Graff J, Joffe P, Ladefoged SD. An assessment of the flow rate within peritoneal
dialysis catheters, using a standardized in vitro technique. Adv Perit Dial
1992;8:294-7.

Grant ME, Lovell HB, Wiegmann TB. Current use of anticoagulation in hemodialysis.
Semin Dial 1991 Jul-Sep;4(3):168-73.

Gray RJ, Dolmatch BL, Buick MK. Directional atherectomy treatment for
hemodialysis access: early results. J Vasc Interv Radiol 1992 Aug;3(3):497-503.

Gray RR. Radiologic placement of indwelling central venous lines for dialysis TPN
and chemotherapy. J Intervent Radiol 1991;6(4):133-44.

Grosse-Siestrup C, Kahl K, Becker H, Gahl GM. A silver device to prevent
catheter-exit-infections [abstract]. Int J Artif Organs 1992;15(9):514.

Grote J, Hausmann D, Daniel WG, Muegge A, Nikutta P, Bahlmann J, Lichtlen PR.
Transesophageal echocardiographic assessment of superior vena cava thrombosis in
patients with long-term central venous dialysis catheters [abstract]. Eur Heart
J 1992;13(Abstr Suppl):284.

Grote J, Hausmann D, Muegge A, Nikutta P, Bahlmann J, Daniel WG. Transesophageal
echocardiographic assessment of superior vena cava thrombosis in patients with
long-term central venous hemodialysis catheters [abstract]. Circulation 1992;86(4
Suppl 1):I124.

Grzegorzewska AE, Moore HL, Chen TW, Nolph KD. Peritoneal transfer during maximal
hyperosmotic ultrafiltration in the rat. ASAIO J 1993;39(1):66-70.

Gurland HJ. Biocompatibility of haemodialysis systems: present and future:
closing remarks. Nephrol Dial Transplant 1991;6 Suppl 2:126.

Gurudev KC, Ramkumar TS, Pathak V, Prabhakar KS, Bhaskar S, Prakash KC, Mani MK.
Subclavian vein catheters for haemodialysis with and without a subcutaneous
tunnel. J Assoc Physicians India 1992 Jun;40(6):370-3.

Gutierrez A, Alvestrand A, Bergstrom J. Membrane selection and muscle protein
catabolism. Kidney Int Suppl 1992;38:S86-90.

Hafner G, Swars H, Ehrenthal W, Schinzel H, Weilemann LS, Prellwitz W. The
control of anti-coagulation in acute dialyses with sensitive laboratory
parameters. Scand J Clin Lab Invest 1992 Jun;52(4):289-96.

Hakim RM, Depner TA, Parker TF 3d. Adequacy of hemodialysis. Am J Kidney Dis 1992
Aug;20(2):107-23.

Hakim RM, Lawrence P, Schulman G, Breyer J, Ismail N. Increasing dose of dialysis
improved mortality and nutritional parameters in hemodialysis (HD) patients
[abstract]. J Am Soc Nephrol 1992;3(3):367.

Han DC, Cha HK, Chung SH, Park MS, Lee SK, Hwang SD, Moon C, Lee HB. Effects of
subcutaneously implanted catheters on the incidence of peritonitis during CAPD
[abstract]. J Am Soc Nephrol 1991;2(3):361.

Han DC, Cha HK, So IN, Chung SH, Park MS, Lee SK, Woo JH, Hwang SD, Moon C, Lee
HB. Subcutaneously implanted catheters reduce the incidence of peritonitis during
CAPD by eliminating infection by periluminal route. Adv Perit Dial
1992;8:298-301.

Hannah A, Buttimore AL. Thrombolysis of blocked hemodialysis catheter using
recombinant tissue-type plasminogen activator. Nephron 1991;59(3):517-8.

Harmon WE. Are there advantages to bicarbonate dialysis as a standard procedure
for chronic hemodialysis in children? Pediatr Nephrol 1991 Jul;5(4):392.

Hasbargen JA, Hasbargen BJ, Fortenbery EJ. Effect of intraperitoneal neostigmine
on peritoneal transport characteristics in CAPD. Kidney Int 1992
Dec;42(6):1398-400.

Hatjibaloglou A, Grekas D, Saratzis N, Megalopoulos A, Moros I, Kiskinis D,
Dalainas V. Transposed basilic vein-brachial arteriovenous fistula: an
alternative vascular access for hemodialysis. Artif Organs 1992 Dec;16(6):623-5.

Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of
solute and fluid transport during peritoneal dialysis. Kidney Int 1992
May;41(5):1320-32.

Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N. The dose of hemodialysis
according to dialysis prescription in Europe and the United States. Kidney Int
Suppl 1992 Oct;38:S16-21.

Hemodialysis machines. Health Devices 1991 Jun;20(6):187-232.

Hernandez D, Diaz F, Suria S, Machado M, Lorenzo V, Losada M, Gonzalez-Posada JM,
De Bonis E, Dominguez ML, Rodriguez AP, et al. Subclavian catheter-related
infection is a major risk factor for the late development of subclavian vein
stenosis. Nephrol Dial Transplant 1993;8(3):227-30.

Hester RL, Ashcraft D, Curry E, Bower J. Non-invasive determination of
recirculation in the patient on dialysis. ASAIO J 1992 Jul-Sep;38(3):M190-3.

Hester RL, Curry E, Bower J. The determination of hemodialysis blood
recirculation using blood urea nitrogen measurements. Am J Kidney Dis 1992
Dec;20(6):598-602.

Hill SL, Donato AT. Complications of dialysis access: a six-year study. Am J Surg
1991;162(3):265-7.

Himmelfarb J, Gerard NP, Hakim RM. Intradialytic modulation of granulocyte C5a
receptors. J Am Soc Nephrol 1991 Oct;2(4):920-6.

Hirsch DJ, Jindal KK. Late leaks in peritoneal dialysis patients. Nephrol Dial
Transplant 1991;6(9):670-1.

Hoenich NA, Smirthwaite PT, Woffindin C, Lancaster P, Frost TH, Vanholder R. A
technique for the laboratory determination of recirculation in single needle
dialysis. Int J Artif Organs 1993 Feb;16(2):63-70.

Holemans JA, McIvor J, Brown EA. Recurrent subclavian vein stenosis following
successful angioplasty. Nephrol Dial Transplant 1993;7(3):270-1.

Holley J, Bernardini J, Piraino B. Catheter infections in insulin-dependent
diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int
1991;11(4):347-50.

Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status
on body composition as measured by dual energy X-ray absorptiometry in normal
volunteers and patients on haemodialysis. Br J Radiol 1992;65(778):895-900.

Horiuchi T, Ohta Y, Tada Y, Dohi T, Azuma N, Matsugane T, Sakurai H, Mizumura H,
Suzuki M. Measurement of peritoneal dialysate volume by CT. ASAIO Trans 1991 Jul-
Sep;37(3):M156-8.

Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of
mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992
Dec;3(6):1227-37.

Horowitz MD, Alkire MJ, Lickstein DA, Bauerlein EJ. Aortic injury as a
complication of central venous catheterization. Am Heart J 1991 Aug;122(2):595-7.

Hull AR. Impact of reimbursement regulations on patient management. Am J Kidney
Dis 1992 Jul;20(1 Suppl 1):8-11.

Hutchison AJ, Gokal R. Improved solutions for peritoneal dialysis: physiological
calcium solutions, osmotic agents and buffers. Kidney Int Suppl 1992;38:S153-9.

Hutchison AJ, Gokal R. Peritoneal dialysis fluids for the future: do we have the
solution? Dial Transplant 1992;21(2):57, 59-61, 63, 108.

Hutchison AJ, Ofsthun NJ, Howarth D, Gokal R. The effect of hemoglobin
concentration on peritoneal mass transfer and drain volumes in continuous
ambulatory peritoneal dialysis. Perit Dial Int 1992;12(2):230-3.

Hyver SW, Petersen J, Cajias J. An in vivo analysis of reverse ultrafiltration
during high-flux and high-efficiency dialysis. Am J Kidney Dis 1992
May;19(5):439-43.

Ifediora OC, Teehan BP, Sigler MH. Solute clearance in continuous venovenous
hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone
membranes. ASAIO J 1992 Jul-Sep;38(3):M697-701.

Ignotus PI, Gray RR, Macklin N. Review of radiological insertion of indwelling
central venous catheters. Minim Invasive Ther 1992;1(6):373-88.

Ikomi-Kumm J, Ljunggren L, Lund U, Monti M, Thysell H. Microcalorimetric
evaluation of blood compatibility of hemodialysis membranes. Blood Purif
1991;9(4):177-81.

Inagaki O, Nishian Y, Iwaki R, Nakagawa K, Takamitsu Y, Fujita Y. Adsorption of
nafamostat mesilate by hemodialysis membranes. Artif Organs 1992 Dec;16(6):553-8.

Ing TS, Yu AW, Thompson KD, Ansari AU, McShane AP, Gandhi VC, Filkins JP.
Peritoneal dialysis using conventional, lactate-containing solution sterilized
by ultrafiltration. Int J Artif Organs 1992 Nov;15(11):658-60.

Ishihara K, Takayama R, Nakabayashi N, Fukumoto K, Aoki J. Improvement of blood
compatibility on cellulose dialysis membrane. 2. Blood compatibility of
phospholipid polymer grafted cellulose membrane. Biomaterials 1992;13(4):235-9.

Jabar Z, Dawson M. An in vitro investigation of the role of surfactant in
continuous ambulatory peritoneal dialysis. Toxicol Vitro 1991;5(5-6):467-71.

Jacobs IG, Gray RR, Elliott DS, Grosman H. Radiologic placement of peritoneal
dialysis catheters: preliminary experience. Radiology 1992 Jan;182(1):251-5.

Jain KM, Simoni EJ. Cross-over bypass to axillary vein in haemodialysis patients.
Eur J Vasc Surg 1992 Jan;6(1):101-3.

Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity
to activate complement. Complement Inflamm 1991;8(2):61-9.

Janicki K, Dmoszynska A, Janicka L, Stettner S, Jesipowicz J. Influence of
antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Int
Urol Nephrol 1992;24(1):83-9.

Jayasree G, Sharma CP. Polyether urethane urea membrane for an improved
hemodialysis. Biomater Artif Cells Immobilization Biotechnol 1991;19(3):649-59.

Jenkins RD, Harrison HL, Jackson EC, Funk JE. Continuous renal replacement in
infants and toddlers. Contrib Nephrol 1991;93:245-9.

Jirasiritham S, Panichapan S, Sumethkul V, Jirasiritham S. Staged vascular access
for hemodialysis in end-stage renal disease patients. Transplant Proc 1992
Aug;24(4):1461.

Joffe P, Christensen AL, Jensen C. Intra-abdominal location of peritoneal
catheters during CAPD. Adv Perit Dial 1991;7:214-7.

Joffe P, Christensen AL, Jensen C. Peritoneal catheter tip location during non-
complicated continuous ambulatory peritoneal dialysis. Perit Dial Int
1991;11(3):261-4.

Joffe P, Ladefoged SD, Cintin C, Lehmann H. 1 alpha-hydroxycholecalciferol
adsorption to peritoneal dialysis bags: influence of time, glucose concentration,
temperature, and albumin. Nephrol Dial Transplant 1992;7(12):1249-51.

Jones CE, Walters GK. Efficacy of the supraclavicular route for temporary
hemodialysis access. South Med J 1992 Jul;85(7):725-8.

Jones JG, Bembridge JL, Sapsford DJ, Turney JH. Continuous measurements of oxygen
saturation during haemodialysis. Nephrol Dial Transplant 1992;7(2):110-6.

Jorres A, Jorres D, Gahl GM, Schulz E, Mahiout A. Leukotriene release from
neutrophils of patients on hemodialysis with cellulose membranes. Int J Artif
Organs 1992 Feb;15(2):84-8.

Jorres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int
J Artif Organs 1992;15(2):79-83.

Kahl K, Grosse-Siestrup C, Kahl A, Becker H, Rueden H, Hahn H, Gahl GM. Clinical
application of a new silver device to prevent catheter-exit infections in
peritoneal dialysis [abstract]. Nephrol Dial Transplant 1992;7(7):744.

Kalra OP, Aggarwal HK, Mahajan SK, Seth RK. Effect of vasodilator and surface
active drugs on the efficacy of peritoneal dialysis. J Assoc Physicians India
1992 Apr;40(4):233-6.

Karatson A, Racz L, Buzogany I. Catheter types and their abdominal implantation
in peritoneal dialysis. Int Urol Nephrol 1992;24(3):327-33.

Kathrein H, Judmaier G, Braunsteiner H. Assessment of arteriovenous haemodialysis
fistulas. Lancet 1992;339(8799):996.

Kaufman JL. Hemodialysis access catastrophies. Semin Dial 1991 Jan-Mar;4(1):33-9.

Kaupke CJ, Ahdout J, Vaziri ND, Deutsch LS. Perforation of the superior vena cava
by a subclavian hemodialysis catheter: early detection by angiography. Int J
Artif Organs 1992 Nov;15(11):666-8.

Kazmi HR, Raffone FD, Kliger AS, Finkelstein FO. Pseudomonas exit site infections
in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1992
Apr;2(10):1498-501.

Keferstein RD, Fiedler C, Pelster FW, Reers B. Infection prophylaxis and
infection control in vascular access surgery. Vasc Surg 1992;26(4):300-6.

Kelber J, Delmez J, Windus D. The effects of double lumen catheter placement site
and blood flow rate on effective clearance in hemodialysis. J Am Soc Nephrol
1992;3(3):373.

Keoghane SR, Leow CK, Gray DW. Routine use of arteriovenous fistula construction
to dilate the venous outflow prior to insertion of an expanded
polytetrafluoroethylene (PTFE) loop graft for dialysis. Nephrol Dial Transplant
1993;8(2):154-6.

Kerns DB, Frymoyer PA, Kopecky RT, Tice D, Fillinger MF, Bruch D, Schwartz RA.
Is heparin-induced platelet activation an unrecognized cause of thrombosis in
chronic dialysis patients? Vasc Surg 1992;26(6):487-93.

Keshaviah P. Adequacy of CAPD: a quantitative approach. Kidney Int Suppl
1992;38:S160-4.

Keshaviah P. Urea kinetic and middle molecule approaches to assessing the
adequacy of hemodialysis and CAPD. Kidney Int Suppl 1993 Feb;40:S28-38.

Keshaviah PR, Nolph KD. Protein catabolic rate calculations in CAPD patients.
ASAIO Trans 1991 Jul-Sep;37(3):M400-2.

Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on
chronic hemodialysis. A multicenter prospective survey. Nephron
1993;64(1):95-100.

Keuchel M, Dittmar A, Saure B, Laage C, Ebel H, Lange H. Fluid-shift during
computer-modulated profile hemodialysis (CMP-HD). Int J Artif Organs 1991
Oct;14(10):630-3.

Khan IH, Catto GRD. Long-term complications of dialysis: infection. Kidney Int
Suppl 1993;41: S143-8.

Khanna S, Sniderman K, Simons M, Besley M, Uldall R. Superior vena cava stenosis
associated with hemodialysis catheters. Am J Kidney Dis 1993 Mar;21(3):278-81.

Kimmelstiel FM, Miller RE, Molinelli BM, Lorch JA. Laparoscopic management of
peritoneal dialysis catheters. Surg Gynecol Obstet 1993;176(6):565-70.

Kirschbaum B. Acid-base regulation in hemodialyzed renal failure patients: effect
of serum proteins and bicarbonate buffering. Artif Organs 1991 Dec;15(6):443-8.

Kitaevich Y, Bissler J, Benzing G 3d, Hemasilpin N, Marchevsky G, McEnery P,
Hammitt M. Development of a high-precision continuous extracorporeal
hemodiafiltration system. Biomed Instrum Technol 1993 Mar-Apr;27(2):150-6.

Kitamoto Y, Kano T, Mishima M, Matsushita K, Yasumoto N, Nakano M, Morioka T,
Sato T. Dermal patch anesthesia: pain-free puncture of blood access in
hemodialysis patients. Am J Kidney Dis 1992 Nov;20(5):489-91.

Kjellstrand P, Boberg U. Toxicity testing of polymer materials for use in
haemodialysis. Toxicol Vitro 1991;5(5-6):443-8.

Kjellstrand P, Okmark P, Odselius R, Thysell H, Riede G, Holmquist B. Adherence
of blood cells to dialyzer membranes as a measure of biocompatibility. Int J
Artif Organs 1991 Nov;14(11):698-702.

Klaus G, Schafer F, Querfeld U, Soergel M, Wolf S, Mehls O. Treatment of
relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit
Dial 1992;8:302-5.

Knabe C, Grosse-Siestrup C, Becker H, Pustelnik A, Gahl G. A new method to
evaluate the CAPD-catheter-exit and other percutaneous devices. Int J Artif
Organs 1991 Feb;14(2):83-6.

Kobrin SM, Kimmel PL, Simmens SJ, Reiss D. Behavioral and biochemical indices of
compliance in hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M378-80.

Kolb G, Muller T, Hoffken H, Joseph K, Lange H, Havemann K. Hemophan versus
hemophan - a philippic against the suggestion of constant membrane quality.
Biomater Artif Cells Immobilization Biotechnol 1992;20(5):1233-48.

Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane
contact in hemodialysis-induced granulocyte activation. Nephron 1991;57(1):64-8.

Kooman JP, Gladziwa UL, Bocker G, Van Bortel LM, Van Hooff JP, Leunissen KM. Role
of the venous system in hemodynamics during ultrafiltration and bicarbonate
dialysis. Kidney Int 1992;42(3):718-26.

Korbet SM, Vonesh EF, Firanek CA. The effect of hematocrit on peritoneal
transport. Am J Kidney Dis 1991 Nov;18(5):573-8.

Korzets A, Chagnac A, Ori Y, Katz M, Zevin D. Subclavian vein stenosis, permanent
cardiac pacemakers and the haemodialysed patient. Nephron 1991;58(1):103-5.

Kouw PM, Olthof CG, Gruteke P, de Vries PM, Meijer JH, Oe PL, Schneider H, Donker
AJ. Influence of high and low sodium dialysis on blood volume preservation.
Nephrol Dial Transplant 1991;6(11):876-80.

Krack G, Viglino G, Cavalli PL, Gandolfo C, Magliano G, Cantaluppi A, Peluso F.
Intraperitoneal administration of phosphatidylcholine improves ultrafiltration
in continuous ambulatory peritoneal dialysis patients. Perit Dial Int
1992;12(4):359-64. Comment in: Perit Dial Int 1992;12(4):346-9.

Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD dialysis fluids in
a model system of quiescent fibroblasts. Nephrol Dial Transplant 1993;8(2):163-7.

Krzesinski JM, Du F, Pequeux ML, Rorive GL. Plasma Na-K ATPase inhibitor activity
and intracellular ions during hemodialysis. Int J Artif Organs 1993
Jan;16(1):23-30.

Kubey W, Holmes CJ. In vitro studies on the microbicidal effectiveness of a
xenon-based ultraviolet light device for continuous ambulatory peritoneal
dialysis connections. Blood Purif 1991;9(2):102-8.

Kumano K, Yokota S, Go M, Suyama K, Sakai T, Era S, Sogami M. Quantitative and
qualitative changes of serum albumin in CAPD patients. Adv Perit Dial
1992;8:127-30.

Kumpe DA, Cohen MA. Angioplasty/thrombolytic treatment of failing and failed
hemodialysis access sites: comparison with surgical treatment. Prog Cardiovasc
Dis 1992 Jan-Feb;34(4):263-78.

Kumpe DA, Cohen MA, Durham JD. Treatment of failing and failed hemodialysis
access sites: Comparison of surgical treatment with thrombolysis/angioplasty.
Semin Vasc Surg 1992;5(2):118-27.

Kuzniewski M, Suowicz W, Lisiewicz J. Effect of heparin and prostacyclin-heparin
infusion on blood coagulation in haemodialysed patients. Int Urol Nephrol
1991;23(1):89-96.

Kuzniewski M, Suowicz W. Influence of prostacyclin infusion on haemodialysis
efficiency and blood cells. Int Urol Nephrol 1992;24(5):555-63.

Kwan JT, Almond MK, Altmann P. Percutaneous insertion of cuffed silicone rubber
double-lumen hemodialysis catheters for long-term use. J Am Soc Nephrol
1991;2(3):335.

Lafleur D, Cordy P, Gallimore B, Adam J. Peritonitis rates for CAPD patients
using the SCD 210 (Inpersol sterile connecting device): a Canadian survey. Adv
Perit Dial 1991;7:196-203.

Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S. A longitudinal, five year
survey of urea kinetic parameters in CAPD patients. Kidney Int 1992
Aug;42(2):426-32.

Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R. Antithrombin III
supplementation reduces heparin requirement and platelet loss during hemodialysis
of patients with fulminant hepatic failure. Hepatology 1991 Aug;14(2):251-6.

Latham D, Geisman J. Case management of the anemic patient. Epoetin alfa: focus
on dialysis efficiency. ANNA J 1991 Dec;18(6):588-9.

Lauster F, Fulle HJ, Gerzer R, Schiffl H. The postdialytic plasma cyclic
guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic
hemodialysis. J Am Soc Nephrol 1992 Mar;2(9):1451-4.

Lauster F, Heim JM, Drummer C, Fulle HJ, Gerzer R, Schiffl H. Plasma cGMP level
as a marker of the hydration state in renal replacement therapy. Kidney Int Suppl
1993;41:S57-9.

Lauster F, Heim JM, Drummer C, Gerzer R, Schiffl H. Plasma ANP and cGMP levels
in CAPD patients. Contrib Nephrol 1993;101:44-50.

Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD):
aetiology, complications and risk factors. Ann Acad Med Singapore 1992
May;21(3):354-60.

Lee SJ, Neiberger R. Subclavian vein stenosis: complication of subclavian vein
catheterization for hemodialysis. Child Nephrol Urol 1991;11(4):212-4.

LeFebvre JM, Spanner E, Heidenheim AP, Lindsay RM. Kt/V: patients do not get what
the physician prescribes. ASAIO Trans 1991 Jul-Sep;37(3):M132-3.

Leitienne P, Trzeciak MC, Adeleine P, Ville D, Dechavanne M, Traeger J, Zech P.
Comparison of hemostasis with two high-flux hemocompatible dialysis membranes.
Int J Artif Organs 1991 Apr;14(4):227-33.

Leonard DK. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991
Aug;18(4):371-6; discussion 377.

Leone M, Bottacchi E, Alloatti S, Nebiolo PE, Aimino M, Baldini S. Follow-up of
nerve conduction in chronic uremic patients during hemodialysis. Ital J Neurol
Sci 1992 May;13(4):317-21.

Lettgen B, Bald M, Vallee H, Bonzel KE, Rascher W. Atrial natriuretic peptide and
cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in
children with chronic renal failure. Pediatr Nephrol 1992 Jan;6(1):60-4.

Leunissen KM, Kouw P, Kooman JP, Cheriex EC, De Vries PM, Donker AJ, Van Hooff
JP. New techniques to determine fluid status in hemodialyzed patients. Kidney Int
Suppl 1993;41:S50-6.

Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis
subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991
Nov;40(5):934-8.

Lev-Ran A, Hwang DL, Ahmad B, Bixby H. Immunoreactive epidermal growth factor in
serum, plasma, platelets, and urine in patients on chronic dialysis. Nephron
1991;57(2):164-6.

Levy FL, Grayburn PA, Foulks CJ, Brickner ME, Henrich WL. Improved left
ventricular contractility with cool temperature hemodialysis. Kidney Int 1992
Apr;41(4):961-5.

Levy SS, Sherman RA, Nosher JL. Value of clinical screening for detection of
asymptomatic hemodialysis vascular access stenoses. Angiology 1992
May;43(5):421-4.

Lewis MA, Nycyk JA. Practical peritoneal dialysis--the Tenckhoff catheter in
acute renal failure. Pediatr Nephrol 1992 Sep;6(5):470-5.

Leypoldt JK, Blindauer KM. Convection does not govern plasma to dialysate
transport of protein. Kidney Int 1992 Dec;42(6):1412-8.

Leypoldt JK, Kablitz C, Gregory MC, Senekjian HO, Cheung AK. Prescribing
hemodialysis using a weekly urea mass balance model. Blood Purif
1991;9(5-6):271-84. Comment in: Blood Purif 1991;9(5-6):241-5.

Leypoldt JK, Schmidt B, Gurland HJ. Measurement of backfiltration rates during
hemodialysis with highly permeable membranes. Blood Purif 1991;9(2):74-84.

Limido A, Cantu P, Renzetti G, Levati M, Farfaglia P, Colombo A. Ultrasonographic
examination of the Tenckhoff catheter course. Nephrol Dial Transplant
1992;7(7):745.

Lindsay RM, Heidenheim AP, Spanner E, Baird J, Simpson K, Allison ME. Urea
monitoring during dialysis: the wave of the future. A tale of two cities. ASAIO
Trans 1991 Apr-Jun;37(2):49-53.

Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake PG. PCR, Kt/V and
membrane. Kidney Int Suppl 1993;41:S268-73.

Lindsay RM, Spanner E, Heidenheim RP, LeFebvre JM, Hodsman A, Baird J,
Allison ME. Which comes first, Kt/V or PCR - chicken or egg?
Kidney Int Suppl 1992;38:S32-6.

Litherland J, Gibson M, Sambrook P, Lupton E, Beaman M, Ackrill P. Investigation
and treatment of poor drains of dialysate fluid associated with anterior
abdominal wall leaks in patients on chronic ambulatory peritoneal dialysis.
Nephrol Dial Transplant 1992;7(10):1030-4.

Ljungberg B, Jacobson SH, Lins LE, Pejler G. Effective anticoagulation by a low
molecular weight heparin (Fragmin) in hemodialysis with a highly permeable
polysulfone membrane. Clin Nephrol 1992 Aug;38(2):97-100.

Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating
prolonged use of chlorhexidine in alcohol in the connection procedure for
continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(2):166-72.
Comment in: Perit Dial Int 1992;12(3):330.

Lo WK, Cheung WC, Chan TM, Lo CY, Lui SL, Cheng IK. Result of lower paramedian
insertion of Tenckhoff catheter. J Hong Kong Med Assoc 1992;44(3):159-63.

Lopot F. Is urea kinetic modelling an appropriate tool for guiding ultrashort
high-flux dialysis therapy? Nephrol Dial Transplant 1991;6 Suppl 3:86-7.

Lopot F, Blaha J, Valek A. An equation for calculating postdialysis plasma
sodium. Int J Artif Organs 1992;15(6):354-7.

Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis.
J Hosp Infect 1991 Jun;18 Suppl A:341-54.

Ludlam HA, Baker LRI. The prevention of infection associated with continuous
ambulatory peritoneal dialysis. Curr Opin Infect Dis 1991;4(4):541-8.

Ludlow MK, Yap E. Vascular access thrombosis following human recombinant
erythropoietin (EPO) therapy. ANNA J 1992 Apr;19(2):154.

Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a
review. Perit Dial Int 1991;11(4):333-40.

Lye WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff
catheters. Scand J Urol Nephrol 1992;26(2):177-80.

Lye WC, Leong SO, Lee EJ. Methicillin-resistant Staphylococcus aureus nasal
carriage and infections in CAPD. Kidney Int 1993;43(6):1357-62.

Lysaght MJ, Moran J, Lysaght CB, Schindhelm K, Farrell PC. Plasma water
filtration and lymphatic uptake during peritoneal dialysis. ASAIO Trans 1991 Jul-
Sep;37(3):M402-4.

Mactier RA. Investigation and management of ultrafiltration failure in CAPD. Adv
Perit Dial 1991;7:57-62.

Mahurkar SD. Memory-induced curved extensions for hemodialysis Mahurkar
catheters. Dial Transplant 1992;21(3):128-9.

Majdalani G, Chomant J, Kachko A, Yanai M, Man NK. Kinetics of technetium-labeled
heparin in hemodialyzed patients. Kidney Int Suppl 1993;41:S131-4.

Malacarne F, De Paoli Vitali E, Prandini N, Feggi L, Perini L, Cervi PM,
Reverberi R, Lodi L, Gilli P. Increased uptake of radio labelled white blood
cells into abdomen of uremics on peritoneal dialysis. Adv Perit Dial
1992;8:39-41.

Malsch G, Paul D, Kramer S, Wolf H, Thomaneck U, Brown GS, Falkenhagen D.
Chemical modification of cellulose membranes with improved blood compatibility.
Clin Mater 1991;8(1-2):65-9.

Man NK, Chauveau P, Kuno T, Poignet JL, Yanai M. Phosphate removal during
hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans
1991 Jul-Sep;37(3):M463-5.

Marangella M, Bagnis C, Bruno M, Petrarulo M, Gabella P, Linari F. Determinants
of oxalate balance in patients on chronic peritoneal dialysis. Am J Kidney Dis
1993 Apr;21(4):419-26.

Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F. Plasma profiles and
removal rates of inorganic sulphate, and their influence on serum ionized
calcium, in patients on maintenance haemodialysis. Clin Sci 1991
May;80(5):489-95.

Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma
profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
Nephron 1992;60(1):74-80.

Marangoni R, Savino R, Colombo R, Cimino R, Civardi F. Short time treatment with
high-efficiency paired filtration dialysis for chronic renal failure. Artif
Organs 1992 Dec;16(6):547-52.

Markell MS, Cohen L, Lundin AP, Hong J, Friedman EA. Hospitalization for
complications of hemodialysis; vascular access variables affecting length of stay
(LOS) [abstract]. J Am Soc Nephrol 1991;2(3):337.

Markert M, Wauters JP. New aspects on oxidative metabolism of neutrophils during
hemodialysis on different dialyzer membranes. Adv Exp Med Biol 1991;297:207-13.

Markwardt F, Nowak G, Bucha E. Hirudin as anticoagulant in experimental
hemodialysis. Haemostasis 1991;21 Suppl 1:149-55.

Martin U, Winney R, Prescott LF. Frusemide disposition in patients on continuous
ambulatory peritoneal dialysis (CAPD). Br J Clin Pharmacol 1991;31(2):227-8.

Martinez V, Garcia Caballero J, Munoz I, Celadilla O, Miranda B, Selgas R. Heat
sterilization of safe.lock connectors using Thermoclav in experimental
conditions. Contrib Nephrol 1991;89:59-61.

Martin-Malo A, Castillo D, Castro M, Perez R, Rios A, Jaraba M, Aljama P.
Biocompatibility of dialysis membranes: a comparative study. Nephrol Dial
Transplant 1991;6 Suppl 2:55-8.

Martin-Malo A, Velasco F, Rojas R, Castillo D, Rodriguez M, Torres A, Aljama P.
Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.
Kidney Int Suppl 1993;41: S213-6.

Martinson E, Wieslander A, Kjellstrand P, Boberg U. Toxicity of heat sterilized
peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992
Jul-Sep;38(3):M370-2.

Marumo F, Shichiri M, Emori T, Ando K. Circulating and excreted forms of atrial
natriuretic peptide in healthy subjects and patients with renal diseases. Clin
Nephrol 1992 Oct;38(4):203-8.

Masin G, Polenakovic M, Ivanovski N, Atanasov N, Olivera S, Cakalaroski K.
Hypersensitivity reactions to ethylene oxide: clinical experience. Nephrol Dial
Transplant 1991;6 Suppl 3:50-2.

Matthews R, Clugston R, Eisenhauer A, Dake M, Schatz R, Feinstein E. Balloon
expandable stents to treat central venous stenoses in hemodialysis patients. Am
J Nephrol 1992;12(6):451-6.

Maurin N. Antithrombotic management with a stable prostacyclin analogue during
extracorporeal circulation. Contrib Nephrol 1991;93:205-9.

Mawhinney WM, Adair CG, Gorman SP. Incidence of microbial biofilm on peritoneal
catheters removed from peritonitis-free CAPD patients following renal transplant
[abstract]. Pharmacotherapy 1991;11(3):277.

Mayers J, Cohen L, Markell M, Friedman E. Factors affecting length of stay (LOS)
in hospitalization for vascular access surgery. ANNA J 1992 Apr;19(2):152.

Mayers JD, Markell MS, Cohen LS, Hong J, Lundin P, Friedman EA. Vascular access
surgery for maintenance hemodialysis. Variables in hospital stay. ASAIO J 1992
Apr-Jun;38(2):113-5.

McMullen K, Hayes D, Hussey JL, Boudreaux JP. Salvage of hemodialysis access in
infected arteriovenous fistulas. Arch Surg 1991 Oct;126(10):1303-5.

Menth M, Rockel A, Abdelhamid S, Fiegel P, Walb D. Low-molecular-weight protein-
permeable cuprammonium rayon haemofilter. Nephrol Dial Transplant
1992;7(8):844-7.

Mineshima M, Watanuki M, Yamagata K, Era K, Nakazato S, Suga H, Agishi T, Ota K,
Sakai K, Fukui K. Development of continuous recirculating peritoneal dialysis
using a double lumen catheter. ASAIO J 1992 Jul-Sep;38(3):M377-81.

Miranda B, Selgas R, Celadilla O, Munoz J, Sanchez Sicilia L. Peritoneal resting
and heparinization as an effective treatment for ultrafiltration failure in
patients on CAPD. Contrib Nephrol 1991;89:199-204.

Mitwalli AH. Does omentectomy affect ultrafiltration in peritoneal dialysis.
Saudi Med J 1991;12(3):232-5.

Miura Y, Ishiyama T, Inomata A, Takeda T, Senma S, Okuyama K, Suzuki Y.
Radiolucent bone cysts and the type of dialysis membrane used in patients
undergoing long-term hemodialysis. Nephron 1992;60(3):268-73.

Moncrief JW, Popovich RP, Broadrick LJ, He ZZ, Simmons EE, Tate RA. The Moncrief-
Popovich catheter. A new peritoneal access technique for patients on peritoneal
dialysis. ASAIO J 1993 Jan-Mar;39(1):62-5.

Montagnac R, Schillinger F. Rifampicin-protamine protocol applied for prevention
of central catheter sepsis in haemodialysis (2). Nephrol Dial Transplant
1993;8(3):289-99.

Montenegro J, Echevarria J, Gonzalez R, Martinez I, Saracho R, Cruz C. Testing
the safety of non-disconnect disposable Y sets for peritoneal dialysis. Adv Perit
Dial 1991;7:183-5.

Montenegro J, Martinez I, Saracho R, Gonzalez R. Beta 2 microglobulin in CAPD.
Adv Perit Dial 1992;8:369-72.

Morgan JD, Tilsed JV, Bell PR, Veitch PS, Donnelly PK. Continuous ambulatory
peritoneal dialysis in patients with aortic grafts. Br J Surg 1992
Aug;79(8):755-6.

Mosquera DA, Gibson SP, Goldman MD. Vascular access surgery: a 2-year study and
comparison with the Permcath. Nephrol Dial Transplant 1992;7(11):1111-5.

Mrowka CH, Schiffl H. Comparative evaluation of beta 2-microglobulin removal by
different hemodialysis membranes: a six-year follow-up. Nephron 1993;63(3):368-9.

Muirhead N, Mitton R. Use of bone char as an adsorbent in preparation of water
for dialysis. ASAIO J 1992 Jul-Sep;38(3):M334-7.

Mujais SK, Ivanovich P. Adequacy of dialytic therapy: hydra complex and
statistical concealment. Artif Organs 1993 Apr;17(4):254-9.

Mulloy LL, Caruana RJ, Steele JC Jr, Wynn JJ. Polymicrobial bacteremia during
long-term hemodialysis. South Med J 1991 May;84(5):594-6.

Mulvihill J, Cazenave JP, Mazzucotelli JP, Crost T, Collier C, Renaux JL,
Pusineri C. Minimodule dialyser for quantitative ex vivo evaluation of membrane
haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan
and polysulphone hollow fibres. Biomaterials 1992;13(8):527-36.

Mwaniki DL, Courtney JM, Forbes CD, Paul JP. Assessment of blood compatibility
of haemodialysis membranes using a miniature flat sheet dialyser. East Afr Med
J 1992 Mar;69(3):149-52.

Nahman NS Jr, Middendorf DF, Bay WH, McElligott R, Powell S, Anderson J.
Modification of the percutaneous approach to peritoneal dialysis catheter
placement under peritoneoscopic visualization: clinical results in 78 patients.
J Am Soc Nephrol 1992 Jul;3(1):103-7.

Nakamura Y, Ikeda T, Takata S, Yokoi H, Hirono M, Abe T, Takazakura E, Kobayashi
K. The role of peripheral capacitance and resistance vessels in hypotension
following hemodialysis. Am Heart J 1991 Apr;121(4 Pt 1):1170-7.

Nakane K, Shinzato T, Maeda K. Continuous measurement of pressure in internal
arteriovenous fistulae and prevention of symptomatic hypotension during
hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M232-4.

Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent
peritonitis in CAPD. Clin Nephrol 1991 Jan;35(1):20-3. Comment in: Clin Nephrol
1991 Oct;36(4):214.

Nannery WM, Stoldt HS, Fares LG 2d. Hemodialysis access operations performed upon
patients with human immunodeficiency virus. Surg Gynecol Obstet 1991
Nov;173(5):387-90.

Navarro J, Serrano C, Donna E, Perez GO. Disordered breathing patterns during
bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone
membranes. ASAIO J 1992 Oct-Dec;38(4):811-4.

Nebel M, Marczewski K, Finke K. Three years of experience with the swan-neck
Tenckhoff catheter. Adv Perit Dial 1991;7:208-13.

Newman GE, Saeed M, Himmelstein S, Cohan RH, Schwab SJ. Total central vein
obstruction: resolution with angioplasty and fibrinolysis. Kidney Int 1991
Apr;39(4):761-4.

Ney AL, Odland MD, Andersen RC. Causes and evaluation of incipient vascular
access failure in chronic hemodialysis. Semin Dial 1991 Jul-Sep;4(3):174-8.

Nicholson ML, Burton PR, Donnelly PK, Veitch PS, Walls J. The role of omentectomy
in continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11(4):330-2.

Nolph KD. Access problems plague both peritoneal dialysis and hemodialysis.
Kidney Int Suppl 1993 Feb;40:S81-4.

Nolph KD. What's new in peritoneal dialysis--an overview. Kidney Int Suppl 1992
Oct;38:S148-52.

Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, Ponferrada L.
Cross-sectional assessment of weekly urea and creatinine clearances in patients
on continuous ambulatory peritoneal dialysis. ASAIO J 1992 Jul-Sep;38(3):M139-42.

Nolph KD, Twardowski ZJ, Keshaviah PR. Weekly clearances of urea and creatinine
on CAPD and NIPD. Perit Dial Int 1992;12(3):298-303.

Nonnast-Daniel B, Martin RP, Lindert O, Mugge A, Schaeffer J, v.d. Lieth H,
Sochtig E, Galanski M, Koch KM, Daniel WG. Colour Doppler ultrasound assessment
of arteriovenous haemodialysis fistulas. Lancet 1992 Jan 18;339(8786):143-5.
Comment in: Lancet 1992 Apr 18;339(8799):996.

Novak Z, Buzas E, Salgo L, Gal G. Effects of haemodialysis with acetate or
bicarbonate-containing solutions on deformability of red blood cells. Rev Port
Hemorreologia 1991;5(2):239-47.

Nube MJ, De Vet JA, Steffens A, Van Geelen JA. Long-term results of continuous
ambulatory peritoneal dialysis: the first hundred patients. A single centre
study. Neth J Med 1993;42(4):112-21.

Odar-Cederlof I, Eriksson CG, Theodorsson E, Kjellstrand C. Antidiuretic hormone
regulation in hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M227-9.

Odar-Cederlof I, Theodorsson E, Ericsson F, Kjellstrand CM. Plasma concentrations
of calcitonin gene-related peptide in fluid overload. Lancet
1991;338(8764):411-2.

Odland MD, Kelly PH, Ney AL, Andersen RC, Bubrick MP. Management of dialysis-
associated steal syndrome complicating upper extremity arteriovenous fistulas:
use of intraoperative digital photoplethysmography. Surgery 1991
Oct;110(4):664-9; discussion 669-70.

Ofsthun NJ, Jensen JC, Kray M. Effect of high hematocrit and high blood flow
rates on transmembrane pressure and ultrafiltration rate in hemodialysis. Blood
Purif 1991;9(3):169-76.

Okadome K, Komori K, Fukumitsu T, Sugimachi K. The potential risk for subclavian
vein occlusion in patients on haemodialysis. Eur J Vasc Surg 1992 Nov;6(6):602-6.

Olivas E, Jimenez C, Lopez A, Andres E, Sanchez Tarraga L. Reduction of the
incidence of peritonitis in CAPD: effectiveness of heat sterilization of
Safe.Lock connectors. Contrib Nephrol 1991;89: 62-7.

Olthof CG, de Vries PM, Kouw PM, Oe PL, Gerlag PG, Schneider H, Donker AJ. The
recovery of the fluid balance after hemodialysis and hemofiltration. Clin Nephrol
1992 Mar;37(3):135-9.

Os I, Nordby G, Lyngdal PT, Eide I. Plasma vasopressin, catecholamines and atrial
natriuretic factor during hemodialysis and sequential ultrafiltration. Scand J
Urol Nephrol 1993;27(1):93-9.

Ota K. Biocompatibility and capability of haemopurification systems: review and
future development. Nephrol Dial Transplant 1991;6 Suppl 2:86-90.

Ota K, Nakagawa Y, Kitano Y, Oshima T, Teraoka S. Clinical application of
modified polyurethane graft to blood access. Artif Organs 1991 Dec;15(6):449-53.

Pacitti A, Tetta C, Mangiarotti G, Canavese C, Segoloni GP. Beta-2-microglobulin
serum profiles in different settings of mass transport and fluid pyrogen content.
Kidney Int Suppl 1993;41:S96-9.

Paczek L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and
interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol
Dial Transplant 1991;6 Suppl 3:41-4.

Padberg FT Jr, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet
1992;174(2):103-8.

Parker TF. Trends and concepts in the prescription and delivery of dialysis in
the United States. Semin Nephrol 1992 May;12(3):267-75.

Pastan S, Gassensmith C, Manatunga AK, Copley JB, Smith EJ, Hamburger RJ.
Prospective comparison of peritoneoscopic and surgical implantation of CAPD
catheters. ASAIO Trans 1991 Jul-Sep;37(3):M154-6.

Patel KR, Chan FA, Batista RJ, Clauss RH. True venous aneurysms and arterial
"steal" secondary to arteriovenous fistulae for dialysis. J Cardiovasc Surg
1992;33(2):185-8.

Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino
MJ, Favero MS, Mackow RC, Jarvis WR. Anaphylactoid reactions associated with
reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int
1992;42(5):1232-7.

Pengloan J, Petit A, Thibaut G, Blanchier D, Bardos P. Biocompatibility of
dialyser membranes: roles of membranes and of patients. Nephrol Dial Transplant
1991;6 Suppl 2:59-60.

Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and
cytokine production in hemodialyzed patients. Kidney Int Suppl 1993;41:S221-5.

Petar B, Tomislav I, Miodrag I, Snezana A. Strecker stent in stenotic
hemodialysis Brescia-Cimino arteriovenous fistulas. Cardiovasc Intervent Radiol
1992 Jul-Aug;15(4):217-20.

Piraino B, Bernardini J, Centa PK, Johnston JR, Sorkin MI. The effect of body
weight on CAPD related infections and catheter loss. Perit Dial Int
1991;11(1):64-8.

Piraino B, Holley JL, Bernardini J, Burkart JM. Are exit-site infection rates
lower with disconnect systems? Perit Dial Int 1993;13(1):67-8.

Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under
various conditions of volume homeostasis. J Intern Med 1991 Mar;229(3):209-16.

Plum J, Sudkamp S, Grabensee B. Is ultrasound a suitable tool to detect and to
control tunnel infections in patients undergoing capd? J Am Soc Nephrol
1992;3(3):416.

Poisetti P, Bergonzi G, Ballocchi S, Fontana F, Scarpioni L. Aging of silastic
peritoneal catheters. Int J Artif Organs 1991 Dec;14(12):765-70.

Ponikvar R, Kovac D, Malovrh M, Premru V. Silicone jugular vein catheters as
permanent vascular access for hemodialysis [abstract]. Int J Artif Organs
1992;15(9):565.

Pontari MA, McMillen MA. The straight radial-antecubital PTFE angio-access graft
in an era of high-flux dialysis. Am J Surg 1991 Apr;161(4):450-3.

Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and
technique failure by CAPD connection technique: a national study. Kidney Int 1992
Oct;42(4):967-74.

Postiglione A, Faccenda F, Gallotta G, Rubba P, Federico S. Changes in middle
cerebral artery blood velocity in uremic patients after hemodialysis. Stroke
1991;22(12):1508-11.

Potempa LA, Motie M, Anderson B, Klein E, Baurmeister U. Conjugation of a
modified form of human C-reactive protein to affinity membranes for
extracorporeal adsorption. Clin Mater 1992;11(1-4):105-17.
Poulain F, Raynaud A, Bourquelot P, Knight C, Rovani X, Gaux JC. Local
thrombolysis and thromboaspiration in the treatment of acutely thrombosed
arteriovenous hemodialysis fistulas. Cardiovasc Intervent Radiol 1991 Mar-
Apr;14(2):98-101.

Premru V, Ponikvar R, Malovrh M, Benedik M. Subclavian vein catheters as long-
term vascular access for hemodialysis [abstract]. Int J Artif Organs
1992;15(9):565.

Pronai W, Silberbauer K. 66 months of hemodialysis without a shunt; longtime
experience with a central vein catheter [abstract]. Int J Artif Organs
1991;14(9):582.

Prowant BF, Warady BA, Nolph KD. Peritoneal dialysis catheter exit-site care:
results of an international survey. Perit Dial Int 1993;13(2):149-54.

Pudelski B, Bednarz D. Nursing intervention to improve dialysis adequacy of
intensive care patients in acute renal failure. ANNA J 1992 Apr;19(2):163.

Purchase L, Gault MH. Hemodialysis with a permcath kept open with streptokinase
and later citrate in a heparin-sensitive patient. Nephron 1991;58(1):119-20.

Quinn SF, Schuman ES, Hall L, Gross GF, Uchida BT, Standage BA, Rosch J, Ivancev
K. Venous stenoses in patients who undergo hemodialysis: treatment with self-
expandable endovascular stents. Radiology 1992 May;183(2):499-504.

Raja RM, Ijelu G, Goldstein M. Influence of Kt/V and protein catabolic rate on
hemodialysis morbidity. A long-term study. ASAIO J 1992 Jul-Sep;38(3):M179-80.

Rallison LR, Kushner RF, Penn D, Schoeller DA. Errors in estimating peritoneal
fluid by bioelectrical impedance analysis and total body electrical conductivity.
J Am Coll Nutr 1993 Feb;12(1):66-72.

Rault R. Optimal dialysate bicarbonate during hemodialysis. ASAIO Trans 1991 Jul-
Sep;37(3):M372-3.

Reber G, Stoermann C, de Moerloose P, Ruedin P, Leski M. Hemostatic disturbances
induced by two hollow-fiber hemodialysis membranes. Int J Artif Organs 1992
May;15(5):269-76.

Redaelli B, Limido D, Sforzini S, Beretta P, Bonoldi G, Dadone C, Di Filippo G,
Mariani P, Mascia F, Pincella G, et al. Forecasting correct sodium balance in
hemodiafiltration procedures involving infusions. Blood Purif 1991;9(3):123-8.

Reed J, Fellner S. Tolerance of high flux hemodialysis hd by elderly patients
[abstract]. J Am Soc Nephrol 1991;2(3):346.

Remuzzi A, Boccardo P, Benigni A. In vitro platelet adhesion to dialysis
membranes. Nephrol Dial Transplant 1991;6 Suppl 2:36-9.

Richards NT, Clarke A, Condon S, Elliot T, Adu D, Michael J. Elimination of CAPD
catheter exit site infection due to staphylococcus-aureus with peri-operative
antiseptics [abstract]. Nephrol Dial Transplant 1992;7(7):745.

Rivers SP, Scher LA, Veith FJ. Correction of steal syndrome secondary to
hemodialysis access fistulas: a simplified quantitative technique. Surgery 1992
Sep;112(3):593-7.

Roberts M. Wearable artificial kidneys for continuous dialysis. A personal view.
ASAIO J 1993 Jan-Mar;39(1):19-23.

Roberts M, Montez AJ, Lee DB. Component selection to optimize blood flow for
continuous arteriovenous hemofiltration and dialysis. ASAIO Trans 1991 Jul-
Sep;37(3):M382-3.

Roberts M, Winney RJ. Errors in fluid balance with pump control of continuous
hemodialysis. Int J Artif Organs 1992 Feb;15(2):99-102.

Robles NR, Murga L, Galvan S, Esparrago JF, Sanchez-Casado E. Hemodialysis with
cuprophane or polysulfone: effects on uremic polyneuropathy. Am J Kidney Dis 1993
Mar;21(3):282-7.

Ronco C, Brendolan A, Bragantini L, Crepaldi C, Dell'Aquila R, Milan M, Feriani
M, Chiaramonte S, Conz P, La Greca G. High-performance continuous arteriovenous
hemofiltration in infants with the new Minifilter plus. Contrib Nephrol
1991;93:254-6.

Rovner MS, Brouhard BH, Cunningham RJ, Firor H. Comparison of cuffed vs. uncuffed
catheters for extracorporeal therapy in pediatric patients. Dial Transplant
1992;21(8):513-15, 518, 520, 522.

Rueckmann I, Berry C, Ouriel K, Hoffart N. The synthetic axillofemoral graft for
hemodialysis access. ANNA J 1991 Dec;18(6):567-71.

Ruedin P, Laverriere C, Bertschi AP, Etienne T, Stoermann C, Leski M. Successful
use of percutaneously inserted double-lumen catheters for permanent haemodialysis
access: a prospective study [abstract]. Nephrol Dial Transplant 1992;7(7):737.

Ruedin P, Laverriere C, Etienne T, Leski M. Three years experience with a
percutaneously inserted double lumen catheter for permanent hemodialysis access
a prospective study [abstract]. J Am Soc Nephrol 1992;3(3):389.

Saad F, Paquin JM, Perreault JP, Faucher R, Mauffette F, Valiquette L. Simple
technique for making subcutaneous tunnel in creation of A-V fistula using
prosthesis. Urology 1991 May;37(5):468-9.

Saha LK, Van Stone JC. Differences between KT/V measured during dialysis and KT/V
predicted from manufacturer clearance data. Int J Artif Organs 1992
Aug;15(8):465-9.

Salem ME, Naga SS. Loop versus straight PFTE gore-tex grafts for arterio-venous
shunts in hemodialysis patients. J Med Res Inst 1992;13(1):95-105.

Sands J, Young S, Miranda C. The effect of Doppler flow screening studies and
elective revisions on dialysis access failure. ASAIO J 1992 Jul-Sep;38(3):M524-7.

Saniabadi AR, Fisher TC, Lau CS, Bridges A, Taylor J, Belch J, Forbes CD.
Dipyridamole increases human red blood cell deformability. Eur J Clin Pharmacol
1992;42(6):651-4.

Scabardi M, Ronco C, Chiaramonte S, Feriani M, Agostini F, La Greca G. Dynamic
catheterography in the early diagnosis of peritoneal catheter malfunction. Int
J Artif Organs 1992 Jun;15(6):358-64.

Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel
infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis
1991 Dec;18(6):674-7.

Schaefer RM, Paczek L, Heidland A. Suppression of beta 2-microglobulin release
from lymphocytes by dialysis membranes. Nephrol Dial Transplant 1991;6 Suppl
3:53-6.

Schambye HT, Flesner P, Pedersen RB, Hardt-Madsen M, Chemnitz J, Christensen HK,
Detmer A, Pedersen FB. Bicarbonate- versus lactate-based CAPD fluids: a
biocompatibility study in rabbits. Perit Dial Int 1992;12(3):281-6. Comment in:
Perit Dial Int 1992;12(3):276-7.

Schanzer H, Skladany M, Haimov M. Treatment of angioaccess-induced ischemia by
revascularization. J Vasc Surg 1992 Dec;16(6):861-4; discussion 864-6.

Schiffl H, D'Agostini B, Held E. Removal of beta 2-microglobulin by hemodialysis
and hemofiltration: a four year follow up. Biomater Artif Cells Immobilization
Biotechnol 1992;20(5):1223-32.

Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein
stenosis in haemodialysis: comparative angiographic study of 50 subclavian and
50 internal jugular accesses. Nephrol Dial Transplant 1991;6(10):722-4.

Schleifer CR, Snyder S, Jones K. The influence of urea kinetic modeling UKM on
gross mortality in hemodialysis [abstract]. J Am Soc Nephrol 1991;2(3):349.

Schmidt DF, Schniepp BJ, Kurtz SB, McCarthy JT. Inaccurate blood flow rate during
rapid hemodialysis. Am J Kidney Dis 1991 Jan;17(1):34-7.

Schmidt R, Zasuwa G, Schell D, Dumler F. Proper dialyzer reprocessing does not
impair urea mass transfer [abstract]. J Am Soc Nephrol 1991;2(3):349.

Schmitz-Rode T, Bohndorf K, Gunther RW. New "mesh basket" for percutaneous
removal of wall-adherent thrombi in dialysis shunts. Cardiovasc Intervent Radiol
1993 Jan-Feb;16(1):7-10.

Schmitz-Rode T, Pfeffer JG, Bohndorf K, Gunther RW. Percutaneous thrombectomy of
the acutely thrombosed dialysis graft: in vitro evaluation of four devices.
Cardiovasc Intervent Radiol 1993 Mar-Apr;16(2):72-5.

Schneditz D, Kaufman AM, Polaschegg HD, Levin NW, Daugirdas JT. Cardiopulmonary
recirculation during hemodialysis. Kidney Int 1992 Dec;42(6):1450-6.

Schneditz D, Polaschegg HD, Levin NW, Cu GA, Morris AT, Kramer M, Daugirdas JT,
Kaufman AM. Cardiopulmonary recirculation in dialysis. An underrecognized
phenomenon. ASAIO J 1992 Jul-Sep;38(3):M194-6.

Schoenfeld PS, Jones DM, Lawson JM. Conducted current on guidewires in single
lumen papillotomes. Gastrointest Endosc 1991 May-Jun;37(3):344-6.

Schohn DC, Jahn HA, Pelletier BC. Dose-related cardiovascular effects of
spironolactone. Am J Cardiol 1993;71(3):40a-45a.

Schroder CH, van Dreumel MJ, Reddingius R, Theeuwes AG, Willems HL, de Jong MC,
Monnens LA. Peritoneal transport kinetics of glucose, urea, and creatinine during
infancy and childhood. Perit Dial Int 1991;11(4):322-5.

Schulak JA, Lukens ML, Mayes JT. Salvage of thrombosed forearm
polytetrafluoroethylene vascular access grafts by reversal of flow direction and
venous bypass grafting. Am J Surg 1991 Apr;161(4):485-7.

Schulman G. A review of the concept of biocompatibility. Kidney Int Suppl
1993;41: S209-12.

Schulman G, Hakim RM. Recent advances in the biocompatibility of haemodialysis
membranes. Nephrol Dial Transplant 1991;6 Suppl 2:10-3.

Segarra A, Capdevila J, Planes AM, Fort J, Roca R, Bartolome J, Olmos J, Piera
LL. Treatment of jugular catheter sepsis by administering antibiotics locally and
systemically without removing the catheter [abstract]. Nephrol Dial Transplant
1992;7(7):739.

Selby JB Jr, Pruett TL, Westervelt FB Jr, Tegtmeyer CJ, Poole CL. Treatment of
hemodialysis fistula pseudoaneurysms with detachable balloons: technique and
preliminary results. J Vasc Interv Radiol 1992 Aug;3(3):505-10.

Selgas R, Cuesta MV, Rinon C, Romero JR, de Alvaro F, Bajo MA, Sanchez-Sicilia
L. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-I
(PAI-I) levels in plasma and peritoneal effluent in patients on CAPD. Adv Perit
Dial 1992;8:160-5.

Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma
lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993
Jan;3(7):1409-15.

Seyfert UT, Hauck W, Kirsch J, Kiesewetter H, Albert FW, Wenzel E. Contributions
to biorheology during hemodialysis. Biorheology 1991;28(5):473-81.

Shaffer D, Madras PN, Williams ME, D'Elia JA, Kaldany A, Monaco AP. Use of Dacron
cuffed silicone catheters as long-term hemodialysis access. ASAIO J 1992 Jan-
Mar;38(1):55-8.

Shaldon S. Dialyzer reuse: the time has come to stop this practice. Dial
Transplant 1993;22(3):122, 125-6.

Shaldon S. Unanswered questions pertaining to dialysis adequacy in 1992. Kidney
Int Suppl 1993;41: S274-7.

Shand BI, Buttimore AL, Hurrell MA, Wells JE, Inkster JA, Bailey RR, Robson RA,
Lynn KL. Hemorheology and fistula function in home hemodialysis patients
following erythropoietin treatment: a prospective placebo-controlled study.
Nephron 1993;64(1):53-7.

Shelton DM. A comparison of the effects of two antiseptic agents on
Staphylococcus epidermidis colony forming units at the peritoneal dialysis
catheter exit site. Adv Perit Dial 1991;7:120-4.

Sherman RA, Levy SS. Assessment of a two-needle technique for the measurement of
recirculation during hemodialysis. Am J Kidney Dis 1991 Jul;18(1):80-3.

Shimomura A, Tahara D, Azekura H, Matsuo H, Kamo M. Key factors to improve
survival of elderly patients on CAPD. Adv Perit Dial 1992;8:166-72.

Shirai D, Kajimoto Y, Ochi S, Tanaka Y, Wada A, Yano F, Izumi M, Fujita Y,
Nakahama H. Evaluation of hemodialysis efficiency by an edema fluid model. Ren
Fail 1992;14(1):63-8.

Silberman H, Berne TV, Escandon R. Prospective evaluation of a double-lumen
subclavian dialysis catheter for acute vascular access. Am Surg 1992
Aug;58(8):443-5.

Silver SM, DeSimone JA Jr, Smith DA, Sterns RH. Dialysis disequilibrium syndrome
(DDS) in the rat: role of the "reverse urea effect". Kidney Int 1992
Jul;42(1):161-6.

Simon P, Ang KS, Cam G, Benziane A, Bonn F. Indices of adequate dialysis in
patients hemodialyzed with AN 69 membrane. Kidney Int Suppl 1993;41:S291-5.

Skroeder R, Jacobsson S, Kjellstrand P, Boberg U, Kjellstrand CM. K & T covariate
with V in hemodialysis. As K increases and T decreases, V also decreases. ASAIO
Trans 1991 Jul-Sep;37(3):M129-32.

Smit JC, Jones JG. Oxygen saturation during hemodialysis. Ren Fail
1993;15(2):239-45.

Smye SW, Evans JH, Will E, Brocklebank JT. Paediatric haemodialysis: estimation
of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas
1992 Feb;13(1):51-62.

Sodemann K, Niedenthal A, Russ A, Weber C, Schafer GE. Automated fluid balance
in continuous hemodialysis with blood safety module BSM 22/VPM. Contrib Nephrol
1991;93:184-92.

Solski J, Ksiazek A, Szymonik-Lesiuk S, Marzec Z. Membrane ATPase, erythrocyte
sodium and potassium in haemodialysis patients. Int Urol Nephrol
1991;23(3):275-80.

Soundararajan R, Soundararajan P. A simple and practical method for assessing the
adequacy of hemodialysis. ASAIO Trans 1991 Jul-Sep;37(3):M393-4.

Spustova V, Gajdos M, Opatrny K Jr, Stefikova K, Dzurik R. Serum hippurate and
its excretion in conservatively treated and dialysed patients with chronic renal
failure. Physiol Res 1991;40(6):599-606.

Stegmayr BG, Granbom L, Tranaeus A, Wikdahl AM. Reduced risk for peritonitis in
CAPD with the use of a UV connector box. Perit Dial Int 1991;11(2):128-30.

Steuer RR, Harris DH, Conis JM. A new optical technique for monitoring hematocrit
and circulating blood volume: its application in renal dialysis. Dial Transplant
1993;22(5):260-5.

Stiller S, Mann H. Microfilter for drawing plasma samples from the extracorporeal
circulation. Contrib Nephrol 1991;93:193-5.

Stiller S, Wirtz D, Waterbar F, Gladziwa U, Dakshinamurty KV, Mann H. Less
symptomatic hypotension using blood volume controlled ultrafiltration. ASAIO
Trans 1991 Jul-Sep;37(3):M139-41.

Strauch BS, O'Connell RS, Geoly KL, Grundlehner M, Yakub YN, Tietjen DP.
Forecasting thrombosis of vascular access with Doppler color flow imaging. Am J
Kidney Dis 1992 Jun;19(6):554-7.

Strauss FG, Holmes DL, Dennis RL, Nortman DF. Pre-spiking dialysate bags:
improved peritonitis prevention in patients on CAPD. Adv Perit Dial 1991;7:193-5.

Sullivan KL, Besarab A, Bonn J, Shapiro MJ, Gardiner GA Jr, Moritz MJ.
Hemodynamics of failing dialysis grafts. Radiology 1993 Mar;186(3):867-72.

Sullivan KL, Besarab A, Dorrell S, Moritz MJ. The relationship between dialysis
graft pressure and stenosis. Invest Radiol 1992;27(5):352-5.

Sumimoto K, Tanaka I, Oshiro H, Ito H, Fukuda Y, Dohi K, Tsuchiya T, Ikada Y.
Clinical use of synthetic absorbable cuff material for peripheral vascular
anastomosis. Surg Gynecol Obstet 1992;175(5):421-7.

Summers S, Drazan K, Gomes A, Freischlag J. Urokinase therapy for thrombosed
hemodialysis access grafts. Surg Gynecol Obstet 1993;176(6):534-8.

Sundaram S, Irvine L, Courtney JM, Lowe GD. Modification of the influence of
biomaterials on contact activation. Int J Artif Organs 1991 Nov;14(11):729-31.

Surratt RS, Picus D, Hicks ME, Darcy MD, Kleinhoffer M, Jendrisak M. The
importance of preoperative evaluation of the subclavian vein in dialysis access
planning. AJR Am J Roentgenol 1991 Mar;156(3):623-5. Comment in: AJR Am J
Roentgenol 1991 Nov;157(5):1125-6.

Suzuki M, Ohno M, Miyagi M, Ukai T. Cellulose triacetate hemodialysis membrane
design for beta-2 microglobulin removal. Blood Purif 1991;9(1):51.

Svehag SE. Adverse effects of clinical intervention on the complement system.
Complement Inflamm 1991;8(5-6):359-69.

Swan SK, Bennett WM. Drug dosing guidelines in patients with renal failure. West
J Med 1992 Jun;156(6):633-8.

Swartz R, Messana J, Holmes C, Williams J. Biofilm formation on peritoneal
catheters does not require the presence of infection. ASAIO Trans 1991 Oct-
Dec;37(4):626-34.

Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and
removal in refractory peritoneal dialysis infections. Kidney Int 1991
Dec;40(6):1160-5.

Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus
aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991
Dec;2(6):1085-91.

Synhavsky A. Central venous hemodialysis catheters. Am J Kidney Dis
1993;21(4):454.

Szromba C, Bowman-Riney S. Successful intervention in the reduction of
methicillin resistant staphylococcus aureus (MRSA) catheter related bacteremia.
ANNA J 1992 Apr;19(2):153.

Taber TE, Hegeman TF, York SM, Kinney RA, Webb DH. Treatment of Pseudomonas
infections in peritoneal dialysis patients. Perit Dial Int 1991;11(3):213-6.

Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M. Echocardiographic findings in
hemodialysis patients treated with recombinant human erythropoietin: proposal for
a hematocrit most beneficial to hemodynamics. Clin Nephrol 1991 Jan;35(1):35-8.

Takai I, Shinzato T, Morita H, Fujita Y, Inoue I, Kobayakawa H, Maeda K. A new
treatment strategy using both intermittent short dialysis and continuous
ambulatory hemofiltration. ASAIO Trans 1991 Jul-Sep;37(3):M325-7.

Tang IY, Vrahnos D, Valaitis D, Lau AH. Vascular access thrombosis during
recombinant human erythropoietin therapy. ASAIO J 1992 Jul-Sep;38(3):M528-31.

Taraba I, Polner K, Mako J. Biocompatibility study on cuprophane and polysulphone
dialysers. Nephrol Dial Transplant 1991;6 Suppl 3:22-5.

Tattersall JE, Cramp M, Shannon M, Farrington K, Greenwood RN. Rapid high-flux
dialysis can cure uraemic peripheral neuropathy. Nephrol Dial Transplant
1992;7(6):539-40.

Tattersall JE, Farrington K, Raniga PD, Thompson H, Tomlinson C, Aldridge C,
Greenwood RN. Haemodialysis recirculation detected by the three-sample method is
an artefact. Nephrol Dial Transplant 1993;8(1):60-3.

Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and
autogenous fistulas. Am J Surg 1993 May;165(5):632-6.

Taylor JE, MacTier RA, Henderson IS, Belch JJ, Stewart WK. Dialysis efficiency
in continuous ambulatory peritoneal dialysis patients treated with
erythropoietin. Perit Dial Int 1992;12(2):221-6.

Taylor JE, McLaren M, Mactier RA, Henderson IS, Stewart WK, Belch JJ. Effect of
dialyzer geometry during hemodialysis with cuprophane membranes. Kidney Int 1992
Aug;42(2):442-7.

Teixido J, Borras M, Bonet J, Galimany R, Biosca C, Caralps A. Peritoneal
function tests: usefulness of simplified methods. Adv Perit Dial 1992;8:177-80.

Tetta C, Segoloni G, Mariano F, Montrucchio G, Turello E, Camussi G. Leukocyte-
derived mediators and biocompatibility. Nephrol Dial Transplant 1991;6 Suppl
2:24-30.

Thomas M, Argiles A, Kerr PG, Canaud B, Flavier JL, Mion CM. Measurement of
vascular access recirculation without contralateral venous puncture. Nephron
1992;62(2):224-5.

Thylen P, Ericsson F, Odar-Cederlof I, Kjellstrand CM. Hypertension profiling by
total body water (TBW) determinations in patients on chronic hemodialysis. Int
J Artif Organs 1991 Jan;14(1):18-22.

Tobe S, Chu MG, Bargman JM. Characterization of peritoneal transport in patients
with failed renal allografts receiving CAPD. Adv Perit Dial 1991;7: 39-43.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of
hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 Jan-
Mar;39(1):71-80.

Tordoir JH, Leunisse KM, Kitslaar PJ, Kootstra G. Arteriovenous fistulas for
hemodialysis and diagnostic methods in the evaluation of fistula complications.
J Nephrol 1991;4(2):97-104.

Turmel-Rodrigues L, Pengloan J, Blanchier D, Abaza M, Birmele B, Haillot O,
Blanchard D. Insufficient dialysis shunts: improved long-term patency rates with
close hemodynamic monitoring, repeated percutaneous balloon angioplasty, and
stent placement. Radiology 1993 Apr;187(1):273-8.

Turner K, Edgar D, Hair M, Uttley L, Sternland R, Hunt L, Gokal R. Does catheter
immobilization reduce exit-site infections in CAPD patients? Adv Perit Dial
1992;8:265-8.

Twardowski ZJ, Dobbie JW, Moore HL, Nichols WK, DeSpain JD, Anderson PC, Khanna
R, Nolph KD, Loy TS. Morphology of peritoneal dialysis catheter tunnel:
macroscopy and light microscopy. Perit Dial Int 1991;11(3):237-51.

Twardowski ZJ, Nichols WK, Nolph KD, Khanna R. Swan neck presternal ("bath tub")
catheter for peritoneal dialysis. Adv Perit Dial 1992;8:316-24.

Twardowski ZJ, Prowant BF, Nichols WK, Nolph KD, Khanna R. Six-year experience
with swan neck catheters. Perit Dial Int 1992;12(4):384-9.

Twardowski ZJ, Van Stone JC, Jones ME, Klusmeyer MS. Blood recirculation (REC)
in intravenous catheters (IVC) for hemodialysis (HD). J Am Soc Nephrol
1992;3(3):399.

Uldall R, Besley ME, Thomas A, Salter S, Nuezca LA, Vas M. Maintaining the
patency of double-lumen silastic jugular catheters for haemodialysis. Int J Artif
Organs 1993 Jan;16(1):37-40.

Uldall R, DeBruyne M, Besley M, McMillan J, Simons M, Francoeur R. A new vascular
access catheter for hemodialysis. Am J Kidney Dis 1993 Mar;21(3):270-7.

Update: acute allergic reactions associated with reprocessed hemodialyzers--
United States, 1989-1990. MMWR Morb Mortal Wkly Rep 1991 Mar 8;40(9):147, 153-4.

Valeri A, Radhakrishnan J, Vernocchi L, Carmichael LD, Stern L. The epidemiology
of peritonitis in acute peritoneal dialysis: a comparison between open- and
closed-drainage systems. Am J Kidney Dis 1993 Mar;21(3):300-9.

Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and
angioplasty in the management of clotted hemodialysis grafts: early and late
clinical results. Radiology 1991 Jan;178(1):243-7.

van Asseldonk JP, Schroder CH, Severijnen RS, de Jong MC, Monnens LA. Infectious
and surgical complications of childhood continuous ambulatory peritoneal
dialysis. Eur J Pediatr 1992 May;151(5):377-80.

van der Meulen J, Janssen MJ, Langendijk PN, Bouman AA, Oe PL. Citrate
anticoagulation and dialysate with reduced buffer content in chronic
hemodialysis. Clin Nephrol 1992 Jan;37(1):36-41.

van Olden RW, van Meyel JJ, Gerlag PG. Acute and long-term effects of therapy
with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol
1992;12(5):351-6.

Vanherweghem JL. Infections in chronic hemodialysis patients. Semin Dial 1991
Oct-Dec;4(4):240-4.

Vanholder R, De Smet R, Gervasio R, Ringoir S. In vivo solute elimination of
paired filtration dialysis. Int J Artif Organs 1991 Jan;14(1):23-7.

Vanholder R, Van Haecke E, Veys N, Ringoir S. Endotoxin transfer through dialysis
membranes: small- versus large-pore membranes. Nephrol Dial Transplant
1992;7(4):333-9.

Vanholder R, Vanhaecke E, Ringoir S. Pseudomonas septicemia due to deficient
disinfectant mixing during reuse. Int J Artif Organs 1992 Jan;15(1):19-24.

Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME.
Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and
hemodialysis. Kidney Int 1992 May;41(5):1400-7.

Vasson MP, Paul JL, Couderc R, Albuisson E, Bargnoux PJ, Baguet JC, Raichvarg D.
Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int
J Artif Organs 1991 Feb;14(2):92-6.

Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega
R, Palop L. Peritoneal dialysis efficiency in CAPD patients in treatment with
rHuEPO. Adv Perit Dial 1992;8: 467-70.

Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesael J, De Waele M.
Evaluation of platelets and hemostasis during hemodialysis with six different
membranes. Nephron 1991;59(4):567-72.

Verreet PR, Passlick-Deetjen J, Grabensee B. The Oreopoulos-Zellermann catheter.
Contrib Nephrol 1991;89:47-52.

Vincent HH, Akcahuseyin E, Vos MC, van Duyl WA, Schalekamp MA. Continuous
arteriovenous hemodiafiltration: filter design and blood flow rate. Contrib
Nephrol 1991;93:196-8.

Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of
125I-beta 2-microglobulin turnover in dialyzed patients. Kidney Int 1992
Dec;42(6):1434-43.

Vitali ED, Malacarne F, Perini L, Soffritti S, Storari A, Gilli P. Haemodialysis
venous catheters jugular and femoral routes. Nephrol Dial Transplant
1992;7(7):723-4.

Vlaanderen K, Bos HJ, de Fijter CW, Oe LP, van der Meulen J, Verbrugh HA, Beelen
RH. Short dwell times reduce the local defence mechanism of chronic peritoneal
dialysis patients. Nephron 1991;57(1):29-35.

von Sengbusch G, Bowry S, Vienken J. Focusing on membranes. Artif Organs 1993
Apr;17(4):244-53.

Vorstrup S, Lass P, Waldemar G, Brandi L, Schmidt JF, Johnsen A, Paulson OB.
Increased cerebral blood flow in anemic patients on long-term hemodialytic
treatment. J Cereb Blood Flow Metab 1992 Sep;12(5):745-9.

Wadhwa NK, Cabralda T, Suh H, Kvilekval K, Mason R. Exit-site/tunnel infection
and catheter outcome in peritoneal dialysis patients. Adv Perit Dial 1992;8:
325-7.

Wadhwa NK, Cabralda T, Suh H, Stratos J, Cascio C, Young N. Multiple use of
cycler set in cycler peritoneal dialysis. Adv Perit Dial 1992;8:192-4.

Waniewski J, Werynski A, Heimburger O, Lindholm B. A comparative analysis of mass
transport models in peritoneal dialysis. ASAIO Trans 1991 Apr-Jun;37(2):65-75.

Waniewski J, Werynski A, Heimburger O, Lindholm B. Simple membrane models for
peritoneal dialysis. Evaluation of diffusive and convective solute transport.
ASAIO J 1992 Oct-Dec;38(4):788-96.

Ward RA, Schaefer RM, Falkenhagen D, Joshua MS, Heidland A, Klinkmann H, Gurland
HJ. Biocompatibility of a new high-permeability modified cellulose membrane for
haemodialysis. Nephrol Dial Transplant 1993;8(1):47-53.

Watson AR, Coleman JE, Taylor EA. Gastrostomy buttons for feeding children on
continuous cycling peritoneal dialysis. Adv Perit Dial 1992;8:391-5.

West JC, Bertsch DJ, Peterson SL, Gannon MP, Norkus G, Latsha RP, Kelley SE.
Arterial insufficiency in hemodialysis access procedures: correction by "banding"
technique. Transplant Proc 1991 Apr;23(2):1838-40.

West ML, Jindal KK. Peritonitis presenting as acute catheter obstruction in
noncontinuous forms of peritoneal dialysis (PD) [abstract]. Clin Invest Med
1992;15(4 Suppl):A97.

Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal
dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991 Jul;40(1):77-9.

Wikdahl AM, Granbom L, Stegmayr BG. CAPD bag changing with integrated disconnect
system gives lower incidence of peritonitis than with UV-box system. Adv Perit
Dial 1992;8:276-80.

Wilcox CM, Woods BL, Mixon HT. Prospective evaluation of a peritoneal dialysis
catheter system for large volume paracentesis. Am J Gastroenterol 1992
Oct;87(10):1443-6.

Wilske J, Bjorck S, Delin K. Serum concentrations of calcitriol and PTH in hemo-
dialysis patients on treatment with calcium carbonate. Scand J Urol Nephrol
1992;26(1):51-4.

Winchester JF, Rottellar C, Goggins M, Robino D, Rakowski TA, Argy WP. Calcium
and phosphate balance in dialysis patients. Kidney Int Suppl 1993;41:S174-8.

Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993
May;21(5):457-71.

Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications
in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992
May;19(5):448-52.

Winters CJ, Vesely DL. Change in plasma immunoreactive N-terminus, C-terminus,
and 4,000-dalton midportion of atrial natriuretic factor prohormone with
hemodialysis. Nephron 1991;58(1):17-22.

Wizemann V, Soetanto R, Thormann J, Lubbecke F, Kramer W. Effects of acetate on
left ventricular function in hemodialysis patients. Nephron 1993;64(1):101-5.

Wood B, Abbott WC, Erickson DG, Tzamaloukas AH. Delayed infectious complications
of peritoneal dialysis catheters. Am J Nephrol 1992;12(3):199-200.

Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, Nishitani
H, Kim M, Kishimoto T, Chiku T, et al. Clinical effects of long-term use of
neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron
1992;60(3):324-9.

Yamazaki M, Asakura H, Sato T, Tsugawa Y, Matsumura M, Kawamura Y, Ohka T,
Matsuda T. Changes in plasma levels of thrombomodulin during haemodialysis. Blood
Coagul Fibrinolysis 1992 Feb;3(1):113-7.

Yan F, Dejardin P, Mulvihill JN, Cazenave JP, Crost T, Thomas M, Pusineri C.
Influence of a preadsorbed terpolymer on human platelet accumulation, fibrinogen
adsorption, and ex vivo blood activation in hemodialysis hollow fibers. J
Biomater Sci Polym Ed 1992;3(5):389-402.

Yasuda T, Ozawa S, Shiba C, Maeba T, Kanazawa T, Sugiyama M, Owada S, Ishida M.
D-lactate metabolism in patients with chronic renal failure undergoing CAPD.
Nephron 1993;63(4):416-22.

Yasumoto N, Kitamoto Y, Yoshimura N, Nakayama M, Sato T. Effect of blood access
on the platelets of azotemic patients initiating dialysis therapy. Artif Organs
1993;17(3):185-8.

Yatzidis H. Hemodialysis with a new single stable bicarbonate dialysate. Nephron
1993;64(1):27-31.

Yeh TJ, Wei CF, Chin TW. Catheter-related complications of continuous ambulatory
peritoneal dialysis. Eur J Surg 1992 May;158(5):277-9.

Yohay DA, Butterly DW, Schwab SJ, Quarles LD. Continuous arteriovenous
hemodialysis: effect of dialyzer geometry. Kidney Int 1992 Aug;42(2):448-51.

Yokobori AT Jr, Yokobori T. The mechanical test method of cardiovascular and
related biomaterials. Biomed Mater Eng 1991;1(1):25-43.

Yu AW, Manahan FJ, Filkins JP, Mohammed MS, Soundararajan R, McShane AP, Gandhi
VC, Ing TS. Peritoneal dialysis using bicarbonate-containing solution sterilized
by ultrafiltration. Int J Artif Organs 1991 Aug;14(8):463-5.

Yu AW, Zhou XJ, Zhou FQ, Nawab ZM, Gandhi VC, Ing TS, Vaziri ND. Neutrophilic
intracellular acidosis induced by conventional, lactate-containing peritoneal
dialysis solutions. Int J Artif Organs 1992 Nov;15(11):661-5.

Zappacosta AR, Perras S, Closkey G. 2.3 mm peritoneal catheter tunnel-exit site
[abstract]. J Am Soc Nephrol 1992;3(3):422.

Zappacosta AR, Perras ST, Closkey GM. Seldinger technique for Tenckhoff catheter
placement. ASAIO Trans 1991 Jan-Mar;37(1):13-5.

Zazgornik J, Kuska J, Kokot F, Koch S, Van Peer A, Huang ML, Heykants J.
Pharmacokinetics of ritanserin in patients undergoing hemodialysis. J Clin
Pharmacol 1991 Jul;31(7):657-61.

Zeplin HE, Schneckenberger K, Fassbinder W, Stegmann T. Percutaneous vena cava
catheters as vascular access for chronic hemodialysis [abstract]. Int J Artif
Organs 1992;15(9):517.

Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant
human growth hormone in adults receiving maintenance hemodialysis. J Am Soc
Nephrol 1991 Dec;2(6):1130-5.

Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F, Curatola A. The
reflex control of vasopressin in haemodialysis patients. Nephrol Dial Transplant
1991;6(9):631-6.

Zucchelli P, Santoro A. Correction of acid-base balance by dialysis. Kidney Int
Suppl 1993;41:S179-83.

Zwaan M, Weiss HD, Gothlin JH, Kummer D, Scheu M, Kagel H, Gmelin E, Rinast E.
Initial clinical experience with a new pulsed dye laser device in angioplasty of
limb ischemia and shunt fistula obstructions. Eur J Radiol 1992 Jan-
Feb;14(1):72-6.

CO-MORBIDITY

-Clinical Trials

Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for
assessing quality of life in patients on hemodialysis. Nephron 1992;60(3):302-6.
Published erratum appears in Nephron 1992;61(2):248.

Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of-life
measures in hemodialysis patients treated with erythropoietin. The Canadian
Erythropoietin Study Group. Controlled Clin Trials 1991 Aug;12(4
Suppl):168S-179S.

Morniere P, Maurouard C, Boudailliez B, Westeel PF, Achard JM, Boitte F, el Esper
N, Compagnon M, Maurel G, Bouillon R, et al. Prevention of hyperparathyroidism
in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in
association with Mg(OH)2 as sole phosphate binder. A randomized comparative study
with the association CaCO3 +/- Mg(OH)2. Nephron 1992;60(2):154-63.

Turk S, Yeksan M, Tamer N, Gurbilek M, Erdogan Y, Erkul I. Effect of 1,25 (OH)2D3
treatment on glucose intolerance in uraemia. Nephrol Dial Transplant
1992;7(12):1207-12.

-Other

Aghanashinikar PN, Al-Dhahry SH, Al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK.
Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus
infections in Omani patients with renal diseases. Transplant Proc 1992
Oct;24(5):1913-4.

al-Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Antibodies to
hepatitis C virus in Omani patients with renal disease. Transplant Proc 1992
Oct;24(5):1938-9.

al-Ghamdi MS, al-Mohanna FA, al-Mustafa ZH, al-Saeed IS. The effect of
haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage
renal disease. Eur J Clin Pharmacol 1992;43(2):197-9.

al-Mugeiren M, al-Faleh FZ, Ramia S, al-Rasheed S, Mahmoud MA, al-Nasser M.
Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal
failure maintained on haemodialysis. Ann Trop Paediatr 1992;12(2):217-9.

al Nasser MN, al Mugeiren MA, Assuhaimi SA, Obineche E, Onwabalili J, Ramia S.
Seropositivity to hepatitis C virus in Saudi haemodialysis patients. Vox Sang
1992;62(2):94-7.

Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, Taher S. Hepatitis C
virus infection in chronic haemodialysis patients, a clinicopathologic study.
Nephrol Dial Transplant 1992;7(4):327-32. Comment in: Nephrol Dial Transplant
1992;7(12):1259-60.

Alivanis P, Derveniotis V, Dioudis C, Grekas D, Mandraveli P, Vasiliou S,
Tourkantonis A. Hepatitis C virus antibodies in hemodialysed and in renal
transplant patients: correlation with chronic liver disease. Transplant Proc
1991;23(5):2662-3.

Allegra V, Vasile A, Maschio M, Mengozzi G. Immune response after vaccination
with recombinant hepatitis surface antigen in maintenance hemodialysis patients
and healthy controls. Nephron 1992;61(3):339-40.

Almroth G, Ekermo B, Franzen L, Hed J. Antibody responses to hepatitis C virus
and its modes of transmission in dialysis patients. Nephron 1991;59(2):232-5.

Amarapurkar DN, Kumar A, Parikh SS, Chopra KB, Murti P, Kalro RH, Desai HG.
Hepatitis C virus infection in chronic liver disease in Bombay. Indian J
Gastroenterol 1992 Oct;11(4):162-3.

Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A. Cardiac pathology in
patients with end-stage renal disease maintained on hemodialysis. Int J Artif
Organs 1993 Jan;16(1):31-6.

Artis AK, Alpert MA, Van Stone J, Kelly DL, Mukerji V, Graham BM, Nolph KD.
Effect of hemodialysis on left ventricular systolic function in the presence and
absence of beta-blockade: influence of left ventricular mass. Am J Nephrol
1991;11(4):289-94.
Asai K, Miura S, Kawahara H, Toriyama T, Kuzuya F. A comparative study of
atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging
(Milano) 1991 Mar;3(1):79-87.

Avella F, Irlando A, Scancariello G, Iovino R. On the positivity of the test for
anti-HCV considerations in dialized patients. Nephron 1992;61(3):341.

Avendano C, Alvarez JS, Sacristan JA, Adin J, Alsar MJ. Interference of digoxin-
like immunoreactive substances with TDx digoxin II assay in different patients.
Ther Drug Monit 1991 Nov;13(6):523-7.

Ayoola EA, Huraib S, Arif M, al-Faleh FZ, al-Rashed R, Ramia S, al-Mofleh IA,
Abu-Aisha H. Prevalence and significance of antibodies to hepatitis C virus among
Saudi haemodialysis patients. J Med Virol 1991 Nov;35(3):155-9.

Bahakim H, Bakir TM, Arif M, Ramia S. Hepatitis C virus antibodies in high-risk
Saudi groups. Vox Sang 1991;60(3):162-4.

Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in
dialysis patients. Mayo Clin Proc 1991 Jan;66(1):45-53.

Bechstein WO, Blumhardt G, Rossaint R, Gahl G, Steffen R, Neuhaus P. Improved
outcome of dialysis after liver transplantation. Transplant Proc 1991
Jun;23(3):1982-3.

Benazzi F. Mania during hemodialysis: causal or casual association? Am J
Psychiatry 1992 Mar;149(3):414.

Bender FH, Piraino B. Polycythemia in diabetic patients on CAPD. Adv Perit Dial
1991;7:77-80.

Benhamou PY, Marwah T, Balducci F, Zmirou D, Borgel F, Cordonnier D, Halimi S,
Papoz L. Classification of diabetes in patients with end-stage renal disease.
Validation of clinical criteria according to fasting plasma C-peptide. Clin
Nephrol 1992 Nov;38(5):239-44.

Berman DH, Friedman EA, Lundin AP. Aggressive ophthalmological management in
diabetic end-stage renal disease: a study of 31 consecutively referred patients.
Am J Nephrol 1992;12(5):344-50.

Besso L, Rovere A, Peano G, Menardi G, Fenoglio LM, Fenoglio S, Ghezzi PM.
Prevalence of HCV antibodies in a uraemic population undergoing maintenance
dialysis therapy and in the staff members of the dialysis unit. Nephron
1992;61(3):304-6.

Blagg CR. Hemodialysis 1991. Blood Purif 1992;10(1):22-9.

Blythe WB, Maddux FW. Hypertension as a causative diagnosis of patients entering
end-stage renal disease programs in the United States from 1980 to 1986. Am J
Kidney Dis 1991 Jul;18(1):33-7.

Borgel F, Benhamou PY, Zmirou D, Balducci F, Halimi S, Cordonnier D. Assessment
of handicap in chronic dialysis diabetic patients (uremidiab section study).
Scand J Rehabil Med 1992;24(4):203-8.

Boros L, Cacek T, Pine RB, Battaglia AC. Distribution characteristics of
mitoxantrone in a patient undergoing hemodialysis. Cancer Chemother Pharmacol
1992;31(1):57-60.

Bracchi O, Orazi E, Lupi GP, Bronzieri C, Cornalba L, Grassi C. Hepatitis C:
reality of a renal unit. Nephron 1992;61(3):369-70.

Brennan DT. Diabetes and end-stage renal disease: issues in diabetic nephropathy.
ANNA Update 1991 Nov-Dec;21(6):1-8.

Breyer JA, Harbison MA. Isolation of human immunodeficiency virus from peritoneal
dialysate. Am J Kidney Dis 1993 Jan;21(1):23-5.

Brown JH, Short CD, Mallick NP. Ischaemic heart disease, lipids and the kidney.
Contrib Nephrol 1993;102:198-219.

Brugnano R, Francisci D, Quintaliani G, Gaburri M, Nori G, Verdura C, Giombini
L, Buoncristiani U. Antibodies against hepatitis C virus in hemodialysis patients
in the central Italian region of Umbria: evaluation of some risk factors. Nephron
1992;61(3):263-5.

Bunchman TE, Meldrum MK, Meliones JE, Sedman AB, Walters MB, Kershaw DB.
Pulmonary function variation in ventilator dependent critically ill infants on
peritoneal dialysis. Adv Perit Dial 1992;8:75-8.

Buur T, Larsson R, Regardh CG, Aberg J. Pharmacokinetics of felodipine in chronic
hemodialysis patients. J Clin Pharmacol 1991 Aug;31(8):709-13.

Byrick RJ, Goldstein MB, Wong PY. Increased plasma tumor necrosis factor
concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous
hemodialysis. Crit Care Med 1992;20(10):1483-6.

Cappa M, del Balzo P, Rizzoni G, Benedetti S, Borrelli P. Somatostatinergic tone
in children on chronic haemodialysis and after renal transplantation. Pediatr
Nephrol 1991 Jul;5(4):548-51.

Carletti P, Bibiano L, Boggi R, Bordoni E, Ricciatti AM, Della Bella S, Pauri P,
Salvoni G, Mioli VA. HBV infection in hemodialysis patients: monitoring and
prevention. Nephron 1992;61(3):269-70.

Carson RW, Dunnigan EJ, DuBose TD Jr, Goeger DE, Anderson KE. Removal of plasma
porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with
end-stage renal disease. J Am Soc Nephrol 1992 Mar;2(9):1445-50.

Cases A, Filella X, Molina R, Ballesta AM, Lopez-Pedret J, Revert L. Tumor
markers in chronic renal failure and hemodialysis patients. Nephron
1991;57(2):183-6.

Cefali EA, Poynor WJ, Sica D, Cox S. Pharmacokinetic comparison of flurbiprofen
in end-stage renal disease subjects and subjects with normal renal function. J
Clin Pharmacol 1991 Sep;31(9):808-14.

Chang DB, Kuo SH, Yang PC, Shen FH, Luh KT. Clearance of theophylline by
hemodialysis in one patient with chronic renal failure. Chest 1992
Nov;102(5):1621-3.

Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not
adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19(5):453-9.

Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus.
Am J Kidney Dis 1993 Jan;21(1):2-8.

Cheung WC, Yuen KY, Chang CM, Cheng KP. Herpes zoster associated encephalitis in
dialysis patients. J Infect 1991 Sep;23(2):169-74.

Chiegh J, Raghavan V, Sullivan J, Tapia L, Rubin A, Stenzel KH. Is insufficient
dialysis a cause for high morbidity in diabetic patients? [abstract]. J Am Soc
Nephrol 1991;2(3):317.

Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC. Health locus of
control and depression in end-stage renal disease. J Consult Clin Psychol 1991
Jun;59(3):419-24.

Chu NF, Ferng SH, Shieh SD. Quality of life assessment in end-stage renal disease
patients with maintenance hemodialysis therapy. Chung Hua I Hsueh Tsa Chih 1992
Aug;50(2):103-7.

Churchill DN, Wallace JE, Ludwin D, Beecroft ML, Taylor DW. A comparison of
evaluative indices of quality of life and cognitive function in hemodialysis
patients. Controlled Clin Trials 1991 Aug;12(4 Suppl):159S-167S.

Conte JE Jr. Pharmacokinetics of intravenous pentamidine in patients with normal
renal function or receiving hemodialysis. J Infect Dis 1991 Jan;163(1):169-75.

Coronel F, Tornero F, Macia M, Sanchez A, De Oleo P, Naranjo P, Barrientos A.
Peritoneal clearances, protein losses and ultrafiltration in diabetic patients
after four years on CAPD. Adv Perit Dial 1991;7: 35-8.

Coronel F, Tornero F, Torrente J, Naranjo P, De Oleo P, Macia M, Barrientos A.
Treatment of hyperlipemia in diabetic patients on dialysis with a physiological
substance. Am J Nephrol 1991;11(1):32-6.

Covarsi A, Rodriguez AM, Marigliano N, Novillo R. Metastasizing renal cell
carcinoma and acquired renal cystic disease in a hemodialysis patient. Am J
Nephrol 1991;11(3):224-8.

Cozma G, Cozma MC, Mattes U. Beneficial effect of recombinant human
erythropoietin in beta thalassaemia patients on dialysis. Nephrol Dial Transplant
1992;7(1):82-3.

Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF.
Lipoprotein(a) is an independent risk factor for cardiovascular disease in
hemodialysis patients. Circulation 1992 Aug;86(2):475-82.

Cressman MD, Hoff HF, Nally JV Jr, Schreiber M Jr, Van Lente F. Lipoprotein a and
the cardiovascular risk of end stage renal disease [abstract]. J Am Soc Nephrol
1991;2(3):234.

Davenport A, Goel S, Mackenzie JC. Neurotoxicity of acyclovir in patients with
end-stage renal failure treated with continuous ambulatory peritoneal dialysis.
Am J Kidney Dis 1992 Dec;20(6):647-9.

De Lima JJ, Abensur H, Bernardes-Silva H, Bellotti G, Pileggi F. Role of arterial
hypertension in left ventricle hypertrophy in hemodialysis patients: an
echocardiographic study. Cardiology 1992;80(3-4):161-7.

Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH,
Edwardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in
normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.
Biochem J 1992 Oct 15;287(Pt 2):509-14.

D'Elia JA, Weinrauch LA, Paine DF, Domey PE, Smith-Ossman SL, Williams ME,
Kaldany A. Increased infection rate in diabetic dialysis patients exposed to
cocaine. Am J Kidney Dis 1991 Sep;18(3):349-52.

Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in
illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and
multiple sclerosis. J Nerv Ment Dis 1993 Jun;181(6):377-81.

Dominguez JM, Cruz N, Ramos-Barroso A, Ramos Umpierre E. Pregnancy in chronic
hemodialysis. Transplant Proc 1991 Apr;23(2):1836-7.

Duntas L, Wolf CF, Keck FS, Rosenthal J. Thyrotropin-releasing hormone:
pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin
Nephrol 1992 Oct;38(4):214-8.

Edmunds ME, Devoy M, Tomson CR, Krishna U, Clayworth A, Durrant ST, Feehally J,
Walls J. Plasma erythropoietin levels and acquired cystic disease of the kidney
in patients receiving regular haemodialysis treatment. Br J Haematol 1991
Jun;78(2):275-7. Comment in: Br J Haematol 1991 Nov;79(3):529-30.

Ekstrand A. Kidney transplantation with and without prior dialysis therapy in
diabetic patients with end-stage renal failure. Scand J Urol Nephrol
1993;27(1):83-7.

Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC.
Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients:
association with hepatitis B serological markers. Nephrol Dial Transplant
1991;6(7):476-9.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Plasma 1,5-anhydroglucitol
concentration in patients with end-stage renal disease with and without diabetes
mellitus. Nephron 1992;61(2):181-6.

Erdberg A, Korzets Z, Neufeld D, Rathaus M, Cordoba M, Bernheim J. Malignant
hypertension: a possible precursor to the future development of mesenteric
ischaemia in chronically haemodialysed patients. Nephrol Dial Transplant
1992;7(6):541-4.

Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol 1993;17 Suppl
3:S67-71.

Evans RW. Recombinant human erythropoietin and the quality of life of end-stage
renal disease patients: a comparative analysis. Am J Kidney Dis 1991 Oct;18(4
Suppl 1):62-70.

Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi
ML. Progression of uremic hyperparathyroidism involves allelic loss on chromosome
11. J Clin Endocrinol Metab 1993 Jan;76(1):139-44.

Faranna P, Cozzi G, Belloni M, Pedrini L. Immunization and vaccination protocol
in hemodialysis patients with naturally acquired hepatitis B antibody. Nephron
1992;61(3):311-2.

Favazza A, Motanaro D, Messa P, Antonucci F, Gropuzzo M, Mioni G. Peritoneal
clearances in hypertensive CAPD patients after oral administration of clonidine,
enalapril, and nifedipine. Perit Dial Int 1992;12(3):287-91.

Fernandez A, Hortal L, Rodriguez JC, Vega N, Plaza C, Palop L. Anemia in
dialysis: its relation to acquired cystic kidney disease and serum levels of
erythropoietin. Am J Nephrol 1991;11(1):12-5.

Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res
Nurs Health 1992 Feb;15(1):29-38.

Franco E, Olivadese A, Valeri M, Albertoni F, Petrosillo N. Control of hepatitis
B virus infection in dialysis units in Latium, Italy. Nephron 1992;61(3):329-30.

Friedman EA. Diabetic nephropathy in the inner city. N Y State J Med 1991
May;91(5):203-7.

Fujiyama S, Kawano S, Sato S, Sato T, Shimada H, Matsushita K, Hara M, Ito J. The
prevalence of anti-HCV antibodies in hemodialysis patients. Gastroenterol Jpn
1991 Jul;26 Suppl 3:206-8.

Fujiyama S, Kawano S, Sato S, Tanaka M, Goto M, Taura Y, Sato T, Kawahara T,
Mizuno K. Prevalence of hepatitis C virus antibodies in hemodialysis patients and
dialysis staff. Hepatogastroenterology 1992 Apr;39(2):161-5.

Fukunishi I, Norris P, Fahrion S, Baer C, Porter R. A comparison of alexithymia
in American and Japanese dialysis patients. Psychother Psychosom
1992;57(1-2):75-80.

Fukunishi I, Saito S, Ozaki S. The influence of defense mechanisms on secondary
alexithymia in hemodialysis patients. Psychother Psychosom 1992;57(1-2):50-6.

Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C,
Drueke TB. Short- and long-term efficacy of total parathyroidectomy with
immediate autografting compared with subtotal parathyroidectomy in hemodialysis
patients. J Am Soc Nephrol 1992 Oct;3(4):1008-17.

Gallar P, Vigil A, Oliet A, Ortega O, Guijo G. Intraperitoneal erythromycin for
diabetic gastroparesis in CAPD. Perit Dial Int 1992;12(2):265-6.

Gallicano KD, Tobe S, Sahai J, McGilveray IJ, Cameron DW, Kriger F, Garber G.
Pharmacokinetics of single and chronic dose zidovudine in two HIV positive
patients undergoing continuous ambulatory peritoneal dialysis (CAPD). J Acquir
Immune Defic Syndr 1992;5(3):242-50.

Galpin C. Body image in end-stage renal failure. Br J Nurs 1992 Apr 23-May
13;1(1):21-3.

Garcia-Maldonado M, Patterson D, Smith ZM. PTH levels correlate with mental
performance in CAPD. Adv Perit Dial 1991;7:234-6.

Garcia-Martin F, De Arriba G, Carrascosa T, Moldenhauer F, Martin-Escobar E, Val
J, Saiz F. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal
disease. Nephrol Dial Transplant 1991;6(8):543-7.

Garred LJ, Pretlac R. Mathematical modeling of erythropoietin therapy. ASAIO
Trans 1991 Jul-Sep;37(3):M457-9.

Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofiltration
countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma
1991 Sep;31(9):1277-84; discussion 1284-5.

Gault MH, Longerich L, Prabhakaran V, Purchase L. Ischemic heart disease, serum
cholesterol, and apolipoproteins in CAPD. ASAIO Trans 1991 Jul-Sep;37(3):M513-4.

Gertz MA, Kyle RA, O'Fallon WM. Dialysis support of patients with primary
systemic amyloidosis. A study of 211 patients. Arch Intern Med 1992
Nov;152(11):2245-50.

Giammaria U, De Meo F, Acitelli S, Tancredi M, Daniele M, Barnabei R, Maschio C.
HCV infection in hemodialyzed patients: incidence and correlation with dialytic
age. Nephron 1992;61(3):335-6.

Gilli P, Cavazzini L, Stabellini N, Malacarne F, Soffritti S, Storari A.
Histological features of non-A, non-B hepatitis in hemodialysis patients. Nephron
1992;61(3):296-7.

Gladziwa U, Wagner S, Dakshinamurty KV, Bechtel B, Mann H, Sieberth HG.
Intragastric long-term pH-metry in hemodialysis patients. A study with
famotidine. Clin Nephrol 1991 Aug;36(2):97-102.

Glass GE, Watson AJ, LeDuc JW, Kelen GD, Quinn TC, Childs JE. Infection with a
ratborne hantavirus in US residents is consistently associated with hypertensive
renal disease. J Infect Dis 1993 Mar;167(3):614-20.

Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney
Int Suppl 1993 Feb;40:S23-7.

Gokal R, Rottembourg J, Friedman EA, Tzamaloukas AH, Becker GJ. Peritoneal
dialysis in diabetic ESRD patients. Dial Transplant 1991;20(2):59-63, 66, 88.

Gubertini G, Scorza D, Beccari M, Buccianti G, Costantino A, Spotti D, Graziani
G. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the
area of Milan. Nephron 1992;61(3):271-2.

Gupta A, Yuan ZY, Balaskas EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis:
no connection. Perit Dial Int 1992;12(3):309-16.

Hampl H, Steinmuller T, Stabell U, Klingenberg HJ, Schnoy N, Neuhaus P. Recurrent
hyperparathyroidism after total parathyroidectomy and autotransplantation in
patients with long-term hemodialysis. Miner Electrolyte Metab 1991;17(4):256-60.

Hampton JK. Long-term effects of hemodialysis in diabetic patients with end stage
renal disease. ANNA J 1992 Oct;19(5):455-6.

Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus
increases with time on hemodialysis. Clin Nephrol 1992 Jul;38(1):44-8.

Hiatt WR, Koziol BJ, Shapiro JI, Brass EP. Carnitine metabolism during exercise
in patients on chronic hemodialysis. Kidney Int 1992 Jun;41(6):1613-9.

Hirschl MM, Heinz G, Sunder-Plassmann G, Derfler K. Renal replacement therapy in
type 2 diabetic patients: 10 years' experience. Am J Kidney Dis 1992
Dec;20(6):564-8.

Hogg RJ. Acquired renal cystic disease in children prior to the start of
dialysis. Pediatr Nephrol 1992 Mar;6(2):176-8.

Hokl J, Sobotova D, Filkuka J. The occurrence of anti-CMV and anti-HIV antibodies
and HBsAG in kidney allograft recipient and haemodialysis patients. Scr Med
(Brno) 1991;64(3):143-6.

Holley J, Bernardini J, Piraino B. Catheter infections in insulin-dependent
diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int
1991;11(4):347-50.

Hong SY, Yang DH, Lee BH, Ki EK, Chung KH. The urine urokinase concentration in
end stage renal disease with acquired renal cyst. Korean J Intern Med 1991
Jul;6(2):64-8.

Hoyer J, Schulte KL, Lenz T. Clinical pharmacokinetics of angiotensin converting
enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet 1993
Mar;24(3):230-54.

Hsieh TT, Chen KC, Cheng BJ, Chiu TH. Pregnancy outcome in patients undergoing
long-term hemodialysis. Acta Obstet Gynecol Scand 1991;70(4-5):299-302.

Huting J. Predictive value of mitral and aortic valve sclerosis for survival in
end-stage renal disease on continuous ambulatory peritoneal dialysis. Nephron
1993;64(1):63-8.

Huting J. Progression of valvular sclerosis in end-stage renal disease treated
by long-term peritoneal dialysis. Clin Cardiol 1992 Oct;15(10):745-50.

Inagaki Y, Amano I. Clinical effect of continuous gastric cooling for massive GI
bleeding in uremia. Int J Artif Organs 1991 Mar;14(3):141-6.

Innocenti M, Mazzoni A, Moretti A, Palla P. Comparison of anti-hepatitis C virus
detection with ELISA assay and RIBA 4 in dialysis patients: our experience.
Nephron 1992;61(3):315.

Ippolito E, Aterini S, Salvadori M, D'Elia G, Amato M. HCV incidence in a
dialysis center: preliminary reports. Nephron 1992;61(3):375-6.

Ishikawa I. Acquired cystic disease: mechanisms and manifestations. Semin Nephrol
1991;11(6):671-84.

Ishikawa I. Acquired renal cystic disease and its complications in continuous
ambulatory peritoneal dialysis patients. Perit Dial Int 1992;12(3):292-7.

Ishikawa I. Renal cell carcinoma in chronic hemodialysis patients - a 1990
questionnaire study in Japan. Kidney Int Suppl 1993;41:S167-9.

Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients
on chronic haemodialysis. Histopathology 1993 Feb;22(2):135-9.

Ishikawa I, Shikura N, Nagahara M, Shinoda A, Saito Y. Comparison of severity of
acquired renal cysts between CAPD and hemodialysis. Adv Perit Dial 1991;7:91-5.

Ishitani M, Wilkowski M, Stevenson W, Pruett T. Outcome of patients requiring
hemodialysis after liver transplantation. Transplant Proc 1993 Apr;25(2):1762-3.

Kemperman FA, van Leusen R, van Liebergen FJ, Oosting J, Boeschoten EW, Struijk
DG, Krediet RT, Arisz L. Continuous ambulatory peritoneal dialysis (CAPD) in
patients with diabetic nephropathy. Neth J Med 1991 Jun;38(5-6):236-45.

Khanna R. Dialysis considerations for diabetic patients. Kidney Int Suppl
1993;40:S58-64.

Ko W, Kreiger KH, Isom OW. Cardiopulmonary bypass procedures in dialysis
patients. Ann Thorac Surg 1993 Mar;55(3):677-84.

Koksal I, Biberoglu K, Biberoglu S, Koc F, Ayma Y, Aker F, Koksal H. Hepatitis
C virus antibodies among risk groups in Turkey. Infection 1991 Jul-
Aug;19(4):228-9.

Kooman JP, Wijnen JA, Draaijer P, van Bortel LM, Gladziwa U, Peltenburg HG,
Struyker-Boudier HA, van Hooff JP, Leunissen KM. Compliance and reactivity of the
peripheral venous system in chronic intermittent hemodialysis. Kidney Int 1992
Apr;41(4):1041-8.

Kopple JD, Brunori G, Leiserowitz M, Mattimore C, Hirschberg R. Growth hormone
treatment for patients with renal failure. Nippon Jinzo Gakkai Shi 1991
May;33(5):468-74.

Korzets A, Chagnac A, Ori Y, Katz M, Zevin D. Subclavian vein stenosis, permanent
cardiac pacemakers and the haemodialysed patient. Nephron 1991;58(1):103-5.

Korzets Z, Golan E, Naftali T, Bernheim J. Peritoneal dialysis in the presence
of a stoma. Perit Dial Int 1992;12(2):258-60.

Kremer D, Munar MY, Kohlhepp SJ, Swan SK, Stinnett EA, Gilbert DN, Young EW,
Bennett WM. Zidovudine pharmacokinetics in five HIV seronegative patients
undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy
1992;12(1):56-60.

Krzesinski JM, Du F, Rorive G. Intracellular cation concentrations in essential
hypertension and chronic renal failure. Clin Exp Hypertens 1993;15(3):461-78.

Kusakari J, Hara A, Takeyama M, Suzuki S, Igari T. The hearing of the patients
treated with hemodialysis: a long term follow-up study. Auris Nasus Larynx
1992;19(2):105-13.

Kutner NG, Brogan DJ. Assisted survival, aging, and rehabilitation needs:
comparison of older dialysis patients and age-matched peers. Arch Phys Med
Rehabil 1992 Apr;73(4):309-15.

Kutner NG, Brogan D, Fielding B, Hall WD. Older renal dialysis patients and
quality of life. Dial Transplant 1991;20(4):171-5.

Kutner NG, Cardenas DD, Bower JD. Rehabilitation, aging and chronic renal
disease. Am J Phys Med Rehabil 1992 Apr;71(2):97-101.

Kwan JT, Hart PD, Raftery MJ, Cunningham J, Marsh FP. Mycobacterial infection is
an important infective complication in British Asian dialysis patients. J Hosp
Infect 1991 Dec;19(4):249-55.

La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis: clinical
laboratory course in patients on hemodialysis and its correlation with the
presence of anti-hepatitis C virus antibodies. Nephron 1992;61(3):273-5.

La Russa A, Bufano G, Cauzzi L, Pecchini P. Non-A, non-B hepatitis in patients
on dialysis: retrospective evaluation of measures taken to limit the diffusion
of the virus. Nephron 1992;61(3):333-4.

Lai KN, Li PK, Woo KS, Lui SF, Leung JC, Law E, Nicholls MG. Vasoactive hormones
in uremic patients on continuous ambulatory peritoneal dialysis. Clin Nephrol
1991 May;35(5):218-23.

Lai KN, Wong KC, Li PK, Lui SF. Use of recombinant erythropoietin in thalassemic
patients on dialysis. Am J Kidney Dis 1992 Mar;19(3):239-45.

Levine E, Slusher SL, Grantham JJ, Wetzel LH. Natural history of acquired renal
cystic disease in dialysis patients: a prospective longitudinal CT study. AJR Am
J Roentgenol 1991 Mar;156(3):501-6.

Lin DY, Lin HH, Huang CC, Liaw YF. High incidence of hepatitis C virus infection
in hemodialysis patients in Taiwan. Am J Kidney Dis 1993 Mar;21(3):288-91.

Lin JL. Varicella pneumonitis in children with hemodialysis. Nephron
1992;61(4):481-2.

Losito A. Essential hypertension and renal failure. Compr Ther 1991
Feb;17(2):20-5.

Lowenthal DT, Saris SD, Paran E, Cristal N. The use of transdermal clonidine in
the hypertensive patient with chronic renal failure. Clin Nephrol 1993
Jan;39(1):37-43.

Luke DR, Awni WM, Halstenson CE, Opsahl JA, Matzke GR. Bioavailability of
labetalol in patients with end-stage renal disease. Ther Drug Monit
1992;14(3):203-8.

Lundin AP. Measuring quality care in hemodialysis. Nephrol News Issues 1991
Feb;5(2):22, 30.

MacGregor RR, Graziani AL, Weiss R, Grunwald JE, Gambertoglio JG. Successful
foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing
hemodialysis: rationale for empiric dosing and plasma level monitoring. J Infect
Dis 1991 Oct;164(4):785-7.

Maheshwari HG, Rifkin I, Butler J, Norman M. Growth hormone binding protein in
patients with renal failure. Acta Endocrinol (Copenh) 1992 Dec;127(6):485-8.

Mak RH. Amelioration of hypertension and insulin resistance by 1,25-
dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992
Jul;6(4):345-8.

Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance
in hemodialysis patients. Kidney Int 1992 Apr;41(4):1049-54.

Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA,
Cerami A, Vlassara H. Advanced glycosylation end products in patients with
diabetic nephropathy. New Engl J Med 1991;325(12):836-42.

Mako J, Potyondi M. Use of Tensiomin in hypertensive patients with impaired renal
function. Ther Hung 1992;40(1):20-4.

Malaguti M, Capece R, Marciano M, Arena G, Luciani MP, Striano M, Biagini M.
Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical
area in dialysis patients, staff members, and blood donors. Nephron
1992;61(3):346.

Malberti F, Surian M, Cosci P. Effect of chronic intravenous calcitriol on
parathyroid function and set point of calcium in dialysis patients with
refractory secondary hyperparathyroidism. Nephrol Dial Transplant
1992;7(8):822-8.

Malberti F, Surian M, Cosci P. Improvement of secondary hyperparathyroidism and
reduction of the set point of calcium after intravenous calcitriol. Kidney Int
Suppl 1993;41:S125-30.

Marangella M, Vitale C, Petrarulo M, Cosseddu D, Gallo L, Linari F. Pathogenesis
of severe hyperoxalaemia in Crohn's disease-related renal failure on maintenance
haemodialysis: successful management with pyridoxine. Nephrol Dial Transplant
1992;7(9):960-4.

Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, London GM.
Arteriosclerosis and antihypertensive response to calcium antagonists in end-
stage renal failure. J Cardiovasc Pharmacol 1991;18 Suppl 5:S14-8.

Marcus EL, Rudensky B, Sonnenblick M. Occult elevation of CK as a manifestation
of rhabdomyolysis in the elderly. J Am Geriatr Soc 1992;40(5):454-6.

Marcus R, Favero MS, Banerjee S, Solomon SL, Bell DM, Jarvis WR, Martone WJ.
Prevalence and incidence of human immunodeficiency virus among patients
undergoing long-term hemodialysis. Am J Med 1991;90(5):614-27.

Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease
patients with preexisting chronic liver disease and ascites. Am J Med 1992
Jul;93(1):35-40.

Markell MS, Friedman EA. Diabetic nephropathy. Management of the end-stage
patient. Diabetes Care 1992 Sep;15(9):1226-38.

Martin KJ, Ballal HS, Domoto DT, Blalock S, Weindel M. Pulse oral calcitriol for
the treatment of hyperparathyroidism in patients on continuous ambulatory
peritoneal dialysis: preliminary observations. Am J Kidney Dis 1992
Jun;19(6):540-5.

Martinez M, Ausejo M, Miguel JL, Gonzalez ML, Balaguer G, Catalan P, Selgas R.
Comparative study between intact PTH and fragments of PTH in patients on
hemodialysis and CAPD. Perit Dial Int 1991;11(2):137-40.

Masumura H, Miki S, Kaifu Y, Kitajima W, Abe Y. Pharmacokinetics and efficacy of
carvedilol in hypertensive patients with chronic renal failure and hemodialysis
patients. J Cardiovasc Pharmacol 1992;19 Suppl 1:S102-7.

Mazzoni A, Innocenti M, Consaga M. Retrospective study on the prevalence of B and
non-A, non-B hepatitis in a dialysis unit: 17-year follow-up. Nephron
1992;61(3):316-7.

Mazzotta L, Landucci G, Pfanner L, Carlini A, Angelini D, Giusti R, Antonelli A.
Comparison between first and second generation tests to determine the frequency
of anti-HCV antibodies in uremic patients in replacement dialytic therapy.
Nephron 1992;61(3):354-5.

Medici G, Depetri GC, Mileti M. Anti-hepatitis C virus positivity and clinical
correlations in hemodialyzed patients. Nephron 1992;61(3):363-4.

Meyer KB, Kurtin PS, Deoreo PB, Kaufman AM, Levin NW, Davies AR. Health-related
quality of life (HBRQL) and clinical variables in hemodialysis patients
[abstract]. J Am Soc Nephrol 1992;3(3):379.

Miki S, Masumura H, Kaifu Y, Yuasa S. Pharmacokinetics and efficacy of carvedilol
in chronic hemodialysis patients with hypertension. J Cardiovasc Pharmacol
1991;18 Suppl 4:S62-8.

Mioli VA, Balestra E, Bibiano L, Carletti P, Della Bella S, Fanciulli E, Gaffi
G, Marinelli R, Perilli R, Ricciatti AM, et al. Epidemiology of viral hepatitis
in dialysis centers: a national survey. Nephron 1992;61(3):278-83.

Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis
1991 Nov;18(5):579-82.

Mitwalli A, al-Mohaya S, al Wakeel J, el Gamal H, Rotimi V, al-Zeben A, al-Aska
A. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992;12(5):288-91.

Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High prevalence
of antibodies to hepatitis C virus in hemodialysis units using a second
generation assay. Nephron 1992;61(3):350-1.

Morachiello P, Landini S, Fracasso A, Righetto F, Scanferla F, Toffoletto P,
Genchi R, Bazzato G. Combined hemodialysis-hemoperfusion in the treatment of
secondary hyperparathyroidism of uremic patients. Blood Purif 1991;9(3):148-52.

Morales Otero LA, Molina M, Gonzalez ZA. Incidence and fate of HIV-positive
dialysis and transplant patients. Transplant Proc 1991;23(2):1841-2.

Moriniere P, El Esper N, Viron B, Judith D, Bourgeon B, Farquet C, Gheerbrant J,
Chapuy MC, Van Orshoven A, Pamphile R, Fournier A. Improvement of severe
secondary hyperparathyroidism in dialysis patients by intravenous 1alpha(OH)
vitamin D3, oral CaCO3 and low dialysate calcium. Kidney Int Suppl
1993;41:S121-4.

Mosconi G, Campieri C, Miniero R, Coli L, Orsi C, La Manna G, De Sanctis LB,
Stefoni S, Sprovieri G, Bonomini V. Epidemiology of hepatitis C in a population
of hemodialysis patients. Nephron 1992;61(3):298-9.

Muirhead N, Churchill DN, Goldstein M, Nadler SP, Posen G, Wong C, Slaughter D,
Laplante P. Comparison of subcutaneous and intravenous recombinant human
erythropoietin for anemia in hemodialysis patients with significant comorbid
disease. Am J Nephrol 1992;12(5):303-10.

Muthny FA, Koch U. Quality of life of patients with end-stage renal failure. A
comparison of hemodialysis, CAPD, and transplantation. Contrib Nephrol
1991;89:265-73.

Nannery WM, Stoldt HS, Fares LG 2d. Hemodialysis access operations performed upon
patients with human immunodeficiency virus. Surg Gynecol Obstet 1991
Nov;173(5):387-90.

Navarro J, Serrano C, Donna E, Perez GO. Disordered breathing patterns during
bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone
membranes. ASAIO J 1992 Oct-Dec;38(4):811-4.

Ng YY, Lee SD, Wu SC, Liu WT, Chia WL, Huang TP. The need for second-generation
antihepatitis C virus testing in uremic patients on continuous ambulatory
peritoneal dialysis. Perit Dial Int 1993;13(2):132-5.

Ng YY, Lee SD, Wu SC, Yang WC, Chiang SS, Huang TP. Antibodies to hepatitis C
virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med
Virol 1991 Dec;35(4):263-6.

Nicolucci A, Cubasso D, Labbrozzi D, Mari E, Impicciatore P, Procaccini DA,
Forcella M, Stella I, Querques M, Pappani A, et al. Effect of coexistent diseases
on survival of patients undergoing dialysis. ASAIO J 1992 Jul-Sep;38(3):M291-5.

Nissenson AR. Chronic peritoneal dialysis in the elderly. Geriatr Nephrol Urol
1991;1(1):3-12.

Nissenson AR. Dialysis therapy in the elderly patient. Kidney Int Suppl 1993
Feb;40:S51-7.

Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated
non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J
Kidney Dis 1992;19(4):345-52.

Niutta A, Scorcia G, Princi P, Palombi E, Perilli R, Mannino G, Balacco Gabrieli
C. Visual disturbances associated with primary empty sella syndrome in patients
with chronic renal failure. Ann Ophthalmol 1992 Feb;24(2):56-63.

Oddone EZ, Cowper PA, Hamilton JD, Feussner JR. A cost-effectiveness analysis of
hepatitis B vaccine in predialysis patients. Health Serv Res 1993
Apr;28(1):97-121.

O'Doherty MJ, Breen D, Page C, Barton I, Nunan TO. Lung 99mTc DTPA transfer in
renal disease and pulmonary infection. Nephrol Dial Transplant 1991;6(8):582-7.

Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa
M, Kanno Y, Aizawa T, et al. Hepatitis virus infection (HBV and HCV) in eleven
Japanese hemodialysis units. Clin Nephrol 1992 Jul;38(1):36-43.

Oliva JA, Maymo RM, Carrio J, Delgado O, Mallafre JM. Late seroconversion of C
virus markers in hemodialysis patients. Kidney Int Suppl 1993;41: S153-6.

Pachon J, Cisneros JM, Castillo JR, Garcia-Pesquera F, Canas E, Viciana P.
Pharmacokinetics of zidovudine in end-stage renal disease: influence of
haemodialysis. AIDS 1992 Aug;6(8):827-30. Comment in: AIDS 1993 Jan;7(1):141-2.

Pannekeet MM, Krediet RT, Boeschoten EW, Arisz L. Acute pancreatitis in patients
on CAPD treatment. Kidney Int 1992;42(5):1287.

Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in
dialysis patients. J Am Soc Nephrol 1991 Jul;2(1):2-12.

Park H, Bang WR, Kim SJ, Kim ST, Lee JS, Kim S, Han JS. Quality of life of ESRD
patients: development of a tool and comparison between transplant and dialysis
patients. Transplant Proc 1992 Aug;24(4):1435-7.

Park YM, Kim IS, Lee CD, Kim BS. Seroprevalence of antibody against hepatitis C
virus (anti-HCV) in various groups of individuals in Korea. Gastroenterol Jpn
1991;26 Suppl 3:159-63.

Parsons V, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin I. Successful control
of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis
using magnesium carbonate and calcium carbonate as phosphate binders. Nephron
1993;63(4):379-83.

Pasqualini T, Zantleifer D, Balzaretti M, Granillo E, Fainstein-Day P, Ramirez
J, Ruiz S, Gutman R, Ferraris J. Evidence of hypothalamic-pituitary thyroid
abnormalities in children with end-stage renal disease. J Pediatr 1991
Jun;118(6):873-8. Comment in: J Pediatr 1991 Jun;118(6):896-8.

Pauri P, Salvoni G, Vitolo W, Carletti P, Fanciulli E, Ricciatti AM, Della Bella
S, Mioli VA. Risk factors and clinical expression of HCV infection in
hemodialysis patients. Nephron 1992;61(3):313-4.

Peterson RA, Kimmel PL, Sacks CR, Mesquita ML, Simmens SJ, Reiss D. Depression,
perception of illness and mortality in patients with end-stage renal disease. Int
J Psychiatry Med 1991;21(4):343-54.

Petrarulo F, Maggi P, Sacchetti A, Pallotta G, Dagostino F, Basile C. HCV
infection occupational hazard at dialysis units and virus spread, among relatives
of dialyzed patients. Nephron 1992;61(3):302-3.

Piccoli G, Bonello F, Massara C, Salomone M, Maffei S, Iadarola GM, Stramignoni
E, Rosati C, Borca M, Belardi P, Quarello F, Piccoli G, Vercellone A. Death in
conditions of cachexia: the price for the dialysis treatment of the elderly?
Kidney Int Suppl 1993;41:S282-6.

Pizzarelli F, Fabrizi F, Postorino M, Curatola G, Zoccali C, Maggiore Q.
Parathyroidectomy and blood pressure in hemodialysis patients. Nephron
1993;63(4):384-9.

Pluvio M, Saggese A, Cirillo D, Castellino P, Pempinello R, Iannece MD,
Guarnaccia D, Tassinaro P, Pluvio C, Cicchella T, et al. Hepatitis C virus-
related acute and chronic hepatitis in hemodialysis patients. Nephron
1992;61(3):322-3.

Poch E, Almirall J, Alsina M, del Rio R, Cases A, Revert L. Calciphylaxis in a
hemodialysis patient: appearance after parathyroidectomy during a psoriatic
flare. Am J Kidney Dis 1992 Mar;19(3):285-8.

Ponz E, Campistol JM, Barrera JM, Gil C, Pinto J, Andreu J, Bruguera M. Hepatitis
C virus antibodies in patients on hemodialysis and after kidney transplantation.
Transplant Proc 1991 Feb;23(1 Pt 2):1371-2.

Portigliatti Barbos M, Cadario A, Canavese C, Pavan I. Clinical, histological,
and chemical characterization of ectopic calcification in dialyzed and non-
dialyzed patients. Ital J Orthop Traumatol 1991 Dec;17(4):523-32.

Raccosta G, Merletti MG, Lisi E, Ciccarelli P, Trivelli G, Capponi E. Prevalence
of hepatitides in our hemodialyzed population. Nephron 1992;61(3):300-1.

Rahman MM, Caglayan F, Rahman B. Periodontal health parameters in patients with
chronic renal failure and renal transplants receiving immunosuppressive therapy.
J Nihon Univ Sch Dent 1992 Dec;34(4):265-72.

Reinberg Y, Matas A, Manivel JC, Gonzalez R, Gillingham KJ, Pryor JL. Outcome of
renal transplantation or dialysis in patients with a history of renal cancer.
Cancer 1992;70(6):1564-7.

Reusser LM, White HJ, Sexson R, Osborn LA, Crawford MH. Increased morbidity
following coronary angioplasty in chronic hemodialysis patients. Clin Res
1993;41(1):12a.

Reyes A, Turchetto E, Bernis C, Cereijo E. Acid-base derangements during sorbent
regenerative hemodialysis in mechanically ventilated patients. Crit Care Med 1991
Apr;19(4):554-9.

Rizzoni G, Ehrich JH, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings
W, Selwood NH, Tufveson G, Wing AJ. Rehabilitation of young adults during renal
replacement therapy in Europe. 1. The presence of disabilities. Nephrol Dial
Transplant 1992;7(7):573-8.

Rosansky SJ, Jackson K. Rate of change of end-stage renal disease treatment
incidence 1978-1987--has there been selection? J Am Soc Nephrol 1992
Apr;2(10):1502-6.

Roy LF, Dufresne LR, Legault L, Long H, Morin C. Acetazolamide in hemodialysis
patients: a rational use after ocular surgery. Am J Kidney Dis 1992
Dec;20(6):650-2.

Rubin J, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one
facility. Am J Kidney Dis 1991 Feb;17(2):165-9.

Ruedin P, Pechere Bertschi A, Chapuis B, Benedet P, Leski M. Safety and efficacy
of recombinant human erythropoietin treatment of anaemia associated with multiple
myeloma in haemodialysed patients. Nephrol Dial Transplant 1993;8(4):315-8.

Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus
infection among long-term hemodialysis patients: detection of hepatitis C virus
RNA in plasma. J Med Virol 1993 Jan;39(1):11-5.

Salunkhe PN, Naik SR, Semwal SN, Naik S, Kher V. Prevalence of antibodies to
hepatitis C virus in HBsAg negative hemodialysis patients. Indian J Gastroenterol
1992 Oct;11(4):164-5.

Sasagawa I, Terasawa Y, Imai K, Sekino H, Takahashi H. Acquired cystic disease
of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic
evaluation. Br J Urol 1992 Sep;70(3):236-9.

Sasagawa I, Terasawa Y, Ishizaki M, Takahashi H, Suzuki K, Imai K, Nakada T.
Comparison of ultrasonography, computerized tomography and angiography in
dialysis patients with renal cell carcinoma. Urol Int 1992;49(4):206-10.

Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM. Peritonitis and the
patient with human immunodeficiency virus (HIV). Adv Perit Dial 1992;8:250-2.

Schmid C, Ziemer G, Laas J, Borst HG. Open-heart surgery in patients requiring
chronic hemodialysis. Scand J Thorac Cardiovasc Surg 1992;26(2):97-100.

Schmidt RJ, Cruz C, Dumler F. Effective continuous ambulatory peritoneal dialysis
following abdominal aortic aneurysm repair. Perit Dial Int 1993;13(1):40-4.

Schneider MS, Friend R, Whitaker P, Wadhwa NK. Fluid noncompliance and
symptomatology in end-stage renal disease: cognitive and emotional variables.
Health Psychol 1991;10(3):209-15.

Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to
measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992
Mar;6(2):187-9.

Scipioni F, Di Filippo L, Maccarone M, Viola D, Ruzzi L, Terlizzi R. HCV in a
group of chronic hemodialysis patients. Nephron 1992;61(3):362.

Scopelite JA. Dietary modifications: impact on diabetic nephropathy. ANNA J 1992
Oct;19(5):447-52

Scotto G, Savastano AM, Forcella M, Tantimonaco G, Amato G, Salatino G, Pappani
A, Stella I. HCV infections in dialysis patients. Nephron 1992;61(3):320-1.

Sennesael J, Verbeelen D, Vanhaelst L, Pirola R, Bareggi SR. Pharmacokinetics of
intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis
[published erratum appears in Eur J Clin Pharmacol 1991;41(4):386]. Eur J Clin
Pharmacol 1991;41(1):65-8.

Sheikh F, Khubchandani IT, Rosen L, Sheets JA, Stasik JJ. Is anorectal surgery
on chronic dialysis patients risky? Dis Colon Rectum 1992;35(1):56-8.

Singlas E, Taburet AM, Lebas FB, De Curzon OP, Sobel A, Chauveau P, Viron B,
Khayat RA, Poignet JL, Mignon F, Humbert G, Fillastre JP. Didanosine
pharmacokinetics in patients with normal and impaired renal function: influence
of hemodialysis. Antimicrob Agents Chemother 1992;36(7):1519-24.

Smetana Z, Leventon-Kriss S, Broide A, Jedwab M, Smetana SS. Varicella-zoster
virus immune status in CAPD and chronic hemodialysis patients. Am J Nephrol
1991;11(3):229-36.

Solhaug MJ, Adelman RD, Chan JC. Hypertension in the child with chronic renal
insufficiency or undergoing dialysis. Child Nephrol Urol 1992;12(2-3):133-8.

Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, Breyer JA. Serum
albumin: a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis
1993 Jan;21(1):26-30.

Spisni C, Stingone A, Di Vito R, Rondinella I, D'Amario C, Tucci E, Caravelli L,
D'Angelo B, Cerasoli P. Serum epidemiological trial on the prevalence of the
anti-cytomegalovirus antibodies in patients under substitutive treatment with
hemodialysis and CAPD. Nephron 1992;61(3):373-4.

Thompson TJ, Fisher M, Hatfield PJ, Morrison RB, Neale TJ. Diabetic end stage
renal failure--the Wellington experience 1975-1988. Aust N Z J Med 1991
Feb;21(1):29-35.

Tomson CR. Renal replacement therapy for patients with diabetes. Pract Diabetes
1992;9(6):224-9.

Tsobanelis T, Kurz P, Hoppe D, Schoeppe W, Vlachojannis J. Hemodialysis and CAPD
in diabetic patients. Contrib Nephrol 1991;89:248-53.

Tzamaloukas AH, Avasthi PS. Hypoglycemia during hemodialysis in diabetics treated
with insulin. Nephron 1992;61(4):470-1.

Tzamaloukas AH, Murata GH, Eisenberg B, Murphy G, Avasthi PS. Hypoglycemia in
diabetics on dialysis with poor glycemic control: hemodialysis versus continuous
ambulatory peritoneal dialysis. Int J Artif Organs 1992 Jul;15(7):390-2.

Tzamaloukas AH, Murata GH, Harford AM, Sena P, Zager PG, Eisenberg B, Wood B,
Simon D, Goldman RS, Kanig SP, et al. Hand gangrene in diabetic patients on
chronic dialysis. ASAIO Trans 1991 Oct-Dec;37(4):638-43.

Tzamaloukas AH, Oreopoulos DG. Subcutaneous versus intraperitoneal insulin in the
management of diabetics on CAPD: a review. Adv Perit Dial 1991;7:81-5.

Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG. CAPD in end stage patients
with renal disease due to diabetes mellitus--an update. Adv Perit Dial
1992;8:185-91.

Vandelli L, Medici G, Savazzi AM, De Palma M, Vecchi C, Zanchetta G, Lusvarghi
E. Behavior of antibody profile against hepatitis C virus in patients on
maintenance hemodialysis. Nephron 1992;61(3):260-2.

Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications
in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992
May;19(5):448-52.

Wizemann V, Kaufmann J, Kramer W. Effect of erythropoietin on ischemia tolerance
in anemic hemodialysis patients with confirmed coronary artery disease. Nephron
1992;62(2):161-5.

Yaqoob M, Ahmad R, McClelland P, Terry E. Continuous ambulatory peritoneal
dialysis in blind diabetic patients. Dial Transplant 1992;21(2):65, 68-9, 108.

Yaqoob M, McClelland P, Bell GM, Ahmad R, Bakran A. Bladder tumours in paraplegic
patients on renal replacement therapy. Lancet 1992;338(8782-8783):1554-5.

Yoshida CF, Takahashi C, Gaspar AM, Schatzmayr HG, Ruzany F. Hepatitis C virus
in chronic hemodialysis patients with non-A, non-B hepatitis. Nephron
1992;60(2):150-3.

Zeferos N, Digenis GE, Christophoraki M, Alexopoulos I, Kostakis A, Gyftaki H,
Moulopoulos S. Tumor markers in patients undergoing hemodialysis or kidney
transplantation. Nephron 1991;59(4):618-20.
Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F. The influence of
autonomic failure on plasma ANF concentration in uremic patients on chronic
hemodialysis. Clin Nephrol 1992 Apr;37(4):198-203.

COMPLICATIONS OF DIALYSIS

Anemia and Erythropoietin

-Clinical Trials

Abraham PA, Macres MG. Blood pressure in hemodialysis patients during
amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991
Oct;2(4):927-36.

Barany P, Freyschuss U, Pettersson E, Bergstrom J. Treatment of anaemia in
haemodialysis patients with erythropoietin: long-term effects on exercise
capacity. Clin Sci (Colch) 1993 Apr;84(4):441-7.

De Marchi S, Cecchin E. Hepatic computed tomography for monitoring the iron
status of haemodialysis patients with haemosiderosis treated with recombinant
human erythropoietin. Clin Sci 1991 Jul;81(1):113-21.

Effect of recombinant human erythropoietin therapy on blood pressure in
hemodialysis patients. Canadian Erythropoietin Study Group. Am J Nephrol
1991;11(1):23-6.

Granolleras C, Leskopf W, Shaldon S, Fourcade J. Experience of pain after
subcutaneous administration of different preparations of recombinant human
erythropoietin: a randomized, double-blind crossover study. Clin Nephrol 1991
Dec;36(6):294-8.

Laupacis A. A randomized double-blind study of recombinant human erythropoietin
in anaemic hemodialysis patients. Canadian Erythropoietin Study Group. Transplant
Proc 1991 Apr;23(2):1825-6.

Muirhead N, Laupacis A, Wong C. Erythropoietin for anaemia in haemodialysis
patients: results of a maintenance study (the Canadian Erythropoietin Study
Group). Nephrol Dial Transplant 1992;7(8):811-6.

Nissenson AR. National cooperative rHu erythropoietin study in patients with
chronic renal failure: a phase IV multicenter study. Report of National
Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis 1991 Oct;18(4 Suppl
1):24-33.

Sheingold S, Churchill D, Muirhead N, Laupacis A, Labelle R, Goeree R. The impact
of recombinant human erythropoietin on medical care costs for hemodialysis
patients in Canada. Soc Sci Med 1992 May;34(9):983-91.

Slingeneyer A, Faller B, Laroche B, Ehmer B, Mion C. Self-administered daily
subcutaneous recombinant human erythropoietin: an open randomised dose-finding
study in ESRD patients receiving peritoneal dialysis. Contrib Nephrol
1991;88:159-68.

-Other

Acchiardo SR, Moore LW, Sargent JA, Burk LB. Is hematologic response to iron and
erythropoietin in hemodialysis patients affected by other factors? ASAIO Trans
1991 Jul-Sep;37(3):M183-5.

Acchiardo SR, Quinn BP, Moore LW, Burk LB, Miles DE. Evaluation of hemodialysis
patients treated with erythropoietin. Am J Kidney Dis 1991 Mar;17(3):290-4.

Adair C, Lappin TR, Cotes PM. Changes in concentrations of ATP and other
nucleotides in erythrocytes during erythropoietin treatment in haemodialysis
patients. Biochem Soc Trans 1992;20(2):93s.

Adamson JW. Erythropoietin: its role in the regulation of erythropoiesis and as
a therapeutic in humans. Biotechnology 1991;19:351-63.

Allegra V, Mengozzi G, Vasile A. Iron deficiency in maintenance hemodialysis
patients: assessment of diagnosis criteria and of three different iron
treatments. Nephron 1991;57(2):175-82.

Anderson S. Effects of erythropoietin in predialysis patients. Am J Kidney Dis
1991 May;17(5 Suppl 1):103-6.

Andre M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P. Performance of an
immunoradiometric assay of erythropoietin and results for specimens from anemic
and polycythemic patients. Clin Chem 1992 May;38(5):758-63.

Auer J, Simon G, Stevens J, Griffiths P, Howarth D, Anastassiades E, Gokal R,
Oliver D. Quality of life improvements in CAPD patients treated with
subcutaneously administered erythropoietin for anemia. Perit Dial Int
1992;12(1):40-2.

Aunsholt NA, Ahlbom G, Steffensen G, Glud T. Fibrinolytic capacity in
hemodialysis patients treated with recombinant human erythropoietin. Nephron
1992;62(3):284-8.

Azzadin A, Bialkowska A, Buczko W, Malyszko J, Kalinowski M, Mysliwiec M.
Serotonergic mechanism of erythropoietin-induced hypertension. Nephrol Dial
Transplant 1992;7(8):882-3.

Bahlmann J, Schoter KH, Scigalla P, Gurland HJ, Hilfenhaus M, Koch KM, Muthny FA,
Neumayer HH, Pommer W, Quelhorst E, et al. Morbidity and mortality in
hemodialysis patients with and without erythropoietin treatment: a controlled
study. Contrib Nephrol 1991;88:90-106.

Bailie GR, Plitnick R, Eisele G, Clement C, Rasmussen R. Experience with
subcutaneous erythropoietin in CAPD patients. Adv Perit Dial 1991;7:292-5.

Baj Z, Pokoca L, Majewska E, Luciak M, Tchorzewski H. T lymphocyte subsets and
NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant
human erythropoietin (rHu-EPO) treatment. Arch Immunol Ther Exp (Warsz)
1992;40(3-4):201-6.

Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR,
Caparros G, Rinon C, Sanchez Sicilia L. Medium term response to H-R
erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels
and the effects on peritoneal transport capacity. Adv Perit Dial 1991;7:296-300.

Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ. Androgens potentiate
the effects of erythropoietin in the treatment of anemia of end-stage renal
disease. Am J Kidney Dis 1991 Jan;17(1):29-33. Comment in: Am J Kidney Dis 1991
Jul;18(1):143; Am J Kidney Dis 1992 Jan;19(1):94.

Barany P, Fehrman I, Godoy C. Long-term effects on lymphocytotoxic antibodies and
immune reactivity in hemodialysis patients treated with recombinant human
erythropoietin. Clin Nephrol 1992 Feb;37(2):90-6.

Barany P, Pettersson E, Ahlberg M, Hultman E, Bergstrom J. Nutritional assessment
in anemic hemodialysis patients treated with recombinant human erythropoietin.
Clin Nephrol 1991 Jun;35(6):270-9.

Bergstrom J. New aspects of erythropoietin treatment. Aten Primaria 1993 Apr
30;11(7):445-62.

Bergstrom J. New aspects of erythropoietin treatment. J Intern Med 1993
Jun;233(6):445-62.

Berns JS, Rudnick MR, Cohen RM. A controlled trial of recombinant human
erythropoietin and nandrolone decanoate in the treatment of anemia in patients
on chronic hemodialysis. Clin Nephrol 1992 May;37(5):264-7.

Besarab A, Besarab FM, Miller D. Effects of dialysis factors and route of
administration on response of hemodialysis patients to recombinant human
erythropoietin. ASAIO Trans 1991 Jul-Sep;37(3):M181-2.

Besarab A, Flaharty KK, Erslev AJ, McCrea JB, Vlasses PH, Medina F, Caro J,
Morris E. Clinical pharmacology and economics of recombinant human erythropoietin
in end-stage renal disease: the case for subcutaneous administration. J Am Soc
Nephrol 1992 Mar;2(9):1405-16.

Besarab A, Golper TA. Response of continuous peritoneal dialysis patients to
subcutaneous recombinant human erythropoietin differs from that of hemodialysis
patients. ASAIO Trans 1991 Jul-Sep;37(3):M395-6.

Besarab A, McCrea JB. Evolution of recombinant human erythropoietin usage in
clinical practice in the United States. Is there an optimal way to use rHuEPO?
ASAIO J 1993 Jan-Mar;39(1):11-8.

Bianchetti MG, Hammerli I, Roduit C, Neuhaus TJ, Leumann EP, Oetliker OH. Epoetin
alfa in anaemic children or adolescents on regular dialysis. Eur J Pediatr 1991
May;150(7):509-12.

Binkley LS. Management of the chronic renal failure patient receiving epoetin
alfa for the treatment of anemia. Transplant Proc 1991 Apr;23(2):1831-2.

Binkley LS. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991
Dec;18(6):540.

Bommer J. Response to EPO therapy. Przegl Lek 1992;49(1-2):36-7.

Bozfakioglu S, Alptekin N, Seckin S, Ark E, Kocak-Toker N. Red cell lipid
peroxidation and antioxidant system in chronic renal failure patients treated
with recombinant human erythropoietin. Nephron 1992;61(2):228-9.

Braun A, Ding R, Seidel C, Fies T, Kurtz A, Scharer K. Pharmacokinetics of
recombinant human erythropoietin applied subcutaneously to children with chronic
renal failure. Pediatr Nephrol 1993;7(1):61-4.

Brown JM. Nursing care of predialysis patients receiving epoetin alfa. ANNA J
1991 Jun;18(3):306-14.

Brown WS, Marsh JT, Wolcott D, Takushi R, Carr CR, Higa J, Nissenson AR.
Cognitive function, mood and P3 latency: effects of the amelioration of anemia
in dialysis patients. Neuropsychologia 1991;29(1):35-45.

Brunati C, Cappellini MD, De Feo T, Stefanoni I, Civati G, Ballerini L, Fiorelli
G, Minetti L. Circulating burst-forming-unit erythroid and the responsiveness to
recombinant human erythropoietin in patients on regular hemodialytic treatment.
Nephron 1992;62(2):150-4.

Brunier G, Graydon J. The relationship of anemia, nonspecific uremic symptoms,
and physical activity to fatigue in patients with end stage renal disease on
hemodialysis. ANNA J 1992 Apr;19(2):157.

Buemi M, Allegra A, Aloisi C, Frisina N. Influence of therapy with recombinant
erythropoietin on serum levels of neopterin in hemodialyzed subjects. Am J
Nephrol 1991;11(4):281-3.

Campos A, Garin EH. Therapy of renal anemia in children and adolescents with
recombinant human erythropoietin (rHuEPO). Clin Pediatr (Phila) 1992
Feb;31(2):94-9.

Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Mombelloni
S, Visioli O, Maiorca R. Reversal of left ventricular hypertrophy following
recombinant human erythropoietin treatment of anaemic dialysed uraemic patients.
Nephrol Dial Transplant 1991;6(1):31-7.

Carletti P, Bibiano L, Boggi R, Taruscia D, Mioli V. Does anemia correction by
rHuEPO improve uremic cardiopathy? Kidney Int Suppl 1993;41: S70-1.

Carlini R, Obialo CI, Rothstein M. Intravenous erythropoietin (rHuEPO)
administration increases plasma endothelin and blood pressure in hemodialysis
patients. Am J Hypertens 1993 Feb;6(2):103-7.

Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinant human
erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.
Kidney Int 1993;43(5):1010-4.

Chan PC, Liu P, Cronin C, Heathcote J, Uldall R. The use of nuclear magnetic
resonance imaging in monitoring total body iron in hemodialysis patients with
hemosiderosis treated with erythropoietin and phlebotomy. Am J Kidney Dis 1992
May;19(5):484-9.

Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D. Correction of anemia in patients
on continuous ambulatory peritoneal dialysis with subcutaneous recombinant
erythropoietin twice a week: a long-term study. Clin Nephrol 1991
May;35(5):207-12.

Cheung AK, Hohnholt M, Leypoldt JK, DeSpain M. Hemodialysis membrane
biocompatibility: the case of erythropoietin. Blood Purif 1991;9(3):153-63.

Conlon PJ, Walshe JJ, O'Donnell R, O'Donohoe A, Spencer R, Donohoe J, Carmody M.
The use of recombinant human erythropoietin in end stage renal disease. Ir J Med
Sci 1993 Jan;162(1):17-9.

Costagliola C, Romano L, Scibelli G, de Vincentiis A, Sorice P, Di Benedetto A.
Anemia and chronic renal failure: a therapeutical approach by reduced glutathione
parenteral administration. Nephron 1992;61(4):404-8.

Cremagnani L, Cantalamessa L, Orsatti A, Vigna L, Vallino F, Buccianti G.
Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone
(GH) response to growth hormone releasing hormone (GHRH) stimulation in
hemodialysis patients. Clin Nephrol 1993;39(5):282-6.

Davenport A, King RF, Ironside JW, Will EJ, Davison AM. The effect of treatment
with recombinant human erythropoietin on the histological appearance and glycogen
content of skeletal muscle in patients with chronic renal failure treated by
regular hospital haemodialysis. Nephron 1993;64(1):89-94.

Davenport A, Will EJ, Khanna SK, Davison AM. Blood lactate is reduced following
successful treatment of anaemia in haemodialysis patients with recombinant human
erythropoietin both at rest and after maximal exertion. Am J Nephrol
1992;12(5):357-62.

De Santo NG, Manzo M, Raiola P, Lanzetti N, Capasso G, Ficociello R, Anastasio
P, Esposito R. Failure of blood pressure to increase following erythropoietin
therapy in the renoprival status. Int J Artif Organs 1992 Mar;15(3):144-6.

Di Paolo B, Di Liberato L, Summa R, Catucci G, Del Rosso G, Muscianese P,
Albertazzi A. Clinical effects of recombinant human erythropoietin in
hemodialysis patients. Results of the "Abruzzo" Multicenter Trial. ASAIO Trans
1991 Jul-Sep;37(3):M380-1.

Diez JJ, Sastre J, Iglesias P, Selgas R, Romero JR, Mendez J, Gomez-Pan A. Growth
hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated
with recombinant human erythropoietin. Adv Perit Dial 1992;8:340-5.

Donnelly SM, Posen GA, Ali MA. Oral iron absorption in hemodialysis patients
treated with erythropoietin. Clin Invest Med 1991 Aug;14(4):271-6.

Drinovec J, Varl J. Subcutaneous erythropoietin in the treatment of renal
anaemia. Przegl Lek 1992;49(1-2):38-40.

Duff DR, Golper TA, Sloan RS, Brier ME, Aronoff GR. Low-dose recombinant human
erythropoietin therapy in chronic hemodialysis patients. Am J Kidney Dis 1991
Jul;18(1):60-4.

Dukanovic L, Clemons GK, Ikonomovski J, Biljanovic-Paunovic L, Pavlovic-Kentera
V. Erythropoietin and improvement of anemia in long-term hemodialysis patients.
Acta Med Iugosl 1991;45(2):151-60.

Dy GR, Bloom EJ, Ijelu GK, Merritts GW, Kramer MS, Raja RM. Effect of recombinant
human erythropoietin on vascular access. ASAIO Trans 1991 Jul-Sep;37(3):M274-5.

Edmunds ME, Walls J. Pathogenesis of seizures during recombinant human
erythropoietin therapy. Semin Dial 1991 Jul-Sep;4(3):163-7.

Effectiveness and safety of recombinant human erythropoietin in predialysis
patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients.
Nephron 1992;61(4):399-403.

Eisele G, Bailie GR, Clement C, Wong E. Erythropoietin in continuous ambulatory
peritoneal dialysis: experience with subcutaneous administration. Perit Dial Int
1992;12(1):34-6.

Eschbach JW. Erythropoietin 1991--an overview. Am J Kidney Dis 1991 Oct;18(4
Suppl 1):3-9.

Eschbach JW, Aquiling T, Haley NR, Fan MH, Blagg CR. The long-term effects of
recombinant human erythropoietin on the cardiovascular system. Clin Nephrol
1992;38 Suppl 1:S98-103.

Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. The safety of epoetin-
alpha: results of clinical trials in the United States. Contrib Nephrol
1991;88:72-80.

Eschbach JW, Haley NR, Egrie JC, Adamson JW. A comparison of the responses to
recombinant human erythropoietin in normal and uremic subjects. Kidney Int 1992
Aug;42(2):407-16.

Evans RW. Recombinant human erythropoietin and the quality of life of end-stage
renal disease patients: a comparative analysis. Am J Kidney Dis 1991 Oct;18(4
Suppl 1):62-70.

Fabris F, Cordiano I, Randi ML, Casonato A, Montini G, Zacchello G, Girolami A.
Effect of human recombinant erythropoietin on bleeding time, platelet number and
function in children with end-stage renal disease maintained by haemodialysis.
Pediatr Nephrol 1991 Mar;5(2):225-8.

Fernandez A, Hortal L, Rodriguez JC, Vega N, Plaza C, Palop L. Anemia in
dialysis: its relation to acquired cystic kidney disease and serum levels of
erythropoietin. Am J Nephrol 1991;11(1):12-5.

Fernandez A, Vega N, Hortal L, Jimenez F, Laraudogoitia E, Macia M, Plaza C,
Perdomo M, Palop L. Could CAPD modulate the hemodynamic changes induced by rHuEPO
treatment? Adv Perit Dial 1992;8:435-9.

Fernandez A, Vega N, Jimenez F, Macia M, Laraudiogoitia E, Hortal L, Perdomo M,
Plaza C, Rodriguez JC, Palop L. Effect of recombinant human erythropoietin
treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis
and hemodialysis patients. Am J Nephrol 1992;12(4):207-11.

Fine RN. Subcutaneous recombinant human erythropoietin treatment of children
undergoing peritoneal dialysis. Contrib Nephrol 1991;89:186-9.

Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
Intraperitoneal administration of recombinant human erythropoietin. Perit Dial
Int 1992;12(4):378-83. Comment in: Perit Dial Int 1992;12(4):350-2.

Fruits RG, Kinney R, Hegeman T. Maintaining iron balance by decreasing blood
loss. ANNA J 1992 Apr;19(2):156

Gallar P, Vigil A, Oliet A, Ortega O, Guijo G. Intraperitoneal erythromycin for
diabetic gastroparesis in CAPD. Perit Dial Int 1992;12(2):265-6.

Glassman E. Oral iron therapy with ferrous fumarate and polysaccharide iron
complex. ANNA J 1992 Jun;19(3):277-8, 323.

Goldberg N, Lundin AP, Delano B, Friedman EA, Stein RA. Changes in left
ventricular size, wall thickness, and function in anemic patients treated with
recombinant human erythropoietin. Am Heart J 1992 Aug;124(2):424-7.

Goldraich I, Goldraich N. Once weekly subcutaneous administration of recombinant
erythropoietin in children treated with CAPD. Adv Perit Dial 1992;8:440-3.

Golper TA. The effect of recombinant erythropoietin on the early hematocrit rise
after CAPD initiation. Perit Dial Int 1992;12(1):37-9.

Granolleras C, Branger B, Shaldon S, Nonnast-Daniel B, Koch KM, Pollok M,
Baldamus CA. Subcutaneous erythropoietin: a comparison of daily and thrice weekly
administration. Contrib Nephrol 1991;88:144-8; discussion 149-51.

Grutzmacher P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kaltwasser J, Kurz
P, Scheuermann EH, Schoeppe W. Effect of recombinant human erythropoietin on iron
balance in maintenance hemodialysis: theoretical considerations, clinical
experience and consequences. Clin Nephrol 1992;38 Suppl 1:S92-7.

Guthrie M, Cardenas D, Eschbach JW, Haley NR, Robertson HT, Evans RW. Effects of
erythropoietin on strength and functional status of patients on hemodialysis.
Clin Nephrol 1993 Feb;39(2):97-102.

Haedersdal C, Mehlsen J, Stenver D, Jeppesen L, Nielsen B, Winther K.
Haemodynamic effects of recombinant erythropoietin in patients on maintenance
haemodialysis. Clin Physiol 1992;12(3):359-60.

Hamzeh Y, Said R. Benefits of recombinant human erythropoietin on the anemia of
chronic renal failure in patients maintained on hemodialysis. Jordan Med J
1991;25(1):25-30, 135.

Harris DC, Chapman JR, Stewart JH, Lawrence S, Roger SD. Low dose erythropoietin
in maintenance haemodialysis: improvement in quality of life and reduction in
true cost of haemodialysis. Aust N Z J Med 1991 Oct;21(5):693-700.

Hase H, Imamura Y, Nakamura R, Inishi Y, Machii K, Yamaguchi T. Effects of rHuEPO
therapy on exercise capacity in hemodialysis patients with coronary artery
disease. Jpn Circ J 1993 Feb;57(2):131-7.

Hegbrant J, Thysell H, Ekman R. Effects of recombinant human erythropoietin on
the plasma levels of vasoactive regulatory peptides in patients on maintenance
hemodialysis. Int J Artif Organs 1991 Jul;14(7):411-6.

Hegbrant J, Thysell H, Ekman R. Erythropoietin treatment and plasma levels of
corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides
in hemodialysis patients. Scand J Urol Nephrol 1992;26(4):393-6.

Hendriks MW, Peters FP, Hooymans PM, Van de Wiel TW, Janknegt D, Janknegt R,
Lohman JJ. Is recormon less painful than Eprex after subcutaneous administration?
Pharm Weekbl Sci 1992;14(2):55-8.

Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, Ichiya Y, Kuwabara
Y, Masuda Y, Fujishima M. CBF and oxygen metabolism in hemodialysis patients:
effects of anemia correction with recombinant human EPO. Am J Physiol 1992
May;262(5 Pt 2):F737-43.

Hisano S, Kaku Y, Ueda K, Onoyama K. Efficacy of once weekly erythropoietin
therapy in children on continuous ambulatory peritoneal dialysis. Acta Paediatr
Jpn 1991 Aug;33(4):450-4.

Hisano S, Kaku Y, Ueda K, Onoyama K. Human erythropoietin in children undergoing
continuous ambulatory peritoneal dialysis. Acta Paediatr Jpn 1992
Feb;34(1):36-41.

Hood VL, Ingraham A. Erythropoietin for chronic ambulatory peritoneal dialysis
patients: once a week can be enough. J Am Soc Nephrol 1992 Apr;2(10):1545-6.

Horina JH, Schmid CR, Roob JM, Winkler HM, Samitz MA, Hammer HF, Pogglitsch H,
Krejs GJ. Bone marrow changes following treatment of renal anemia with
erythropoietin. Kidney Int 1991 Nov;40(5):917-22.

Horl WH. Optimal route of administration of erythropoietin in chronic renal
failure patients: intravenous versus subcutaneous. Acta Haematol 1992;87 Suppl
1:16-9.

Hotta T, Ogawa H, Saito A, Ito A. Iron balance following recombinant human
erythropoietin therapy for anemia associated with chronic renal failure. Int J
Hematol 1991 Jun;54(3):195-200.

Hou S, Orlowski J, Pahl M, Ambrose S, Hussey M, Wong D. Pregnancy in women with
end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis
1993 Jan;21(1):16-22.

Howarth JE, Waters HM, Shanks D, Hyde K, Yin JA, Geary CG, Anastassiades E,
Howarth D, Gokal R. Effects of azathioprine on response of renal anaemia to
subcutaneous recombinant human erythropoietin. J Clin Pathol 1993 Jan;46(1):41-4.

Hughes RT, Smith T, Hesp R, Hulme B, Dukes DC, Bending MB, Pearson J, Raja KB,
Cotes PM, Pippard MJ. Regulation of iron absorption in iron loaded subjects with
end stage renal disease: effects of treatment with recombinant human
erythropoietin and reduction of iron stores. Br J Haematol 1992 Oct;82(2):445-54.

Humphries JE. Anemia of renal failure: use of erythropoietin. Med Clin North Am
1992;76(3):711-25.

Huraib S, al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H. Effect of
recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic
hemodialysis patients. Clin Nephrol 1991 Nov;36(5):252-7.

Icardi A, Paoletti E, Traverso GB, Sarchi C, Cappelli G, Molinelli G. Red cell
membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
Int J Artif Organs 1991 Mar;14(3):147-9.

Ishimitsu T, Tsukada H, Ogawa Y, Numabe A, Yagi S. Genetic predisposition to
hypertension facilitates blood pressure elevation in hemodialysis patients
treated with erythropoietin. Am J Med 1993 Apr;94(4):401-6.

Johnson CA, Rosowski E, Zimmerman SW. A prospective open-label study evaluating
the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients
receiving EPOGEN. Adv Perit Dial 1992;8:444-7.

Jones-Lecointe A, Green PJ, Lee HA. Sub-optimal doses of human recombinant
erythropoietin markedly lower serum ferritin. Clin Lab Haematol 1991;13(3):251-3.

Kamata K, Marumo F, Onoyama K. Hemodynamic mechanism of the elevation in blood
pressure following the improvement of anemia with recombinant human
erythropoietin. Jpn Circ J 1991 Jul;55(7):649-56.

Kampf D, Eckardt KU, Fischer HC, Schmalisch C, Ehmer B, Schostak M.
Pharmacokinetics of recombinant human erythropoietin in dialysis patients after
single and multiple subcutaneous administrations. Nephron 1992;61(4):393-8.

Kirlin L. Epoetin alfa: focus on hematocrit... case management of the anemic
patient. ANNA J 1992 Feb;19(1):66-7.

Klinkmann H, Schmidt R, Wieczorek L, Scigalla P. Adverse events of subcutaneous
recombinant human erythropoietin therapy. Contrib Nephrol 1992;100: 127-38.

Klinkmann H, Wieczorek L, Scigalla P. Adverse events of subcutaneous recombinant
human erythropoietin therapy: results of a controlled multicenter European study.
Artif Organs 1993 Apr;17(4):219-25.

Kokot F, Wiecek A, Schmidt-Gayk H, Marcinkowski W, Nieszporek T, Rudka R,
Trembecki J. Influence of long-term erythropoietin therapy on endocrine
abnormalities in haemodialyzed patients. Przegl Lek 1992;49(1-2):43-9.

Komatsu Y, Ito K. Erythropoietin associated hypertension among pediatric
dialysis patients. Adv Perit Dial 1992;8:448-52.

Korbet SM. Anemia and erythropoietin in hemodialysis and continuous ambulatory
peritoneal dialysis. Kidney Int Suppl 1993 Feb;40:S111-9.

Lai KN, Lui SF, Leung JC, Law E, Nicholls MG. Effect of subcutaneous and
intraperitoneal administration of recombinant human erythropoietin on blood
pressure and vasoactive hormones in patients on continuous ambulatory peritoneal
dialysis. Nephron 1991;57(4):394-400.

Lai KN, Wong KC, Li PK, Lui SF. Use of recombinant erythropoietin in thalassemic
patients on dialysis. Am J Kidney Dis 1992 Mar;19(3):239-45.

Latham D, Geisman J. Case management of the anemic patient. Epoetin alfa: focus
on dialysis efficiency. ANNA J 1991 Dec;18(6):588-9.

Laupacis A, Bargman JM. Erythropoietin: a hormone finds a purpose. J Rheumatol
1992;19(6):1007.

Ledermann SE, Randall M, Knight L, Barratt TM, Dillon MJ, Trompeter RS.
Evaluation of recombinant human erythropoietin (RHEPO) in children under 8 years
with end stage renal failure (ESRF) [abstract]. Pediatr Nephrol 1992;6(5):C171.

Leonard DK. Vascular access thrombosis in epoetin alfa therapy. ANNA J 1991
Aug;18(4):371-6; discussion 377.

Levin NW. Quality of life and hematocrit level. Am J Kidney Dis 1992 Jul;20(1
Supplement 1):16-20.

Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W. Therapy with
recombinant human erythropoietin reduces cardiac size and improves heart function
in chronic hemodialysis patients. Am J Nephrol 1991;11(1):54-60.

Ludlow MK, Yap E. Vascular access thrombosis following human recombinant
erythropoietin (EPO) therapy. ANNA J 1992 Apr;19(2):154.

Lui SF, Law CB, Ting SM, Li P, Lai KN. Once weekly versus twice weekly
subcutaneous administration of recombinant human erythropoietin in patients on
continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 Nov;36(5):246-51.

Lui SF, Wong KC, Li PK, Lai KN. Once weekly versus twice weekly subcutaneous
administration of recombinant human erythropoietin in haemodialysis patients. Am
J Nephrol 1992;12(1-2):55-60.

Lundin AP. Recombinant erythropoietin and chronic renal failure. Hosp Pract (Off
Ed) 1991 Apr 15;26(4):61-9.

Lundin AP, Akerman MJ, Chesler RM, Delano BG, Goldberg N, Stein RA, Friedman EA.
Exercise in hemodialysis patients after treatment with recombinant human
erythropoietin. Nephron 1991;58(3):315-9.

Lye WC, Lee EJ. Subcutaneous recombinant human erythropoietin in patients on
CAPD. Adv Perit Dial 1991;7:285-7.

MacDougall IC, Davies ME, Hallett I, Cochlin DL, Hutton RD, Coles GA, Williams
JD. Coagulation studies and fistula blood flow during erythropoietin therapy in
haemodialysis patients. Nephrol Dial Transplant 1991;6(11):862-7.

MacDougall IC, Hutton RD, Coles GA, Williams JD. The use of erythropoietin in
renal failure. Postgrad Med J 1991 Jan;67(783):9-15.

Marsden JT, Sherwood RA, Hillis A, Peters TJ. Monitoring erythropoietin therapy
for anaemia of chronic renal failure by serum erythropoietin assays. Ann Clin
Biochem 1993 Mar;30(Pt 2):205-6.

Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR.
rHuEPO treatment improves brain and cognitive function of anemic dialysis
patients. Kidney Int 1991 Jan;39(1):155-63.

Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA. Long-term
myocardial effects of correction of anemia with recombinant human erythropoietin
in aged patients on hemodialysis. Am J Kidney Dis 1992 Apr;19(4):353-7.

Mayer G, Cada EM, Watzinger U, Barnas U, Graf H. Hemodynamic effects of partial
correction of chronic anemia by recombinant human erythropoietin in patients on
dialysis. Am J Kidney Dis 1991 Mar;17(3):286-9.

McMahon LP, Dawborn JK. Subjective quality of life assessment in hemodialysis
patients at different levels of hemoglobin following use of recombinant human
erythropoietin. Am J Nephrol 1992;12(3):162-9.

Metra M, Cannella G, La Canna G, Guaini T, Sandrini M, Gaggiotti M, Movilli E,
Dei Cas L. Improvement in exercise capacity after correction of anemia in
patients with end-stage renal failure. Am J Cardiol 1991 Oct 15;68(10):1060-6.

Moinard J, Guenard H. Membrane diffusion of the lungs in patients with chronic
renal failure. Eur Respir J 1993 Feb;6(2):225-30.

Montini G, Zacchello G, Perfumo F, Edefonti A, Bassi S, Cantaluppi A, Sarchi C,
Cazzin M, Ferrari V, Boccazzi A, et al. Pharmacokinetics and hematologic response
to subcutaneous administration of recombinant human erythropoietin in children
undergoing long-term peritoneal dialysis: a multicenter study. J Pediatr 1993
Feb;122(2):297-302.

Moore GE, Bertocci LA, Painter PL. 31P-magnetic resonance spectroscopy assessment
of subnormal oxidative metabolism in skeletal muscle of renal failure patients.
J Clin Invest 1993 Feb;91(2):420-4.

Moreno F, Aracil J, Perez-Garcia R, Valderrabano F. Improvement of the quality
of life (QL) of elderly patients on haemodialysis (HD) treated with
erythropoietin (EPO). Nephrol Dial Transplant 1992;7(7):770-1.

Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H. Effect of erythropoietin in
continuous ambulatory peritoneal dialysis patients: comparison between
intravenous and intraperitoneal administration. Perit Dial Int 1992;12(4):373-7.
Comment in: Perit Dial Int 1992;12(4):350-2.

Navarro M, Alonso A, Avilla JM, Espinosa L. Anemia of chronic renal failure:
treatment with erythropoietin. Child Nephrol Urol 1991;11(3):146-51.

Ng YY, Chow MP, Lyou JY, Hu HY, Yung CH, Fan CD, Huang TP. Resistance to
erythropoietin: immunohemolytic anemia induced by residual formaldehyde in
dialyzers. Am J Kidney Dis 1993 Feb;21(2):213-6.

Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis 1992 Jul;20(1 Suppl
1):21-4.

Nissenson AR, Nimer SD, Wolcott DL. Recombinant human erythropoietin and renal
anemia: molecular biology, clinical efficacy, and nervous system effects. Ann
Intern Med 1991 Mar 1;114(5):402-16. Comment in: Ann Intern Med 1991 Jun
15;114(12):1063.

Norton J, Spiezio R, LaManna L, DeLorme B. Varying heparin requirements in
hemodialysis patients receiving erythropoietin. ANNA J 1992 Aug;19(4):367-72,
408; discussion 409.

Nuwayri-Salti N, Jabre F, Daouk M, Sa'ab G, Salem Z. Hematologic parameters and
iron stores in patients on hemodialysis for chronic renal failure. Clin Nephrol
1992 Aug;38(2):101-4.

Okada K, Takahashi S. Effect of low doses of recombinant human erythropoietin on
the anemia in hemodialyzed patients. Nephron 1991;59(4):689-90.
Ongkingco JR, Ruley EJ, Turner ME. Use of low-dose subcutaneous recombinant human
erythropoietin in end-stage renal disease: experience with children receiving
continuous cycling peritoneal dialysis. Am J Kidney Dis 1991 Oct;18(4):446-50.

Ono K, Hisasue Y. Is folate supplementation necessary in hemodialysis patients
on erythropoietin therapy. Clin Nephrol 1992 Nov;38(5):290-2.

Ono K, Hisasue Y. The rate of increase in hematocrit, humoral vasoactive
substances and blood pressure changes in hemodialysis patients treated with
recombinant human erythropoietin or blood transfusion. Clin Nephrol 1992
Jan;37(1):23-7.

Onoyama K, Hori K, Osato S, Fujishima M. Haemodynamic effect of recombinant human
erythropoietin on hypotensive haemodialysis patients. Nephrol Dial Transplant
1991;6(8):562-5.

Park JS, Kim SB, Park SK, Lim TH, Lee DK, Hong CD. Effect of recombinant human
erythropoietin on muscle energy metabolism in patients with end-stage renal
disease: a 31P-nuclear magnetic resonance spectroscopic study. Am J Kidney Dis
1993 Jun;21(6):612-8.

Pascual J, Teruel JL, Marcen R, Liano F, Moya JL, Jimenez M, Ortuno J.
Hemodynamic and cardiac effects of erythropoietin in patients on regular
dialysis. Int J Artif Organs 1992 Jun;15(6):349-53.

Pascual J, Teruel JL, Marcen R, Liano F, Ortuno J. Blood pressure after three
different forms of correction of anemia in hemodialysis. Int J Artif Organs
1992;15(7):393-6.

Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J. Regression of
left ventricular hypertrophy after partial correction of anemia with
erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol
1991 Jun;35(6):280-7. Comment in: Clin Nephrol 1992 Sep;38(3):174-6.

Piazza V, Villa G, Galli F, Segagni S, Bovio G, Poggio F, Picardi L, Salvadeo A.
Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels
in patients on chronic dialysis. Nephron 1992;61(1):54-7.

Powe NR, Griffiths RI, De Lissovoy G, Anderson GF, Watson AJ, Greer JW, Herbert
RJ, Eggers PW, Milam RA, Whelton PK. Access to recombinant erythropoietin by
Medicare-entitled dialysis patients in the first year after FDA approval. J Am
Med Assoc 1992;268(11):1434-40.

Ramirez B, Flores A, Perez F, Cordoba C, Garcia L, Vazquez G. Human recombinant
erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal
failure (CRF): experience with a group of patients on chronic haemodialysis
treatment. Transplant Proc 1991 Apr;23(2):1833-4.

Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow
fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993 Jan
21;328(3):171-5. Comment in: N Engl J Med 1993 Jan 21;328(3):205-6.

Reddingius RE, Schroder CH, Monnens LA. Intraperitoneal administration of
recombinant human erythropoietin in children on continuous ambulatory peritoneal
dialysis. Eur J Pediatr 1992 Jul;151(7):540-2.

Rees L, Rigden SP, Chantler C. The influence of steroid therapy and recombinant
human erythropoietin on the growth of children with renal disease. Pediatr
Nephrol 1991 Jul;5(4):556-8.

Richmond D, Broyan P, Shea S, Reft C, Poseno M, Gimenez LF. How does rHuEPO
effect D/P creatinine ratios? Adv Perit Dial 1992;8:457-9.

Roger SD, Baker LR, Raine AE. Autonomic dysfunction and the development of
hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
Clin Nephrol 1993 Feb;39(2):103-10.

Roger SD, Harris DC, Stewart JH. Possible relation betweeen restless legs and
anaemia in renal dialysis patients. Lancet 1991;337(8756):1551.

Romero R, Novoa D, Otero S, Alonso MC, Alonso R, Arcocha V, Arza D, Lens XM,
Sanchez-Guisande D. Direct effect of deferoxamine on hemoglobin synthesis in
patients on hemodialysis treated with recombinant human erythropoietin. Nephron
1993;63(2):164-7.

Saldanha LF, Weiler EW, Gonick HC. Effect of continuous ambulatory peritoneal
dialysis on blood pressure control. Am J Kidney Dis 1993 Feb;21(2):184-8.

Saleh A, Krane NK, Caballero M, Starks E. Once weekly subcutaneous erythropoietin
is an effective maintenance therapy in the treatment of anemia of end stage renal
disease in patients on CAPD. Adv Perit Dial 1991;7:288-91.

Sallay P, Reusz G. The use of human recombinant erythropoietin in children on
chronic dialysis. Acta Paediatr Hung 1992;32(4):333-45.

Salvati F, Strippoli P, Barchetti M, Scatizzi A. Effect on hemoglobin F synthesis
by erythropoietin in patients with anemia of end-stage renal disease maintained
by chronic hemodialysis. Nephron 1992;60(3):371.

Samtleben W, Ehmer B, Lutz-Knochenhauer I, Hagmann C, Scigalla P, Gurland HJ.
Side effects during recombinant human erythropoietin therapy in 2,000 ESRD
patients. Contrib Nephrol 1991;88: 107-16; discussion 117.

Schaefer RM, Paczek L, Berthold G, Gilge U, Heidland A. Improved immunoglobulin
production in dialysis patients treated with recombinant erythropoietin. Int J
Artif Organs 1992 Apr;15(4):204-8.

Schaefer RM, Schaefer L, Heidland A. Recombinant human erythropoietin for anaemia
associated with chronic renal failure in predialysis patients. Przegl Lek
1992;49(1-2):41-2.

Schober HC, Winkler R, Schmidt R, Abendroth K, Klinkmann H. Bone histomorphometry
in recombinant human erythropoietin-treated patients on chronic haemodialysis.
Contrib Nephrol 1991;88:127-35.

Schwartz AB, Kahn SB, Kelch B, Kim KE, Pequignot E. RBC improved survival due to
recombinant human erythropoietin explains effectiveness of less frequent, low
dose subcutaneous therapy. Clin Nephrol 1992 Nov;38(5):283-9.

Siems W, Grune T, Hampl H, Wendel G, Gerber G, Riedel E. Changed purine
nucleotide concentrations and enzyme activities in erythrocytes of haemodialysis
patients undergoing erythropoietin therapy. Eur J Clin Chem Clin Biochem 1992
Aug;30(8):455-60.

Siimes MA, Ronnholm KA, Antikainen M, Holmberg C. Factors limiting the
erythropoietin response in rapidly growing infants with congenital nephrosis on
a peritoneal dialysis regimen after nephrectomy. J Pediatr 1992;120(1):44-8.

Singh AB, Singh M, Palekar S, Levy S, Nunn C, Mann RA. The effects of recombinant
human erythropoietin on the cell mediated immune response of renal failure
patients. J Med 1992;23(5):289-302.

Sisk JE, Gianfrancesco FD, Coster JM. Recombinant erythropoietin and Medicare
payment. JAMA 1991 Jul 10;266(2):247-52. Comment in: JAMA 1991 Nov
20;266(19):2705-6.

Sobh MA, Abd el Hamid IA, Atta MG, Refaie AF. Effect of erythropoietin on sexual
potency in chronic haemodialysis patients. A preliminary study. Scand J Urol
Nephrol 1992;26(2):181-5.

Sobh MA, el-Tantawy AE, Said E, Atta MG, Refaie A, Nagati M, Ghoneim M. Effect
of treatment of anaemia with erythropoietin on neuromuscular function in patients
on long term haemodialysis. Scand J Urol Nephrol 1992;26(1):65-9.

Spinowitz BS, Arslanian J, Charytan C, Golden RA, Rascoff J, Galler M. Impact of
epoetin beta on dialyzer clearance and heparin requirements. Am J Kidney Dis 1991
Dec;18(6):668-73.

Standage BA, Schuman ES, Ackerman D, Gross GF, Ragsdale JW. Does the use of
erythropoietin in hemodialysis patients increase dialysis graft thrombosis rates?
Am J Surg 1993 May;165(5):650-4.

Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K.
Effect of the correction of anemia with recombinant human erythropoietin on
growth of children treated with CAPD. Adv Perit Dial 1992;8:460-3.

Stefenelli T, Boszotta A, Kaliman JF, Mayer G, Graf H. Digital vascular
reactivity in patients on haemodialysis treated with human recombinant
erythropoietin. Vasa 1991;20(1):70-3.

Steinberg H, Stead RB. Erythropoietin and visual hallucinations. New Engl J Med
1991;325(4):285.

Steinhauer HB, Lubrich-Birkner I, Dreyling KW, Schollmeyer P. Effect of human
recombinant erythropoietin on anaemia and dialysis efficiency in patients
undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Invest 1991
Feb;21(1):47-52.

Stevens JM, Auer J, Strong CA, Hughes RT, Oliver DO, Winearls CG, Cotes PM.
Stepwise correction of anaemia by subcutaneous administration of human
recombinant erythropoietin in patients with chronic renal failure maintained by
continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant
1991;6(7):487-94.

Strauss MJ, Port FK, Somen C, Wolfe RA. An estimate of the size of the US
predialysis population with renal insufficiency and anemia. Am J Kidney Dis 1993
Mar;21(3):264-9.

Sundal E, Businger J, Kappeler A. Treatment of transfusion-dependent anaemia of
chronic renal failure with recombinant human erythropoietin. A European
multicentre study in 142 patients to define dose regimen and safety profile.
Nephrol Dial Transplant 1991;6(12):955-65.

Sungur C, Sungur A, Arik N, Akpolat T, Arinsoy T, Yasavul O, Turgan C, Caglar S.
Bone marrow involvement in systemic amyloidosis: another mechanism for
erythropoitin resistance. Nephron 1993;63(2):232.

Suwata J, Maeda H, Ohmori N, Ohwa M, Ohtsuka H, Shimoyama H. Recombinant human
erythropoietin therapy and autonomic nervous system. Nephron 1992;61(1):115-6.

Suzuki H, Murakami M, Ichihara A, Saruta T. Alterations in sex hormones and
sexual function of patients with renal failure treated with recombinant human
erythropoietin. Nippon Jinzo Gakkai Shi 1992 Jan;34(1):79-84.

Suzuki Y, Ogura Y, Otsubo O, Mimura N, Takaku F, Maeda T. Changes of enzyme
activity levels in red blood cells in hemodialysis patients by recombinant human
erythropoietin. Nippon Jinzo Gakkai Shi 1992 Sep;34(9):1019-23.

Takahashi K, Totsune K, Imai Y, Sone M, Nozuki M, Murakami O, Sekino H, Mouri T.
Plasma concentrations of immunoreactive-endothelin in patients with chronic renal
failure treated with recombinant human erythropoietin. Clin Sci 1993
Jan;84(1):47-50.

Takayama K, Nagai T, Kinugasa E, Akizawa T, Koshikawa S. Changes in endothelial
vasoactive substances under recombinant human erythropoietin therapy in
hemodialysis patients. ASAIO Trans 1991 Jul-Sep;37(3):M187-8.

Tanaka H, Kan E, Takegaki Y, Inariba H, Yoshimoto M, Ohno Y, Maekawa M, Tatsumi
N, Kishimoto T. Multicenter study with recombinant human erythropoietin. Artif
Organs 1993 Apr;17(4):213-8.

Tang IY, Vrahnos D, Valaitis D, Lau AH. Vascular access thrombosis during
recombinant human erythropoietin therapy. ASAIO J 1992 Jul-Sep;38(3):M528-31.

Taylor JE, Henderson IS, Mactier RA, Stewart WK. Effects of withdrawing
erythropoietin. BMJ 1991 Feb 2;302(6771):272-3. Comment in: BMJ 1991 Feb
2;302(6771):248-9.

Taylor JE, Henderson IS, Stewart WK, Belch JJ. Erythropoietin and spontaneous
platelet aggregation in haemodialysis patients. Lancet 1991 Nov
30;338(8779):1361-2.

Taylor JE, Henderson IS, Stewart WK, Belch JJ. Platelet aggregation in
erythropoietin treated dialysis patients. Platelets 1992;3(1):47-52.

Taylor JE, MacTier RA, Henderson IS, Belch JJ, Stewart WK. Dialysis efficiency
in continuous ambulatory peritoneal dialysis patients treated with
erythropoietin. Perit Dial Int 1992;12(2):221-6.

Temple RM, Langan SJ, Deary IJ, Winney RJ. Recombinant erythropoietin improves
cognitive function in chronic haemodialysis patients. Nephrol Dial Transplant
1992;7(3):240-5.

Teruel JL, Pascual J, Jimenez M, Liano F, Rivera M, Martinez J, Moya JL, Ortuno
J. Hemodynamic changes in hemodialyzed patients during treatment with recombinant
human erythropoietin. Nephron 1991;58(2):135-7.

Tomson CR, Feehally J, Walls J. Crossover comparison of intravenous and
subcutaneous erythropoietin in haemodialysis patients. Nephrol Dial Transplant
1992;7(2):129-32.

Tsai JC, Lai YH, Tsai ZY, Chien LJ, Tsai JH. Clinical efficacy of recombinant
human erythropoietin in the treatment of anemia in hemodialysis patients:
influence of dosing regimen, iron status, and serum aluminum. Kao Hsiung I Hsueh
Ko Hsueh Tsa Chih 1991 Mar;7(3):126-35.

Tsao CJ, Kao RH, Cheng TY, Huang CC, Chang SL, Lee FN. The effect of recombinant
human erythropoietin on hemostatic status in chronic uremic patients. Int J
Hematol 1992 Apr;55(2):197-203.

Turi S, Nemeth I, Varga I, Bodrogi T, Matkovics B. The effect of erythropoietin
on the cellular defence mechanism of red blood cells in children with chronic
renal failure. Pediatr Nephrol 1992 Nov;6(6):536-41.

Urena P, Bonnardeaux A, Eckardt KU, Kurtz A, Drueke TB. Insulin-like growth
factor I: a modulator of erythropoiesis in uraemic patients? Nephrol Dial
Transplant 1992;7(1):40-4.

Valderrabano F, Moreno F, Aracil FJ. A controlled study on the effect of
erythropoietin (EPO) on the quality of life (QL) of elderly hemodialysis patients
[abstract]. J Am Soc Nephrol 1992;3(3):432.

van de Borne P, Tielemans C, Vanherweghem JL, Degaute JP. Effect of recombinant
human erythropoietin therapy on ambulatory blood pressure and heart rate in
chronic haemodialysis patients. Nephrol Dial Transplant 1992;7(1):45-9.

Van Wyck DB. Impact of erythropoietin on the dialysis prescription. Am J Kidney
Dis 1991 Oct;18(4 Suppl 1):71-5.

Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega
R, Palop L. Peritoneal dialysis efficiency in CAPD patients in treatment with
rHuEPO. Adv Perit Dial 1992;8:467-70.

Veys N, Vanholder R, Lameire N. Pain at the injection site of subcutaneously
administered erythropoietin in maintenance hemodialysis patients: a comparison
of two brands of erythropoietin. Am J Nephrol 1992;12(1-2):68-72.

Veys N, Vanholder R, Ringoir S. Correction of deficient phagocytosis during
erythropoietin treatment in maintenance hemodialysis patients. Am J Kidney Dis
1992 Apr;19(4):358-63.

Viron B, Jaar B, Verdy E, Mignon F, Fournier A, El Elsper N, Moriniere P.
Erythropoietin-induced protein S deficiency and vena cava thrombosis. Nephrol
Dial Transplant 1992;7(9):979-80.

Warady BA, Sabath RJ, Smith CA, Alon U, Hellerstein S. Recombinant human
erythropoietin therapy in pediatric patients receiving long-term peritoneal
dialysis. Pediatr Nephrol 1991 Nov;5(6):718-23.

Washio M, Iseki K, Onoyama K, Oh Y, Nakamoto M, Fujimi S, Fujishima M. Elevation
of serum erythropoietin after subtotal parathyroidectomy in chronic haemodialysis
patients. Nephrol Dial Transplant 1992;7(2):121-4.

Watschinger B, Watzinger U, Templ H, Spona J, Graf H, Luger A. Effect of
recombinant human erythropoietin on anterior pituitary function in patients on
chronic hemodialysis. Horm Res 1991;36(1-2):22-6.

Wirtz JJ, van Esser JW, Hamulyak K, Leunissen KM, van Hooff JP. The effects of
recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis
patients. Clin Nephrol 1992 Nov;38(5):277-82.

Wizemann V, Kaufmann J, Kramer W. Effect of erythropoietin on ischemia tolerance
in anemic hemodialysis patients with confirmed coronary artery disease. Nephron
1992;62(2):161-5.

Wizemann V, Schafer R, Kramer W. Follow-up of cardiac changes induced by anemia
compensation in normotensive hemodialysis patients with left-ventricular
hypertrophy. Nephron 1993;64(2):202-6.

Yamakado M, Umezu M, Nagano M, Tagawa H. Mechanisms of hypertension induced by
erythropoietin in patients on hemodialysis. Clin Invest Med 1991 Dec;14(6):623-9.

Yaqoob M, Ahmad R, McClelland P, Shivakumar KA, Sallomi DF, Fahal IH, Roberts NB,
Helliwell T. Resistance to recombinant human erythropoietin due to aluminium
overload and its reversal by low dose desferrioxamine therapy. Postgrad Med J
1993 Feb;69(808):124-8.

Yaqoob M, Morris K, Bell GM, Ahmad R. Suppression of the renin-angiotensin-
aldosterone axis with erythropoietin therapy by a negative feedback loop. Nephrol
Dial Transplant 1992;7(2):125-8.

Zappacosta AR, Perras ST, Bell A. Weekly subcutaneous recombinant human
erythropoietin corrects anemia of progressive renal failure. Am J Med 1991
Sep;91(3):229-32.

Zehnder C, Zuber M, Sulzer M, Meyer B, Straumann E, Jenzer HR, Blumberg A.
Influence of long-term amelioration of anemia and blood pressure control on left
ventricular hypertrophy in hemodialyzed patients. Nephron 1992;61(1):21-5.

Zimmerman SW, Johnson CA. Erythropoietin use in peritoneal dialysis patients. Am
J Kidney Dis 1991 Oct;18(4 Suppl 1):38-41.

Zirkman DM, Zeigler ZR, Fraley DS, Bruns FJ, Adler S. Evaluation of platelet
hyperfunction in hemodialysis patients receiving recombinant human
erythropoietin. Am J Kidney Dis 1993 Jan;21(1):31-7.

Peritonitis

-Clinical Trials

Cheng IK, Chan CY, Wong WT. A randomised prospective comparison of oral ofloxacin
and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial
peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Perit
Dial Int 1991;11(1):27-30.

Ejlersen E, Brandi L, Lukkegaard H, Ladefoged J, Kopp R, Haarh P. Is initial (24
hours) lavage necessary in treatment of CAPD peritonitis? Perit Dial Int
1991;11(1):38-42.

Nakamura Y, Hara Y, Ishida H, Moriwaki K, Shigemoto K. A randomized multicenter
trial to evaluate the effects of UV-Flash system on peritonitis rates in CAPD.
Adv Perit Dial 1992;8:313-5.

Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC. Vaccination for
prevention of CAPD associated staphylococcal infection: results of a prospective
multicentre clinical trial. Clin Nephrol 1991 May;35(5):198-206.

Wale MC, Finch RG, Morgan AG, Burden RP, Holliday A. A prospective randomised
trial of teicoplanin plus aztreonam versus cefuroxime in CAPD peritonitis. Int
J Antimicrob Agents 1992;1 Suppl 1:S7-14.

-Other

Abreo K, Flanagan R, White R, Mccoy R. Catheter-related mycobacterium-fortuitum
infections in CAPD patients [abstract]. J Am Soc Nephrol 1992;3(3):405.

Adair CG, Gorman SP, Mawhinney WM, Mcclurg B. Long-term stability of teicoplanin
in CAPD dialysis fluid implications for the home-treatment of catheter-related
peritonitis [abstract]. Pharmacotherapy 1991;11(3):275.

Adcock A, Fox K, Jones D, Kenny R, Harbison J, Taber T, Bloomfield R. Clinical
experiences with a single use Y bagless CAPD system applying a quick disconnect
clamp for external occlusion. Adv Perit Dial 1991;7:190-2.

Ahijado F, Luno J, Soto I, Gallego E, Junco E, Polo JR, Galan A, Valderrabano F.
Tuberculous peritonitis in patients on CAPD. Contrib Nephrol 1991;89:79-86.

Ahlmen J, Schonborg C. Grading of exit sites cannot predict peritonitis in
patients on CAPD. Adv Perit Dial 1991;7:117-9.

Ahmed S, Rahman M. Complications of intermittent peritoneal dialysis. Bangladesh
Renal J 1991;10(2):57-61.

Allen SM, Matthews HR. Surgical treatment of massive hydrothorax complicating
continuous ambulatory peritoneal dialysis. Clin Nephrol 1991 Dec;36(6):299-301.

Al-Wali W, Baillod R, Brumfitt W, Hamilton-Miller JM. Differing prognostic
significance of reinfection and relapse in CAPD peritonitis. Nephrol Dial
Transplant 1992;7(2):133-6.

Al-Wali W, Baillod RA, Brumfitt W, Hamilton-Miller JM. Teicoplanin in the
treatment of peritonitis in patients receiving continuous ambulatory peritoneal
dialysis: a comparative trial against vancomycin. Int J Antimicrob Agents 1992;1
Suppl 1:S1-6.

Andreoli SP, Langefeld CM, Stadler S, Smith P, Sears A. Risks of peritoneal
membrane failure in children undergoing peritoneal dialysis [abstract]. Pediatr
Res 1992;31(4 Pt 2):328a.

Antonsen S, Pedersen FB, Wang P. Detection of neutrophil granulocytes in
peritoneal dialysis effluents by means of the Cytur-test. Danish Study Group on
Peritonitis in Dialysis (DASPID). Scand J Clin Lab Invest 1991 Apr;51(2):149-54.

Anwar N, Gokal R. Experience with vancomycin, aminoglycosides and newer B-lactam
antibiotics in CAPD peritonitis. Dial Transplant 1993;22(3):134, 136, 138.

Ariza M, Lopez M, Quesada T. Complications of CAPD in children: six years
experience in Caracas, Venezuela. Adv Perit Dial 1991;7:269-71.

Bailie GR, Eisele G. Continuous ambulatory peritoneal dialysis: a review of its
mechanics, advantages, complications, and areas of controversy. Ann Pharmacother
1992 Nov;26(11):1409-20.

Bailie GR, Eisele G, Venezia RA, Yocum D, Hollister A. Prediction of serum
vancomycin concentrations following intraperitoneal loading doses in
continuousambulatory peritoneal dialysis patients with peritonitis. Clin Pharmacokinet
1992;22(4):298-307.

Bailie GR, Rasmussen R, Eisele G, Luscombe DK. Peritonitis rates in CAPD patients
using the UVXD and O-set systems. Ren Fail 1993;15(2):225-30.

Barnish MJ. Peritonitis in patients undergoing continuous ambulatory peritoneal
dialysis. Complications Surg 1992;11(3):42-8.

Beelen RH, Bos HJ, Meyer F, Calame W, van der Meulen J, de Fijter CW, Oe PL. A
single administration of peritoneal dialysis fluid in the rat induces an acute
inflammatory exudate. Adv Perit Dial 1991;7:138-41.

Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of
ten-year trends in infections in adults on continuous ambulatory peritoneal
dialysis (CAPD). Clin Nephrol 1991 Jul;36(1):29-34.

Boeschoten EW, Rietra PJ, Struijk DG, Krediet RT, Arisz L. Changing antimicrobial
resistance in CAPD peritonitis? Contrib Nephrol 1991;89:87-95.

Boeschoten EW, Struijk DG, Krediet RT, Arisz L. Metabolic disturbances in CAPD
patients. Adv Perit Dial 1991;7:243-6.

Bonnardeaux A, Ouimet D, Galarneau A, Falardeau M, Cardinal J, Nolin L, Houde M.
Peritonitis in continuous ambulatory peritoneal dialysis: impact of a compulsory
switch from a standard to a Y-connector system in a single North American Center.
Am J Kidney Dis 1992 Apr;19(4):364-70.

Bowman RA, Medley AS, Karthigasu KT. Limulus amoebocyte lysate assay in the
diagnosis of peritonitis in patients receiving continuous ambulatory peritoneal
dialysis. J Clin Pathol 1992 Jan;45(1):72-4.

Brown AL, Stephenson JR, Baker LR, Tabaqchali S. Epidemiology of CAPD-associated
peritonitis caused by coagulase-negative staphylococci: comparison of strains
isolated from hands, abdominal Tenckhoff catheter exit site and peritoneal fluid.
Nephrol Dial Transplant 1991;6(9):643-8.

Brown AL, Stephenson JR, Baker LR, Tabaqchali S. Recurrent CAPD peritonitis
caused by coagulase-negative staphylococci: re-infection or relapse determined
by clinical criteria and typing methods. J Hosp Infect 1991 Jun;18(2):109-22.

Burkart J, Haigler S, Caruana R, Hylander B. Usefulness of peritoneal fluid
amylase levels in the differential diagnosis of peritonitis in peritoneal
dialysis patients. J Am Soc Nephrol 1991 Apr;1(10):1186-90.

Campbell MA. Using information systems to track peritonitis rates. Nephrol News
Issues 1993 Mar;7(3):18-9.

Chan TM, Lok AS, Cheng IK. Hepatitis C infection among dialysis patients: a
comparison between patients on maintenance haemodialysis and continuous
ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991;6(12):944-7.

Chen WT, Kobayashi Y, Huang TP, Chiu CC, Lin CY. Decreased size of peritoneal
macrophage during peritonitis in continuous ambulatory peritoneal dialysis
patients. Am J Nephrol 1991;11(5):374-9.

Chong TK, Piraino B, Bernardini J. Vestibular toxicity due to gentamicin in
peritoneal dialysis patients. Perit Dial Int 1991;11(2):152-5.

Churchill DN. CAPD peritonitis: a critical appraisal of prophylactic strategies.
Semin Dial 1991 Apr-Jun;4(2):94-100.

Dabbagh S, Fassinger N, Clement K, Fleischmann LE. The effect of aggressive
nutrition on infection rates in patients maintained on peritoneal dialysis. Adv
Perit Dial 1991;7:161-4.

Dadone C, Redaelli B. Branhamella catarrhalis peritonitis in CAPD: an avoidable
complication? Perit Dial Int 1991;11(2):185.

Dasgupta MK, Anwar H, Costerton JW. Bacterial biofilms and peritonitis in
continuous ambulatory peritoneal dialysis. Int Biodeterior Biodegrad 1992;30(2-
3):167-76.

Dasgupta MK, Fox S, Gagnon D, Bettcher K, Ulan RA. Significant reduction of
peritonitis rate by the use of Twin-bag system in a Canadian regional CAPD
program. Adv Perit Dial 1992;8:223-6.

Dasgupta MK, Kowalewska-Grochowska K, Bettcher KB, Tyrrell DL. Stable biofilms
causing recurrent peritonitis and catheter loss in continuous ambulatory
peritoneal dialysis (CAPD) [abstract]. Clin Invest Med 1991;14(4 Suppl):A136.

Dasgupta MK, Kowlaska-Grochowska K, Costerton JW. Biofilm culture of peritoneal
dialysis (PD) effluents as an indicator of treatment failure in peritonitis
[abstract]. J Am Soc Nephrol 1992;3(3):407.

Davenport A, Dealler SF. The epidermo-peritoneal potential in patients treated
with continuous ambulatory peritoneal dialysis. Int J Artif Organs 1993
Feb;16(2):71-4.

de Fijter CW, Verbrugh HA, Oe LP, Peters ED, van der Meulen J, Donker AJ, Verhoef
J. Peritoneal defense in continuous ambulatory versus continuous cyclic
peritoneal dialysis. Kidney Int 1992;42(4):947-50.

Delapenha RA, Padmore D, Williams W. Peritonitis in acute peritoneal dialysis at
the University Hospital of the West Indies (a five-year review). West Indian Med
J 1991 Mar;40(1):29-32.

Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing
peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12(1):14-27.

Domoto DT, Weindel ME, Blalock S, Ballal HS. Efficacy of streptokinase in
resistant, relapsing or recurrent CAPD peritonitis. Adv Perit Dial 1991;7: 173-5.

Dratwa M, Glupczynski Y, Lameire N, Matthys D, Verschraegen G, Vaneechoutte M,
Boelaert J, Schurgers M, Van Landuyt H, Verbeelen D, Lauwers S. Treatment of
gram-negative peritonitis with aztreonam in patients undergoing continuous
ambulatory peritoneal dialysis. Rev Infect Dis 1991;13 Suppl 7:S645-7.

Dryden MS, Ludlam HA, Wing AJ, Phillips I. Active intervention dramatically
reduces CAPD-associated infection. Adv Perit Dial 1991;7:125-8.

Dryden MS, Talsania H, Rodgers J, Bayston R, Phillips I. Serological response to
coagulase-negative staphylococci in patients with peritonitis on continuous
ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1993;12(2):87-92.

Dryden MS, Wing AJ, Phillips I. Low dose intraperitoneal ciprofloxacin for the
treatment of peritonitis in patients receiving continuous ambulatory peritoneal
dialysis (CAPD). J Antimicrob Chemother 1991 Jul;28(1):131-9.

Edward A, Nolph K. Streptococcus peritonitis with urticaria. Perit Dial Int
1992;12(2):214-5.

Eisele G, Bailie GR, Lomaestro B. Relationship between peritonitis and exit site
infections in CAPD. Adv Perit Dial 1992;8:227-9.

Elsey RM, Carson RW, DuBose TD Jr. Pasteurella multocida peritonitis in an HIV-
positive patient on continuous cycling peritoneal dialysis. Am J Nephrol
1991;11(1):61-3.

Faber MD, del Busto R, Cruz C, Mezger E. Response of Weeksella virosa peritonitis
to imipenem/cilastin. Adv Perit Dial 1991;7:133-4.

Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL. Prostaglandin E2 inhibits the
release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from
human macrophages. Immunol Lett 1992 Jan;31(1):85-90.

Fieren MW, van den Bemd GJ, Bonta IL. Peritoneal macrophages from patients on
continuous ambulatory peritoneal dialysis show a differential secretion of
prostanoids and interleukin-1 beta. Prostaglandins Leukot Essent Fatty Acids 1992
Sep;47(1):23-8.

Fieren MW, van den Bemd GJ, Bonta IL, Ben-Efraim S. Peritoneal macrophages from
patients on continuous ambulatory peritoneal dialysis have an increased
capability to release tumour necrosis factor during peritonitis. J Clin Lab
Immunol 1991 Jan;34(1):1-9.

Fox L, Tzamaloukas AH, Murata GH. Metabolic differences between persistent and
routine peritonitis in CAPD. Adv Perit Dial 1992;8:346-50.
Freiman JP, Graham DJ, Reed TG, McGoodwin EB. Chemical peritonitis following the
intraperitoneal administration of vancomycin. Perit Dial Int 1992;12(1):57-60.

Gendeh BS, Said H, Gibb AG, Aziz NS, Zahir ZM. Gentamicin administration via
peritoneal dialysis fluid: the risk of ototoxicity. J Laryngol Otol
1991;105(12):999-1001.

Glancey GR, Cameron JS, Ogg CS. Peritoneal drainage: an important element in host
defence against staphylococcal peritonitis in patients on CAPD. Nephrol Dial
Transplant 1992;7(7):627-31.

Gokal R. Recent perspectives on peritoneal dialysis. Contrib Nephrol
1993;102:98-109.

Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80
years of age. Perit Dial Int 1993;13(2):140-1.

Gorman SP, Mawhinney WM, Adair CG. The influence of catheter surface
microrugosity on the development and persistence of recurrent peritonitis in CAPD
[abstract]. Pharmacotherapy 1991;11(3):267.

Greaves I, Kane K, Richards NT, Elliott TS, Adu D, Michael J. Pigeons and
peritonitis? Nephrol Dial Transplant 1992;7(9):967-9.

Gretz N, Lasserre JJ, Drescher P, Mall K, Strauch M. Experimental CAPD: a rat
model. Contrib Nephrol 1991;89:43-6.

Gulanikar AC, Jindal KK, Hirsch DJ. Is chronic peritoneal dialysis safe in
patients with intra-abdominal prosthetic vascular grafts? Nephrol Dial Transplant
1991;6(3):215-7.

Hart PH, Jones CA, Finlay-Jones JJ. Peritoneal macrophages during peritonitis.
Phenotypic studies. Clin Exp Immunol 1992;88(3):484-91.

Hodde LA, Sandroni S. Emergency department evaluation and management of dialysis
patient complications. J Emerg Med 1992 May-Jun;10(3):317-34.

Holley JL, Bernardini J, Piraino B. A comparison of peritoneal dialysis-related
infections in black and white patients. Perit Dial Int 1993;13(1):45-9.

Holley JL, Bernardini J, Piraino B. Polymicrobial peritonitis in patients on
continuous peritoneal dialysis. Am J Kidney Dis 1992 Feb;19(2):162-6.

Holley JL, Bernardini J, Piraino B. Risk factors for tunnel infections in
continuous peritoneal dialysis. Am J Kidney Dis 1991 Sep;18(3):344-8.

Hollman AS, McMillan MA, Briggs JD, Junor BJ, Morley P. Ultrasound changes in
sclerosing peritonitis following continuous ambulatory peritoneal dialysis. Clin
Radiol 1991 Mar;43(3):176-9.

Honkanen E, Kala AR, Gronhagen-Riska C. Divergent etiologies of CAPD peritonitis
in integrated double bag and traditional systems? Adv Perit Dial 1991;7: 129-32.

Hutchison AJ, Turner K, Gokal R. Effect of long-term therapy with 1.25 mmol/L
calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD. Perit
Dial Int 1992;12(3):321-3.

Jethon FU, Weber-Fursicht I, Steudle V, Guleke R, Kirschner U. Peritonitis
prevention by eliminating the risk factor disconnection. Contrib Nephrol
1991;89:53-8.

Joffe P, Jensen LT. Type I and III procollagens in CAPD: markers of peritoneal
fibrosis. Adv Perit Dial 1991;7:158-60.

Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokin
1992;22(6):434-46.

Kampf D, Borner K, Hain H, Conrad W. Multiple-dose-kinetics of ofloxacin after
intraperitoneal application in CAPD patients. Perit Dial Int 1991;11(4):317-21.

Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M,
Vas S, Verbrugh HA. Peritoneal dialysis-related peritonitis treatment
recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis
Management. International Society for Peritoneal Dialysis. Perit Dial Int
1993;13(1):14-28.

Klaus G, Schafer F, Querfeld U, Soergel M, Wolf S, Mehls O. Treatment of
relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit
Dial 1992;8:302-5.

Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk factors for
peritonitis among an urban CAPD population. Perit Dial Int 1993;13(2):126-31.

Korzets Z, Korzets A, Golan E, Zevin D, Bernheim J. CAPD peritonitis--initial
presentation as an acute abdomen with a clear peritoneal effluent. Clin Nephrol
1992 Mar;37(3):155-7.

Kraus LM, Kraus AP Jr. Tyrosine and N-carbamoyl-tyrosine in end-stage renal
disease during continuous ambulatory peritoneal dialysis. J Lab Clin Med 1991
Dec;118(6):555-62.

Lafleur D, Cordy P, Gallimore B, Adam J. Peritonitis rates for CAPD patients
using the SCD 210 (Inpersol sterile connecting device): a Canadian survey. Adv
Perit Dial 1991;7:196-203.

Lam TY, Vas SI, Oreopoulos DG. Long-term, intraperitoneal vancomycin in the
prevention of recurrent peritonitis during CAPD: preliminary results. Perit Dial
Int 1991;11(3):281-2.

Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD):
aetiology, complications and risk factors. Ann Acad Med Singapore 1992
May;21(3):354-60.

Lewis J, Abbott J, Crompton K, Fowler I, Smith B. CAPD disconnect systems: UK
peritonitis experience. Adv Perit Dial 1992;8:306-12.

Ludlam H, Johnston L, Hopkins P. Susceptibility testing of bacteria recovered
from patients with peritonitis complicating continuous ambulatory peritoneal
dialysis. Antimicrob Agents Chemother 1992 May;36(5):1097-101.

Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis.
J Hosp Infect 1991 Jun;18 Suppl A:341-54.

Ludlam HA, Baker LRI. The prevention of infection associated with continuous
ambulatory peritoneal dialysis. Curr Opin Infect Dis 1991;4(4):541-8.

Luzar MA. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
Nephrologie 1992;13(4):171-7.

Lye WC, Lee EJ, Ang KK. Acinetobacter peritonitis in patients on CAPD:
characteristics and outcome. Adv Perit Dial 1991;7:176-9.

Lye WC, Leong SO, Lee EJ. Methicillin-resistant Staphylococcus aureus nasal
carriage and infections in CAPD. Kidney Int 1993;43(6):1357-62.

MacKenzie RK, Coles GA, Williams JD. The response of human peritoneal macrophages
to stimulation with bacteria isolated from episodes of continuous ambulatory
peritoneal dialysis-related peritonitis. J Infect Dis 1991;163(4):837-42.

Makin AJ, Cartwright KA, Banks RA. Keeping the cat out of the bag: a hazard in
continuous ambulatory peritoneal dialysis. Br Med J 1991;303(6817):1610-1.

Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of alpha 1-
proteinase inhibitor in restraining peritoneal inflammation in CAPD patients.
Kidney Int 1992 Sep;42(3):735-42.

Mawhinney WM, Adair CG, Gorman SP, McClurg B. Stability of vancomycin
hydrochloride in peritoneal dialysis solution. Am J Hosp Pharm 1992;49(1):137-9.

Melita-Manoli H, Vatopoulos A, Toutouza M, Drivas G, Katirtzoglou A. The
significance of slime-producing coagulase-negative staphylococci in CAPD
peritonitis. Clin Nephrol 1993;39(2):111.

Melocoton T, Kuhn M, Foley J, Holloway M, Ingles S, Salusky IB. Infectious
complications in children on CAPD-CCPD: a ten years experience at a single center
[abstract]. J Am Soc Nephrol 1991;2(3):365.

Merchant MR, Anwar N, Were A, Uttley L, Tooth JA, Gokal R. Imipenem versus
netilmicin and vancomycin in the treatment of CAPD peritonitis. Adv Perit Dial
1992;8:234-7.

Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis
associated with continuous ambulatory peritoneal dialysis. Perit Dial Int
1991;11(3):252-60. Comment in: Perit Dial Int 1991;11(3):206.

Murphy G, Tzamaloukas AH, Eisenberg B, Gibel LJ, Avasthi PS. Intraperitoneal
thrombolytic agents in relapsing or persistent peritonitis of patients on
continuous ambulatory peritoneal dialysis. Int J Artif Organs 1991
Feb;14(2):87-91.

Murugasu B, Conley SB, Lemire JM, Portman RJ. Fungal peritonitis in children
treated with peritoneal dialysis and gastrostomy feeding. Pediatr Nephrol 1991
Sep;5(5):620-1.

Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambulatory
peritoneal dialysis--the Auckland experience. Am J Kidney Dis 1992
Nov;20(5):492-6.

Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent
peritonitis in CAPD. Clin Nephrol 1991 Jan;35(1):20-3. Comment in: Clin Nephrol
1991 Oct;36(4):214.

Neiberger R, Aboushaar MH, Tawan M, Fennell R, Iravani A, Richard G. Peritonitis
in children on chronic peritoneal dialysis: analysis at 10 years. Adv Perit Dial
1991;7:272-4.

Nye KJ, Gibson SP, Nwosu AC, Manji MR, Robinson BH, Hawkins JB. Single-dose
intraperitoneal vancomycin and oral ciprofloxacin for the treatment of
peritonitis in CAPD patients: preliminary report. Perit Dial Int
1993;13(1):59-60.

Pasadakis P, Thodis E, Euthimiadou A, Panagoutsos S, Oustoglou E, Kartali S,
Vargemezis V. Treatment of CAPD peritonitis with clavulanate potentiated
ticarcillin. Adv Perit Dial 1992;8:238-41.

Peer G, Serban I, Blum M, Cabili S, Iaina A. Early diagnosis of gram-negative
peritonitis in continuous ambulatory peritoneal dialysis patients with the
Lymulus amebocyte lysate assay. Am J Nephrol 1992;12(1-2):19-21.

Perez-Fontan M, Rodriguez-Carmona A, Fernandez-Rivera C, Moncalian-Leon J.
Aspergillus peritonitis complication continuous ambulatory peritoneal dialysis
[letter]. Nephron 1991;57(4):493-4.

Perez-Fontan M, Rosales M, Fernandez F, Moncalian J, Fernandez-Rivera C, Alonso
A, Valdes F. Ciprofloxacin in the treatment of gram-positive bacterial
peritonitis in patients undergoing CAPD. Perit Dial Int 1991;11(3):233-6.

Phua RT, Winney IR, Ghosh HK. The microbiology of peritonitis in continuous
ambulatory peritoneal dialysis--experience in a provincial centre 1986-1989.
Pathology 1991 Oct;23(4):344-5.

Piraino B, Bernardini J, Centa PK, Johnston JR, Sorkin MI. The effect of body
weight on CAPD related infections and catheter loss. Perit Dial Int
1991;11(1):64-8.

Piraino B, Bernardini J, Holley JL, Perlmutter JA. Increased risk of
Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25
mmol/L calcium. Am J Kidney Dis 1992 Apr;19(4):371-4.

Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and
technique failure by CAPD connection technique: a national study. Kidney Int 1992
Oct;42(4):967-74.

Pylypchuk GB, Conly J, Kappel JE, Stein K, Rennie R. Sensitivity of CAPD/IPD
peritonitis organisms to ciprofloxacin. Adv Perit Dial 1991;7:135-7.

Rubin J, Herrera GA, Collins D. An autopsy study of the peritoneal cavity from
patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991
Jul;18(1):97-102.

Sanyal D, Bhandari S. CAPD peritonitis caused by Lactobacillus rhamnosus
[letter]. J Hosp Infect 1992;22(4):325-7.

Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM. Peritonitis and the
patient with human immunodeficiency virus (HIV). Adv Perit Dial 1992;8:250-2.

Schroder CH, de Jong MC, Monnens LA. Group B streptococcus: an unusual cause of
severe peritonitis in young children treated with continuous ambulatory
peritoneal dialysis. Am J Kidney Dis 1991 Feb;17(2):231-2.

Shelton DM. A comparison of the effects of two antiseptic agents on
Staphylococcus epidermidis colony forming units at the peritoneal dialysis
catheter exit site. Adv Perit Dial 1991;7:120-4.

Shusterman NH, Jacobs J. Management of refractory peritonitis to maintain the
peritoneum for subsequent dialysis. Perit Dial Int 1992;12(2):211-3.

Smith JA. Treatment of intra-abdominal infections with quinolones. Eur J Clin
Microbiol Infect Dis 1991 Apr;10(4):330-3.

Stegmayr BG, Granbom L, Tranaeus A, Wikdahl AM. Reduced risk for peritonitis in
CAPD with the use of a UV connector box. Perit Dial Int 1991;11(2):128-30.

Strauss FG, Holmes DL, Dennis RL, Nortman DF. Pre-spiking dialysate bags:
improved peritonitis prevention in patients on CAPD. Adv Perit Dial 1991;7:193-5.

Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and
removal in refractory peritoneal dialysis infections. Kidney Int 1991
Dec;40(6):1160-5.

Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus
aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 1991
Dec;2(6):1085-91.

Taber TE, Hegeman TF, York SM, Kinney RA, Webb DH. Treatment of Pseudomonas
infections in peritoneal dialysis patients. Perit Dial Int 1991;11(3):213-6.

Tan HW, Kon SP, Chua CT, Ngeow NF. Oral pefloxacin in the treatment of CAPD
peritonitis. Med J Malaysia 1992 Jun;47(2):128-33.

Thomas CA, Interwies EW, Ziegler BL, Vlachojanis J, Kurz P, Shah PM. Bactericidal
activity of human peritoneal macrophages from patients undergoing peritoneal
dialysis. Nat Immun Cell Growth Regul 1991;10(1):12-8.

Valdez JM, Asperilla MO, Smego RA Jr. Acinetobacter peritonitis in patients
receiving continuous ambulatory peritoneal dialysis. South Med J 1991
May;84(5):607-10.

van der Hulst RJ, Boeschoten EW, Nielsen FW, Struijk DG, Dreschler WD, Tange RA.
Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal
dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol
Relat Spec 1991;53(1):19-22.

Verrina E, Edefonti A, Bassi S, Perfumo F, Zacchello G, Andreetta B, Caringella
D, Lavoratti G, Picca M, Rinaldi S, et al. Peritonitis in children undergoing
chronic peritoneal dialysis (CPD): data from the Italian Registry of Pediatric
CPD. Adv Perit Dial 1992;8:419-22.

Viglino G, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Lupo A, Salomone M,
Segoloni GP, Giangrande A. The impact of peritonitis on CAPD results. Adv Perit
Dial 1992;8:269-75.

von Graevenitz A, Amsterdam D. Microbiological aspects of peritonitis associated
with continuous ambulatory peritoneal dialysis. Clin Microbiol Rev 1992
Jan;5(1):36-48.

Wadhwa NK, Cabralda T, Suh H, Kvilekval K, Mason R. Exit-site/tunnel infection
and catheter outcome in peritoneal dialysis patients. Adv Perit Dial 1992;8:
325-7.

Waite NM, Johnson MD, Webster NR, Fong IW. Poor response to oral ciprofloxacin
in the treatment of peritonitis in patients on intermittent peritoneal dialysis.
Perit Dial Int 1993;13(1):50-4.

Wang T, Ye R, Li H. Treatment of resistant peritonitis by temporary
discontinuation of peritoneal dialysis [abstract]. J Am Soc Nephrol
1992;3(3):420.

Weber J, Kuhlmann U. Intraperitoneal cefazolin and gentamicin in the management
of CAPD-related peritonitis. Contrib Nephrol 1991;89:108-18.

Were AJ, Marsden A, Tooth A, Ramsden R, Mistry CD, Gokal R. Netilmycin and
vancomycin in the treatment of peritonitis in CAPD patients. Clin Nephrol 1992
Apr;37(4):209-13.

Wilcox MH, Finch RG, Burden RP, Morgan AG. Peritonitis complicating continuous
ambulatory peritoneal dialysis in Nottingham 1983-1988. J Med Microbiol
1991;34(3):137-41.

Wilcox MH, Geary I, Spencer RC. In-vitro activity of imipenem, in comparison with
cefuroxime and ciprofloxacin, against coagulase-negative staphylococci in broth
and peritoneal dialysis fluid. J Antimicrob Chemother 1992 Jan;29(1):49-55.

Wilcox MH, Williams P, Smith DG, Modun B, Finch RG, Denyer SP. Variation in the
expression of cell envelope proteins of coagulase-negative staphylococci cultured
under iron-restricted conditions in human peritoneal dialysate. J Gen Microbiol
1991 Nov;137(Pt 11):2561-70.

Williams JD, Coles GA. Gram-positive infections related to CAPD. J Antimicrob
Chemother 1991 Apr;27 Suppl B:31-5.

Williams JD, Dharmasena D, Coles GA, Harding I. Short course antimicrobial
therapy in CAPD-related peritonitis. Int J Antimicrob Agents 1992;1 Suppl 1:
S21-4.

Winchester JF, Rotellar C, Rakowski TA, Argy WP, Schreiner GE. Assist devices
used in the prevention of peritonitis in the USA. Contrib Nephrol 1991;89: 74-8.

Wood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC. Campylobacter peritonitis
in continuous ambulatory peritoneal dialysis: report of eight cases and a review
of the literature. Am J Kidney Dis 1992 Mar;19(3):257-63.

Yuen KY, Seto WH, Ching TY, Cheung WC, Kwok Y, Chu YB. An outbreak of Candida
tropicalis peritonitis in patients on intermittent peritoneal dialysis. J Hosp
Infect 1992;22(1):65-72.

Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis
in patients on continuous ambulatory peritoneal dialysis: six years' experience.
Am J Kidney Dis 1991 Jan;17(1):43-6. Published erratum appears in Am J Kidney Dis
1991 Jun;17(6):726.

Zimmerman SW, Oxton L, Roecker E, Wakeen M, Johnson CA. Risk factors for
peritoneal dialysis (PD) related infections [abstract]. J Am Soc Nephrol
1991;2(3):371.